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SUMMARY  
      Milling is commonly used in pharmaceutical secondary manufacturing for reducing 
particle size of crystalline active pharmaceutical ingredients (APIs) as it is difficult to 
achieve a narrow particle size distribution via crystallization alone. However, milling leads 
to generation of thermodynamically unstable amorphous regions on particle surfaces which 
undergo re-crystallization on storage of pharmaceutical drug products. This reversion affects 
physicochemical properties of APIs such as solubility, physical stability, flow properties and 
aerosolization behavior eventually affecting performance of the drug product. Literature 
reports the use of co-milling in effectively improving solubility and physical stability of 
various APIs. This research explores new approach of co-milling. 
In the first part, co-milling with crystalline excipients, lactose, adipic acid and 
magnesium stearate, reduced the amorphization of salbutamol sulphate. These excipients 
acted as seed crystals to induce re-crystallization of amorphous salbutamol sulphate formed 
by milling. During co-milling, both salbutamol sulphate and lactose became predominantly 
amorphous after 45 min but re-crystallized after 60 min. The use of crystalline excipients 
mitigated the amorphous content of an API to below detection limits. The results provide a 
new dimension to the potential application of co-milling in handling the challenges of the 
unstable amorphous state of milled APIs and possibly other materials.  
In the second part, studies on co-milling with use of an amorphous excipient polyvinyl 
pyrrolidone were conducted. Probable hydrogen bond interaction between salbutamol 
sulphate and polyvinyl pyrrolidone by infrared spectroscopic analysis and homogeneous 
distribution of salbutamol sulphate and polyvinyl pyrrolidone by Raman microscopy 
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analysis suggested formation of a stable amorphous molecular dispersion of salbutamol 
sulphate with a minimum of 80% polyvinyl pyrrolidone content on storage for a period of 7 
days under accelerated stability conditions (22°C/75% RH). It demonstrates that a stable and 
homogenous amorphous dispersion of API can be obtained with the addition of sufficient 
amorphous excipient. 
 In the third part, stabilization of the milled amorphous form of clarithromycin, a poorly 
soluble antibiotic, with Eudragit EPO and co-povidone (Kollidon VA64) polymers was 
investigated. Milled clarithromycin is partially amorphous, unstable and re-crystallizes 
under accelerated storage conditions (40°C/82% RH) within 7 days. Results showed that 
only co-milled mixtures with Eudragit EPO remained stable for a period of 90 days under 
accelerated storage conditions of 40°C and 75% RH. Infrared spectroscopic analysis and 
differential scanning calorimeter studies with co-milled mixtures containing EPO indicated 
that the drug-polymer ionic interactions produced stable amorphous form of API on co-
milling and for subsequent storage. 
In the last part, the potential of stable amorphous co-milled mixtures in reducing 
triboelectrification of clarithromycin was explored. Stable co-milled mixtures of 
clarithromycin containing Eudragit EPO showed a reduction in surface electrostatic charge 
in comparison to milled clarithromycin. An increase in surface basicity studied using 
inverse gas chromatography correlated to surface electrostatic charge in milled and co-
milled clarithromycin samples. In comparison, crystalline co-milled mixtures of Ibuprofen 
with magnesium stearate charged to a greater propensity in comparison to physical 
mixtures. In addition, Ibuprofen-colloidal SiO2 co-milled and physical mixtures showed an 
increase in electrostatic chargeability. The study showed that stable amorphous co-milled 
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mixtures with suitable additives were more effective in minimizing the surface electrostatic 
charge than co-milling with additives which do not alter the crystalline surfaces of charged 
APIs. 
These findings may contribute to the fields of formulation science and manufacturing of 
pharmaceutical, food, chemical and other products where size reduction of the ingredients 
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1.1 Particle Science and Technology 
The interest in particle technology began in the period of post second world war. The 
particle products due to their high surface to volume ratios were found to have 
applications in the areas of reaction, coating, solubility and dispersion. In comparison to 
other solid forms, preparation of particle products involving processes such as drying, 
separating, mixing, moving, storing and packaging appeared to be simpler. Particles can 
be found everywhere in the form of rainbows, sunsets and in earth’s crust contributing to 
progress in agriculture. The initial impact of particle science and technology was seen in 
the mining industry as it governed the national and economic resource development. The 
fundamentals of particle technology in its mechanical engineering aspects involving 
physics and mathematics was studied by a group headed by Hans Rumpf in the 1950s 
(Davies, 2001). Rumpf and his co-workers showed that a change in the size of the 
particle affects both the single and bulk particle systems. The change can be either 
advantageous or detrimental. A set of unique material properties can be achieved as the 
particle size is reduced especially when it reaches micro and nano levels. This led to the 
emergence of particle engineering techniques such as submicron particle synthesis 
employed extensively by manufacturers of pigments, inks, colloidal silicas, silver halides 
etc. (Davies, 2001). In industry as well as academia, particle size and technology is 
structured on a unit operation basis namely Reaction Engineering, Crystallization, 
Precipitation, Comminution, Solid/Liquid, Solid/Gas separation, Coating, Drying, Solids 
Transport etc. These operations are generally viewed as independent entities. Integration 
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of these processes is essential so that the throughput, capacity, first-pass quality of the 
production processes can be optimized. In particular, the process of comminution has 
been widely employed in the last fifty years. In the early days, comminution research was 
mainly centered in the area of mining. Comminution is a generic term for particle size 
reduction and these terms, such as grinding, disintegration, pulverization, milling and 
dispersion, have also been used synonymously (Parrott, 1974). Comminution is a part of 
the science of mechanochemistry, which encompasses physico-chemical transformations 
and chemical reactions affecting substances on application of mechanical energy 
(Tkáčov, 1993). Mechanochemistry was earlier inclined to processing of raw minerals, 
mineral fertilizers and functional ceramics. The ball milling production of nickel and iron 
based super-alloys, an improbable task achieved by the conventional melting and casting 
processes, facilitated the entry of mechanochemistry into the field of material science. 
(Suryanarayana, 1999). Then Japanese researchers in the area of mechanical alloying 
further established mechanochemistry followed by development of interest for 
pharmaceutical industrial applications (Boldyrev, 2004). With adoption of high abrasion 
resistant materials as grinding media, the pharmaceutical industry filed patents for a 
range of applications and innovations. (Lovrecich, 1995; Dobetti and Bresciani, 2003).   
1.2 Milling  
In pharmacy, the appropriateness of applying size reduction is determined by the 
improvement of the clinical efficacy of the dosage form and the characteristics of the 
intermediates which facilitate the production process rather than the cost of the milling 
operation (Parrott, 1974). The role of particle size is significant in defining drug delivery 
and bioavailability for an increasing range of pharmaceutical applications. This 
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formulation aspect affects performance of a pharmaceutical product. It governs for 
instance, sedimentation and flocculation rates in suspensions, therapeutic effect of dry 
powder inhalers (DPIs) and good powder homogeneity in tablets (Chikhalia et al., 2006; 
Mackin et al., 2002a; Mackin et al., 2002b; Begat et al., 2003). Thus, the aim of milling is 
to achieve particle size reduction by maximizing the specific surface of the ground 
material and obtaining adequate mixing with minimum energy expenditure in the shortest 
time possible (Colombo et al., 2009). To achieve the required particle size and size 
distribution for the desired application, different milling machines were developed and 
used. The milling machines are divided into 1) ball mills, 2) shear action mills, and shock 
action mills depending on the mode of energy transfer to the material to be ground or 
milled (Boldyrev and Tkáčová, 2000; Boldyrev, 1993). The milling mechanism, 
advantages and disadvantages along with reported use in API milling of different mills 
are summarized in Table 1.1. A schematic representation of each type of mill is shown in 
Fig. 1.1. 
1.2.1 Wet and Cryomilling   
In addition to the above classification, milling of thermolabile, metastable or volatile 
materials can be carried out by the process of wet milling. The process is found to be 
more efficient with the addition of liquid such as water (Barnett and James, 1962). For 
wet milling, a slower mill speed is used than that in dry milling to prevent the mass from 
being carried around the mill. The use of wetting agents and electrolytes have been found 
to increase the efficiency of milling and also aid in providing physical stability to the  
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Table 1.1 Mechanism of milling, advantages and disadvantages of mills used for API milling 
Type of Mill Milling mechanism Advantages Disadvantages  API  
A. Ball mills 


















Friction between grinding ball  
and mill wall breaking particles 
 by impaction 






mechanism provides vibrational 
energy for size reduction  
(Colombo et al., 2009) 
 
 
Size reduction facilitated by high 
energy impaction of balls against 






Impact between balls, ball and drum 
wall, interparticle collisions provide 
mechanical energy for size 
reduction 
(Colombo et al., 2009)  
 
Ultrafine grinding, Mechanical 
activation (Tkáčová, 1989). 
Batch size of feed: 4 - 250g. 
Suitable for production of large 




Less compaction and finer grinding 
(Krycer and Hersey, 1980) as 
compared to planetary ball mill. 
Suitable for grinding and mechanical 
activation in pilot-plant and 
industries (Tkáčová, 1989) 
 
High energy milling commonly 








Batch size of feed (0.5-100kg) 
Suitable for production of large 
quantities of milled powders 
Used in laboratories and industries  
(Suryanarayana, 2001)  
 
Temperature rise upto 
220°C during milling, 
Time taken to reach 
similar particle size is  




Temperature rise upto 
100°C during milling, 
(Suryanarayana, 2001). 
Feed particle size ≤  60 
mesh (Parrott, 1974). 
 
 
Temperature rise upto 
300°C during milling. 
Batch size of feed  






Temperature rise upto 









teroneacetate (MPA)  
(Carli et al., 1987) 
 
Indomethacin  
(Watanabe et al., 2003),  
Glisentide (Mura et al., 
2002), Drug X 




(Magarotto et al., 2001) 
Cefixime trihydrate 
(Kitamura et al., 
1989), Nifedipine 
(Sugimoto et al., 
1998), Sulfathiazole 
(Boldyrev et al., 2005) 
 
Fenofibrate  
(Mochalin et al., 2009) 
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Table 1.1 Mechanism of milling, advantages and disadvantages of mills used for API milling (continued)
Type of Mill  Mechanism of milling  Advantages Disadvantages  API  
B. Shear action mills 
 






C. Shock action mills 
 





2. High peripheral 






D. Cryomills  
 
 
Gravity feeding of mill charge 
into a multiple grinding sections 
having vertically stacked pair of 
rollers. Size reduction occurs by 
induced stress or shear action 
between rollers 




collisions  influenced by a carrier 
fluid (generally compressed air) 
(Colombo et al., 2009) 
 
 
The particles are centrally fed in 
which they collide with each 
other and with pin breakers due to 
movement of counter-rotating 
rotors carrying pin breakers. 
(Colombo et al., 2009) 
 
Cryogenic milling using liquid 
nitrogen (< 196°C) resulting into 
brittle nature of material 
(Colombo et al., 2009) 
Generation of fewer fines as 
compared to ball mill, low 
temperature rise, low energy 






Size reduction upto sub-micron  
(< 1µm) particle sizes. Can be 
operated under sterile air, inert 
gas as carrier for susceptible 
compounds. (Parrott, 1974) 
 
Size reduction upto 1µm 
particle size.  Power 
consumption is lower than jet 
mill. Commonly employed in 
manufacture of APIs (Telko 
and Hickey, 2005). 
 
Ideal for thermolabile, volatile, 
low melting materials (Parrott, 
1974). Hindrance of occurrence 
of undesirable chemical 
reactions (Ye and Schnoeung, 
2004), reduction in aggregation 
behavior (Shakhtshneider and 
Boldyrev, 1999) 
Limited to friable, easily 
broken under low shear 







Handling problems due to 
packing and 
agglomeration of fine 
particles (Parrott, 1974) 
 
 
Low capacity and high 







feasible due to cost of 
liquid nitrogen. Milling 
time is dependent on 
replacement or 
continuous supply of 
liquid nitrogen. 
(Colombo et al., 2009) 
Griseofulvin 









et al., 1994), 
Fusafungine (Giry et 
al., 2006),  
 
 
Aspirin (Heng et al., 
2001), Ethenzamide 












(Feng et al., 2009)  
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Figure 1.1 Illustrative representations of different mills a) Planetary ball mill (reproduced from Telko and Hickey, 2005); b) 
Vibrational ball mill (reproduced from Kobayashi et al., 2004); c) Spex mill (reproduced from Suryanarayana, 2001); d) Attritors 
(reproduced from Suryanarayana, 2001); e) Roller mill (reproduced from Will, 2010); f) Jet mill (reproduced from Midoux et al., 
1999); g) Pin mill (reproduced from Telko and Hickey, 2005); h) Cryomill (reproduced from www.retsch.com/milling/mixer mills) 
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product by reducing the electrostatic forces and preventing rewelding of cracks and 
particles. The process also improves the efficiency of milling and achieves submicron 
particle size (Parrott, 1974). Wet milling can be carried out in presence of cryogenic 
media such as liquid nitrogen at cryogenic temperatures. The milling process is termed as 
cryomilling. The milling mechanism, its advantages and disadvantages along with the 
reported use of cryomill for milling of APIs are summarized in Table 1.1. Different 
models of cryogenic ball mills are available. The most common is the Spex Model which 
has stainless steel vessels consisting of stainless steel rods. These rods vibrate by means 
of a magnetic coil. The vessels are immersed in liquid nitrogen before milling (Crowley 
and Zografi, 2002; Lolo et al., 2007). Another ball mill which could be operated under 
continuous flow of liquid nitrogen has been developed by Retsch
®
 cryomill (Pommerin, 
et al., 2010). The mill is similar to Retsch
®
 mixer mill MM 301. Its stainless steel jars are 
present in a chamber which has a continuous supply by liquid nitrogen and the mill can 
be operated for a continuous time period depending on the quantity of liquid nitrogen 
(Fig. 1h).  
1.3 Theory of Milling  
  The amount of energy expenditure involved in the process of milling is 
dependent on the type of mill involved which eventually causes the fracture of the solid. 
This behavior of the solids under stress can be best understood by the stress-strain curve 
where the initial linear portion of the curve obey’s Hooke’s law (Fig. 1.2). The Hooke’s 
law defines a linear relationship between stress and strain and the Young’s modulus 
(which expresses the softness of material in dynes/cm
2
).  The further application of stress 
results into a non-linear curve which is indicated by the yield point. This yield point is the 
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measure of material resistance to a permanent or plastic deformation. An increase in 
stress beyond this point results into a region of irreversible plastic deformation. The 
adherence to this stress-strain relationship is dependent on the characteristics of the solid 
material. In general, metals show a reversible stress-strain curve relationship in the elastic 
region before the yield point, while in case of polymeric materials, the release and 
subsequent application of the force results in an elastic hysteresis loop in the stress-strain 
curve. This behavior of polymeric materials has been attributed to the dissipation of 

















Figure 1.2 Stress-strain behavior, with the area under the curve representing the energy 
required to fracture the solid (reproduced from Parrott, 1974). 
 
1.3.1 Griffith Theory  
The permanent deformation as described in the section 1.3 involves the release of 
energy which causes the material to fracture. As the force or the stress exceeds the elastic 
limit or the yield point, the material fractures. The fracturing of material results in the 
formation of new surfaces which are dependent on the characteristics of the material. A 
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crystalline material normally fractures along its cleavage planes while materials which 
are not highly crystalline may show a random behavior. These cracks form even before 
the strain has reached equilibrium if the impact stress is rapidly applied. Most of the 
common pharmaceutical ingredients are crystalline in nature. Although being crystalline 
or pure substances, they still have internal weaknesses or microscopic cracks or flaws 
(Parrott, 1974) which play an important role in the expenditure of energy needed to 
fracture the material especially in the process of milling. The role of microscopic cracks 
or flaws was explained by an English aeronautical engineer, A.A. Griffith (Tkáčová, 
1989; Tipper, 1962). He assumed that for brittle materials there are microscopic cracks of 
elliptical nature in the material which reduces mechanical resistance. The theory 
contradicted the dependence of strength of the material on the Young’s modulus of the 
material, where for an ideally brittle material fracture or breakdown, the energy required 
should equate to the surface energy completing the formation of two newly formed 
surfaces (Tkáčová, 1989; Tipper, 1962). The rupturing of the material is based on the 
following equation (Colombo et al., 2009).         
                                                                                                (1.1)                                                                                                                                    
Where, σs is the applied stress, E is the Young’s Modulus, γSV is the surface energy and a 
is the distance separating two consecutive crystalline planes. Griffith postulated that the 
applied stress is concentrated at the tip of the microscopic cracks present in the material 
(Colombo et al., 2009). The fracture of the material is then governed by both the surface 
energy and the strain energy which is released as the crack propagates. The crack thus 
propagates enough to fracture when the increase in surface energy is equal to the loss of 
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strain energy. The strain energy in turn is proportional to the square of the crack length 
(Tkáčová, 1989; Tipper, 1962). Based on Griffith theory, the crack propagation implies 
an increase in the system energy; it then may not produce brittle fracture. Eq.1.1 was 
further improved as  
    
 Plane stress    =        
                                                                                                                       (1.2) 
 
 Plane strain    =   
 
 
Where, µ is the Poisson modulus, c is the half length of crack major axis. Pharmaceutical 
crystals may not be ideally brittle, however, if the surface energy is replaced by effective 
surface energy (γsve) which includes surface energy (γsv) and energy needed for plastic 
deformation (γpl) then Eq.1.2 yields a satisfactory agreement with the experimental data. 
The factors influencing the effective surface energy are external factors such as mode and 
magnitude of applied stress, rate of shear, temperature and internal factors such as 
particle size, concentration of the impurity, material structure (Tkáčová, 1989).  
1.3.2 Thermodynamics  
The purpose of milling is basically to form cracks which propagate through the 
material and cause fracture resulting in the formation of new surfaces. This process 
involves a definite role of thermodynamics in which work in the form of surface energy 
is utilized to fracture the particles (Zeleny and Piret, 1962). Other factors such as rate of 
strain and temperature (Boozer et al., 1963) have been found to have a definite impact on 
the efficiency of the milling process. Number of researchers has attempted to correlate 
the energy to the size of the milled material. Von Rittinger in 1867 (Parrott, 1974) 
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proposed using Eq.1.3 where the energy (Er) needed for particle size reduction directly 
correlated with the increase in surface area.  
    Er = K1(S1- S2)                                                                                         (1.3) 
Where, K1 is a term which includes the relationship between the particle surface and 
diameter, While S1 and S2 are the specific surfaces before and after milling. These 
surfaces were further related to particle diameter using Eq.1.4: 
           Er = C(1/D2 – 1/ D1)                                                                                (1.4) 
Where, D1 and D2 correspond to diameters before and after milling respectively. The 
term C is the reciprocal efficiency constant. It has been further derived as C= Krfc and has 
found applications in the field of engineering. Kr is known as Rittinger’s constant while fc 
represents the crushing strength of the material. Rittinger’s relationship has been found to 
be applicable in fine grinding (Walker and Shaw, 1954). A similar relationship (Eq.1.5) 
was also proposed by Kick in 1885 (Parrott, 1974). He proposed a direct relationship 
between the energy expended for size reduction (Ee) to the diameter reduction ratio 
(D1/D2). The proposal was developed on a stress-strain relationship for cubes under 
compression. The energy term relates to the energy expended for elastic deformation 
before the fracture occurs. The relationship is applicable for coarse grinding (Walker and 
Shaw, 1954). 
            Ee= Cln (D1/ D2)                                                                                       (1.5) 
A relationship (Eq.1.6) between energy and the diameter of the milled material was also 
proposed by Bond in 1952 (Parrott, 1974). He proposed a mathematical expression where 
the energy required for the milling process was inversely related to the square root of the 
diameter of the milled material.  
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  Er= 2C(1/√D2 - 1/√D1)                                                                 (1.6) 
The energy was further expressed in terms of work index Wi, which was defined as the 
amount of energy needed to reduce the unit mass of the material from theoretically 
infinite particle size to the size, such that 80% of the particles can pass through a 100-µm 
sieve. The work index could be quantified using Eq. 1.7: 
                         Wi = (W √D2/100) (√D1/ D2/√ D1/ D2 -1)                                 (1.7) 
Where, W is the work input. Wi is not constant and varied with reference to the shifts in 
the particle size distribution and structural characteristics of the material. This method 
has been to be used to compare efficiency of the milling operation. The value of work 
index is useful under conditions of the final operation. The dry grind work index was 
found to be 1.3 times the wet grind index.    
1.4 Pharmaceutical Applications and Limitations  
 The development of solid dosage forms requires an accurate control on powder 
granulometry characteristics for optimized drug release and performance. As a result, 
processes like mechanical milling or micronization forms an integral part of 
pharmaceutical secondary manufacturing (Chikhalia et al., 2006; Mackin et al., 2002a; 
Begat et al., 2003) as they allow controlled reduction of the particle size. The following 
section discusses the reported pharmaceutical applications of milling. 
1.4.1 Achieving Desired Particle Size 
             Solution crystallization is normally used for crystallization of pharmaceutical 
actives. However particle size or shape control is difficult (Chikhalia et al., 2006) and 
hence milling is used to obtain the desired particle size range. The process aids in 
achieving a lower product strength resulting in better dose control and reduction of side 
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effects. The modifications via milling could further aid in increasing specific surface area 
with formation of interparticular bonds easing the compression of tablets (De Gusseme et 
al., 2008). Effectiveness and product injectability of procaine penicillin G intramuscular 
suspensions improved on micronization (Ober et al., 1958). Xemilofiban, an 
antithrombotic drug forms agglomerates during processing and hence is milled to achieve 
the required particle size specifications (Mackin et al., 2002a). Milling to an optimal 
particle size facilitates extraction of animal glands and crude vegetable drugs (Parrott, 
1974). Removal of occluded solvent on drying of some pharmaceutical solids followed 
by micronization increased their stability (Garret et al., 1959). In tablet manufacturing, 
milling has been found to be effective in facilitating drying of wet masses after 
granulation process by increasing the surface and reducing the distance for the solvent to 
travel to the outer surface (Cooper and Rees, 1972). Air jet milling is one of the 
commonly used equipment for the manufacture of metered dose inhalers (MDIs) and 
DPIs. LiCalsi and research team (2001) found that use of jet milling was able to obtain 
fine particle of measles vaccine which could be further formulated into powder aerosol 
system for the purpose of immunization. The milling process did not induce major 
physical changes while ensuring the standard dose content and viral potency were 
retained. Steckel and co-workers (2006) have also compared the use of milled and 
fractionated lactoses with sieved lactose for the preparation of DPIs. Use of milled and 
fractionated lactoses led to an improvement in aerosolization behaviour. The effect was 
attributed to the fine material produced during milling, adhering to the surfaces of the 
larger crystals hindering the drug being attached to the surface clefts of the lactose 
crystals. Ticehurst and co-workers (2000) in their study on micronized revatropate 
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hydrochloride found that optimization of micronization energy of jet milling could help 
to achieve a respirable fraction of the drug (< 5µm) with less than 1 wt% amorphous 
content. The micronized drug was found to be physically stable and thus could be 
delivered in a suspension-MDIs or DPIs. 
1.4.2 Improvement in Solubility 
Particle size reduction via milling normally leads to an increase rate of solubility 
having a positive influence on drug bioavailability (De Gusseme et al., 2008). When 
milling crystalline APIs, the mechanical stress inherent to the process often produces 
structural changes on the crystal (Feng et al., 2008). Milling is often accompanied by a 
disorder in the crystalline structure leading to the formation of amorphous regions, 
particularly at the surface. The highly soluble amorphous state has an increased surface 
area, solubility, dissolution rate and better compression characteristics (Vogt et al., 2008; 
Yu, 2001). The amorphous form is desirable as it helps to improve the water solubility of 
NCEs under development. Low water solubility and poor oral bioavailability affect the 
inherent efficacy of the NCEs (Vasconcelos et al., 2007). Particle size influences 
dissolution rate of the drug, hence milling is carried out to reduce particle size to 
micrometer levels. This leads to an increase in dissolution rate with higher oral 
bioavailability for a number of poorly soluble drugs including progesterone (Hargrove et 
al., 1989), nitrofurantoin (Watari et al., 1983), estradiol and estrone (Englund and 
Johansson, 1981), oxfendazole (Shastri et al., 1980), and proquazone (Nimmerfall and 
Rosenthaler, 1980). Kondo and team (1993) found that the bioavailability of HO-221 was 
increased two-fold with a particle size reduction from 4.15 to 0.45 µm. The use of a 
planetary ball mill to carry out fine grinding has been attempted and has led to 
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improvement in the solubility of poorly soluble drugs. Kim and his co-workers (2008) 
reported a significant improvement in solubility of poorly soluble drugs such as 
ursodeoxycholic acid (UDCA), diphenyl hydantoin (phenytoin) and biphenyl dimethyl 
dicarboxylate (DDB) using the fine grinding technique in a wet milling process (with 
ionized water). The increase in solubility was due to a decrease in particle size and 
crystallinity of the grounded products. Kraml and co-workers (1962) also reported that a 
0.5 g of micronized form resulted in obtaining serum levels which were comparable to 
the one obtained using 1 g of unmicronized form. The technique of size reduction is 
found to be useful for drugs with low water solubility compared to their doses and the 
aqueous volumes of the GI tract. This limit could be overcome by increasing the effective 
surface area of the API. Another relevant illustration is the development of Tricor
®
, the 
poorly soluble cholesterol lowering fenofibrate. Progressive particle size reduction 
reduced the dose of fenofibrate from a 300-mg capsule (containing particulate form of the 
drug) to a 145-mg tablet containing the nanoparticulate drug. The nanoparticulate drug 
formulation resulted in more than two-fold increase in the bioavailability of fenofibrate 
(Perrett and Venkatesh, 2006). 
1.4.3 Limitations of Milling  
Despite useful applications, the process of milling also induces unexpected disorders 
in the crystal structure of molecular solids. The nature of these disorders is not yet clearly 
established making the process difficult to understand and control for optimizing a 
formulation protocol (De Gusseme et al., 2008).  These disorders could have potential 
implications on the efficacy of the drug. Disorders may result in the following 
undesirable changes. 
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1.4.3.1 Polymorphic Transformation  
       A range of pharmaceutical actives including indomethacin (Otsuka et al., 1994), 
chloramphenicol (Otsuka and Kaneniwa, 1986), cimetidine (Bauer-Brandl, 1996), 
sulfamerazine (Zhang et al., 2002) and phenylbutazone (Matsumoto et al., 1988) undergo 
polymorphic transformations on milling. The resultant polymorphic forms are physically 
unstable with re-crystallization pattern of the metastable polymorphic forms difficult to 
understand as they may not revert to their stable polymorphs. 
1.4.3.2 Amorphous Transformation  
Pharmaceutical actives, such as piroxicam (Shakhtshneider, 1997), budesonide 
(Dudognon, et al., 2006) generate amorphous regions on milling. These amorphous 
regions are mostly concentrated on the particle surface. The amount of amorphous 
regions created depends on the intensity of the milling process. The intensity is 
characterized by pressure applied in the case of a jet mill and the efficiency of the mill.  
During post-milling storage, these amorphous regions being highly energized and 
unstable have the tendency to revert back to their stable crystalline forms. These changes 
make the surfaces electrostatically charged and cause the particles to agglomerate due to 
increase cohesivity (De Villiers, 1995; De Villiers and Tiedt, 1996). The agglomeration 
leads to a broad particle size distribution with presence of particles having heterogeneous 
shapes (Steckel et al., 2003). These undesired changes affect powder properties such as 
flow which eventually has a negative impact on the blending uniformity of the drug-
excipient blends (Mackin et al., 2002a). Mackin and co-workers found that the milled 
form of the drug failed the blend content uniformity when compared with the unmilled 
form of the drug having similar particle size. The partially amorphous form generated on 
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milling as detected by dynamic vapour sorption (DVS) analysis was found to have 
contributed to the non-uniformity of the blend. The agglomeration behavior further 
contributed to increased adhesion of particles on the surfaces of the milling equipment 
subsequently resulting in decrease in classification ability of the mill along with 
operational problems of uniform feeding and continuous usage. The post micronization 
stress relaxation can also occur due to further reduction in size on storage (Joshi et al., 
2002). These changes are difficult to control as particle surfaces in micronized or milled 
powders do not naturally grow, with the crystals cleaving at the crystal face with the 
smallest attachment energy. This crystal face contains the lowest energy (Roberts et al., 
1994). These non-equilibrium transformations are critical to the physical stability of the 
drug as it could modify its shelf-life, affect its dissolution properties and finally, the 
performance of the drug product (Guinot and Leveiller, 1999).  
1.4.3.3 Dehydration  
Apart from changes in polymorphic forms and generation of amorphous forms, 
mechanical milling has resulted in loss of crystalline water. Puttipipatkhachorn and co-
authors (1990) have reported that mechanical milling accelerated the dehydration of 
theophylline hydrate. Otsuka and his team (1999) reported the conversion of 
carbamazepine into its polymorphic forms on grinding under different humidity 
conditions such that its dihydrate form loses crystalline water to convert to an amorphous 
form which on further grinding converts to an anhydrate form. As the control of relative 
humidity plays an essential part in quality assurance of pharmaceutical solid dosage 
products, changes to their polymorphic form could be detrimental to the solubilities, 
especially for poorly soluble drugs such as carbamazepine.  
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1.4.3.4 Chemical Instability 
 Milling may induce chemical changes in the crystal structure of some materials 
(Parrott, 1974). Although wet milling is a useful alternative to dry milling in case of 
thermolabile materials, it has been reported to affect the chemical stability of the 
molecules on the particle surface, thus limiting this technique for milling of 
pharmaceutical compounds (Rasenack and Müller, 2004). Kitamura and co-workers have 
reported an increase in discoloration in cefixime trihydrate crystals in a ball mill with 
increased grinding time (Kitamura et al., 1989). Qiu and co-workers (2005) investigated 
the effect of milling and compression on the solid state Maillard reaction between 
metoclopromide hydrochloride and lactose. An increase in milling time was found to 
increase the reactivity of the drug towards the Maillard reaction, which was attributed to 
the increased surface area, generation of amorphous content and creation of defects on 
milling. The study by Waltersson and Lundgren (1985) on the milling of acetylsalicylic 
acid and procaine penicillin G in suspension and solid state, showed the rate of 
degradation of both drugs increased with increase in milling time. The degradation was 
related to an increase in solubility of the drugs due to the hydrolytic degradation on 
milling.  
1.5 Co-milling and Applications  
  The limitations associated with the milling process makes it paramount that the 
effects of milling on the physicochemical properties of the materials are understood prior 
exposing them to high-energy milling (Rasenack and Müller, 2004). Milling is used to 
increase the dissolution rate of poorly soluble drugs, but this is counter-productive if the 
newly created surfaces are hydrophobic and poorly wettable when poorly soluble drugs 
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are milled. This meant that the surface needs to be hydrophilized to increase dissolution 
rate with the addition of hydrophilic polymers or surfactants in the milling process 
(Rasenack and Müller, 2004). This process has been termed as co-milling.  
Co-milling (or milling of two or more materials concurrently) alternatively referred to 
as co-grinding is a simple and effective method of improving the physicochemical 
properties such as solubility, stability of various active pharmaceutical ingredients (APIs) 
(Shakhtshneider et al., 1996). Although it is a highly energy intensive process, co-milling 
has been found to be economical, does not require sophisticated instruments and is 
environment friendly without the use of organic solvents (Friedrich et al., 2005). Table 
1.2 summarizes the applications of co-milling with additives reported in literature. 
1.6 Amorphous Solid Dispersions  
 Pharmaceutical drug discovery programmes may provide poorly water soluble drugs 
which need amorphization to achieve acceptable dissolution rates and enhanced oral 
bioavailabilities (Hancock and Zografi, 1997; Yu et al., 2001). Thus, co-milling is used to 
increase drug solubility with the addition of excipients or polymers imparting physical 
stability to the amorphous drug. Amorphous materials which are more prone to heat and 
degradation have been effectively prepared by co-milling with excipients (Crowley and 
Zografi, 2002; Watanabe et al., 2003). Co-milling has already been employed in the 
preparation of amorphous solid dispersions of poorly water soluble drugs such as 
indomethacin (Watanabe et al., 2003), carbamazepine (Barzegar-Jalali et al., 2007), 
chlordiazepoxide (Nokhodchi et al., 2007) and gliclazide (Barzegar-Jalali et al., 
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Table 1.2 Changes in co-milling of APIs with additives 
API Milling with / without additives Characteristics changed     References 
A. Improvement in dissolution 
properties  











2. Sulfathiazole, Ibuprofen,  











B. Improvement in stability 







Milling in a ball mill  
 
 
Ball milling with polyvinyl 
pyrrolidone (PVP),  sodium 
dodecyl sulfate (SDS), 
hydroxypropyl methylcellulose 
(HPMC), polyethylene glycol 
(PEG), urea and Pluronic F108  
 
 
Milling in a planetary- centrifugal  












Milling in a porcelain jar mill with 
zirconium balls  
 





 Electrostatically charged particles 
followed by agglomeration, decreased 
drug release 
 
 Prevention of re-aggregation of finely 
divided drug particles 
 Improved wettability 
 Reduction in re-crystallization behavior of 
the drug 
 Increased dissolution rate  
 
 Sulfathiazole shows polymorphic 
transformation and re-crystallization on 
subsequent storage 
 Ibuprofen shows no change in dissolution 
rate on milling 
 Piroxicam undergoes partial 
amorphization, changes color to yellow. 
Slight improvement in dissolution 
 
 Increased dissolution rate due  to 
formation of more soluble complexes and 
stabilization of active state on co-milling 
 
 No amorphization  
 
 
 Spontaneous amorphization 
 Higher solubility 
 Physically stable at 40°C and 75% RH 






























Bahl and Bogner 
(2006) 
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Table 1.2 Changes in co-milling of APIs with additives (continued) 
 
API Milling with / without additives Characteristics changed     References 
C. Improvement in stability  















D. Improvement in biopharmaceutics 













Milling in a cryogenic mill  
 
 













Milling  in a jet mill 
 
 









Jet Milling with lactose 
 
 Amorphization of drug 
 Re-crystallization of drug on storage  
 
 No re-crystallization of drug on co-milling 
at PVP (≥  60 wt%) on storage  
 Formation of molecular alloy with PVP 
 
 Amorphization of drug 
 Re-crystallization of drug on storage  
 
 Formation of glass solutions  
 No re-crystallization of drug on co-milling 
at PVP (≥ 50 wt%) on storage  
 Increased dissolution rate  
 
 No amorphization 
 Slow dissolution rate 
 
 Rapid dissolution with stable 
supersaturation 
 Improved oral bioavailability 
 
 
 No detectable amorphization 
 Poor flowability 
 Low respirable fraction of 4% 
 
 Good flowability 
 Respirable fraction of 23.2% 
 

























Giry et al., (2006) 
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2010). These amorphous solid dispersions are found to be amenable for further 
development as solid dosage forms. They have advantages such as lower manufacturing 
cost, small pill burden, improved physical and chemical stability as well as the possibility 
of combination dosage forms (Qian et al., 2010). Bahl and Bogner (2006; 2008) reported 
the improvement in the dissolution profile of indomethacin on co-grinding with silicates 
and the effects of humidity and drug-excipient ratios on the stability of amorphous 
indomethacin as a co-ground mixture. A stable amorphous indomethacin-silica alloy was 
formed due to plasticization of amorphous drug leading to mechanical transfer of drug to 
silicate, vapor-phase mass transfer and water in facilitating particle-particle surface 
migration of the drug to the silicate.  
Physical stabilization of the amorphous form is affected by several factors such as 
controlling molecular mobility, inter and intra-molecular interactions and variations in 
processing conditions (Bhugra and Pikal, 2008). With reference to drug-polymer systems, 
the stability of the amorphous form primarily depends on factors such as drug and 
polymer interaction, viscosity of polymer and glass transition temperature of the mixture 
(Choksi et al., 2008).  In addition, the presence of polymer has been shown to increase 
the activation energy towards crystallization and could act as a physical barrier against 
crystallization. The Tg represents a kinetic boundary for molecular mobility. The Tg of a 
binary solid dispersion can be experimentally determined using thermal analysis, while it 
could be theoretically estimated using the weight average theory of Gordon-Taylor 
equation where deviations from the predicted values are attributed to drug-polymer 
interactions (Marsac et al., 2008; 2009; Gordon and Taylor, 1952 ). This suggests that 
although Tg serves as an important indicator of crystallization tendency, the modes of 
Chapter 1                                                                                                       Introduction  
 23 
molecular mobility not reflected by Tg
 
should also be considered (Marsac et al., 2008). 
Apart from factors discussed above, intra and intermolecular interactions such as 
hydrogen bonding and acid-base interactions also play a key role in achieving stable 
amorphous dispersions Miyazaki and co-workers (2004) attributed the ability of 
polyacrylic acid (PAA) to stabilize amorphous dispersions of acetaminophen to the 
strength of acid-base interaction between the hydroxyl group of acetaminophen and the 
carboxyl group in PAA in comparison to the hydrogen bonding in case of 
acetaminophen-PVP interactions. Similar acid-base interactions have been reported 
previously between loperamide and PAA (Weuts, et al., 2005). Proton transfer between 
the basic drugs and acidic polymer PAA resulted in formation of stable amorphous 
dispersions indicated by a positive deviation in the Tg of the drug polymer system from 
the predicted Gordon-Taylor equation. The increase in Tg values was found to suggest a 
possible salt formation between the ionic components. A similar salt formation was 
earlier reported by Lee’s group (1991) between a basic drug propranolol with an amino 
function and a methacrylic acid co-polymer. Tang and his team (2002) investigated the 
differences in hydrogen bonding tendencies in the crystalline and amorphous states of 
seven dihydropyridines analogues. The authors concluded that for some compounds, 
hydrogen bonding was stronger in the crystalline state while for others; it was stronger in 
the amorphous state. A strong relation of hydrogen bonding in molecules to molecular 
mobility was also found in case of acetaminophen glass (Gunawan et al., 2006). This 
meant that the strength of the hydrogen bonding could significantly impact the structural 
relaxation time i.e. the molecular mobility and hence impact the tendency to crystallize. 
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Hence, the mechanism by which solid dispersions stabilize amorphous drugs is governed 
by different mechanisms and is not fully understood. 
1.6.1 Drug-polymer Solubility and Miscibility 
 Solubility of the crystalline drug and/or miscibility of the amorphous drug in the 
polymer matrix govern the important assumption that the drug and polymer for co-
milling are homogeneously mixed at the molecular level. The polymer is usually the 
dominant phase in drug-polymer solid dispersions developed in the pharmaceutical 
industry. Hence, miscibility of the small molecule drug in the large polymer matrix is 
relevant although the estimate of the miscibility of the drug in polymer matrix is not 
straightforward as the amorphous drug is metastable and can reach equilibrium with 
regard to the crystalline drug. Hence at equilibrium, the composition of the mixture 
would govern the solubility of the drug in the polymer. The determination of miscibility 
of the drug-polymer solid dispersions is conducted, when the drug is in the form of a 
supercooled liquid at a temperature above the Tg and below the crystalline melting point 
of the drug over the time frame of the experiment (Qian et al., 2010).  
The estimations of drug solubility and miscibility are important for the development 
of drug-polymer solid dispersions but established methods are not available as the high 
viscosity of the polymers employed in solid dispersion hinders the determination of 
solubility and miscibility at equilibrium. These estimations require model prediction at 
temperatures below Tg while some experimental approaches have been attempted for 
drug-polymer systems at temperatures above or close to Tg (Qian et al., 2010). Tao and 
researchers (2009) reported that crystallization of the drug in the polymer systems was a 
slow process and took several months even at temperatures above Tg in the presence of 
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crystalline seeds. The method had advantages of avoiding model prediction and had 
general applications to drug-polymer systems. The limitation of this method is that the 
solubility could only be determined at temperatures 30°C above Tg as systems were 
found to be too viscous at temperatures closer to Tg. Similarly, a study determining the 
solubility of trehalose in a three component system with dextran and PVP has been 
reported. Changes in Tg as a function of mixture composition and moisture were used to 
determine the solubility. Temperature measurement was done well above the Tg of the 
system (Vasanthavada et al., 2004). A direct method for estimating solubility of the 
crystalline drug in the polymer matrix has yet to be developed.  
The miscibility of amorphous drug-polymer has been reported previously in the 
literature. The homogeneous mixing of drug and polymer in solid dispersions is judged 
by presence of the single Tg in between the Tg of the components. The differential 
scanning calorimetry (DSC), spectroscopy namely infrared (IR) and Raman spectroscopy 
(RS), isothermal water sorption by DVS, spin-lattice calculations using solid state nuclear 
magnetic resonance (SS-NMR) and X-ray powder diffraction (XRPD) with the required 
sensitivity have been found to be useful for elucidating the mechanism of drug-polymer 
interactions and the miscibility of solid dispersions at molecular level. These techniques, 
though useful, do not explain equilibrium miscibility (Qian et al., 2010). As discussed 
before, estimating equilibrium miscibility at temperatures below and closer to Tg of the 
system is difficult, hence extrapolation of data above Tg by modeling is commonly 
employed to understand the thermodynamics of the system. Marsac and co-workers 
(2006) utilized the Florey-Huggins theory to estimate the interaction parameter (X) and 
understand the drug-polymer miscibility. The theory has been previously applied for 
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amorphous system of polymer blends. The miscibility between components is based on a 
model where free energy of mixing is dependent on entropy (favouring mixing) and 
enthalpy (facilitate or prevent mixing) parts. The free energy of mixing is governed by 
the nature and intensity of the interaction. The equilibrium miscibility in the composition 
is judged by the value of X where a value closer to or less than zero favors complete 
miscibility at a particular temperature while values higher than zero favors 
thermodynamic phase separation (Qian et al., 2010). The value of the parameter was 
compared with the experimentally obtained values using melting point depression method 
or determining the drug activity in the polymer’s low molecular weight analog. The 
method had limitations and required verifications as assumptions made limited its 
application to polymers like PVP which has liquid oligomers (Marsac et al., 2009). The 
use of modeling to estimate solubility of the drug in such systems at temperatures closer 
to Tg of the system was attempted but results were found to be inconsistent. Thus in order 
to understand the effects of drug polymer solubility and miscibility during formulation 
process, development and shelf life assessment of solid dispersion product and reduce the 
development time, a rational and exhaustive approach is needed. Currently solid 
dispersions are prepared by trial and error method and a rational approach in the form of 
a working diagram as proposed by Qian and group (2010) could help to improve the 
industrial development of solid dispersions.  
1.7 Electrostatics  
 
 Generation of static electrification or electrostatic charges is inevitable during 
pharmaceutical processes such as milling, powder mixing, coating, spray drying, melt 
agglomeration, powder transport and when formulating interactive mixtures for DPIs 
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(Chow et al., 2008). Electrostatic charges are caused by contact charging or more 
accurately, triboelectrification which includes charging from frictional effects such as 
rubbing, sliding, rolling or impaction. Contact electrification occurs when two dissimilar 
materials make and then break contact, leading to charge transfer from one material to the 
other (Bailey, 1984). Hence, when the two materials are separated, there is a net charge 
left on both materials with similar magnitude but opposing polarity (Bailey, 1984). This 
is due to the fact that different materials have different abilities to transfer an electron 
which in turn is dependent on the ability of the surface to donate or accept electrons. This 
could be contributed by the polar component of the surface energy of the material which 
is related to electron donor and acceptor properties (acid-base parameters) of the material 
(Ahfat et al., 2000). Charge transfer can also occur between two uncharged particles 
having different work functions (Zeng et al., 2000). Work function is the minimum 
energy required to remove the weakest bound electron from the surface. Electrons would 
be transferred from the material with a higher work function to that of a lower work 
function (Bailey, 1993). Based on this principle, Elajnaf’s group (2006) proposed a 
triboelectric series where the higher positioned materials in the series having a lower 
work function would acquire a more electropositive charge when in contact with lower 
positioned materials in the series. The work by researchers led by Eilbeck (1999) and 
Elajnaf (2006) reported that electrostatic charge generation was found to be dependent on 
the powder charge as well as charge on the container surface. This charge transfer 
between insulating materials needs presence of free energy levels and could be formed by 
presence of dislocations or impurities on the surface (Bailey, 1984; Chow et al., 2008). 
Contact charging can take place between real materials in which impurities and surface 
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defects such as amorphicity increased energy levels allowing the charge to move (Cross, 
1987). As the milling process usually involves particle-surface or particle-particle 
contact, generation of amorphous surface is inevitable leading to electrostatic charging 
and agglomeration of the milled material. Charged particles are also attracted to metallic 
surfaces, adhering firmly to such surfaces and clogging may result if powder resistivity is 
high (Bailey, 1984).  
Triboelectrification is more complex in case of particulate systems in which 
parameters such as contact pressure, area, time, and frequency are difficult to quantify 
(Rowley, 2001). Contact surface properties namely (surface resistivity, surface roughness 
and contamination) particle properties namely (size, crystal properties and particle 
surface resistivity) and atmospheric conditions have been found to influence the charging 
process (Elajnaf et al., 2006). Attempts have been made to understand the effects of 
electrostatic charging on different pharmaceutical processes and to eventually improve 
stability of the formulations. The effect of particle size on the triboelectrification of 
carriers for DPIs was studied by Bennett and group (1999) and mixes of fine particle 
lactose (< 10µm) (0 – 5 wt%) with coarser lactose (63 - 90 µm) were found to reduce the 
magnitude of charge of coarser lactose on mixing. In a study by Chow’s group (2008), 
the static charge of bulk lactose was significantly lowered when the RH was increased to 
80% while the dynamic charge of lactose demonstrated a linear increase with RH. 
Rowley and Mackin (2003) studied the effect of storage RH on the triboelectrification of 
powders using different contact surfaces and found that RH had a negligible effect on the 
charging of lactose monohydrate and dextrose monohydrate with low hygroscopicity upto 
80% RH. On the other hand, a decrease in charging of highly hygroscopic sodium starch 
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glycolate with an increase in storage RH was noted. The excipients showed different 
charging behaviour with contact surfaces. The study showed that moisture sorption along 
with contact surface could be useful in predicting the electrostatic charging of 
pharmaceutical powders. In another study by Elajnaf’s team (2006), mixing lactose with 
salbutamol sulphate or ipratropium was observed to alter the triboelectrification and 
adhesion of lactose. Charging properties of the drug-coated lactose particles began to 
resemble that of the drug rather than lactose due to reduce surface contact. Pu and co-
workers (2008) studied the effect of conventional blending, blending with charge 
neutralization, blending with corona charging on minimization of electrostatic charges in 
pharmaceutical active-excipient blends. The use of oppositely charged drug excipient 
combinations, such as positively charged caffeine and negatively charged lactose, was 
found to improve blend uniformity, while on the other hand elimination of electrostatic 
charges was not useful. In a recent study by Pingali and co-workers (2009a), the use of a 
static eliminator alone was compared with combined use of static eliminator and 
additives. The static eliminator alone was sufficient to improve the flow properties of 
micronized acetaminophen, but the combined use of the eliminator and blending with 
flow enhancing additives such as magnesium stearate, talc and silica were found to have 
little effect on the flow properties. The authors speculated that use of flow enhancing 
additives reduced the frictional charges on blending, which made the use of static 
eliminator ineffective. Thus, the effect of triboelectrification on a solid dosage 
formulation up to its end usage is significant and needs to be addressed and optimization 
of processes is required in order to ensure uniform product quality.   
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1.8 Research Objectives and Approach  
The purpose of the current research work is to explore potential applications of co-
milling for improving the physical stability and processability that is the reduction of 
triboelectrification, of different model compounds. The research objectives are as 
follows: 
1.8.1 Mitigating Milling-induced Amorphization of a Crystalline Pharmaceutical 
Active  
Salbutamol Sulfate (SS), a crystalline pharmaceutical active is a hydrophilic 
compound, however it’s not highly hygroscopic. It amorphizes on milling and has a 
tendency to undergo moisture induced re-crystallization at elevated humidity conditions 
(Brodka-Pfeiffer et al., 2003a). Re-crystallization leads to a shift in particle size as the 
particles agglomerate. A shift in particle size is detrimental for inhalation drugs like SS 
because it has a direct impact on the aerosolization performance and therapeutic effect 
(Brodka-Pfeiffer et al., 2003b).  Co-milling with additives have aided in retaining 
crystallinity of milled ursodeoxycholic acid, however it was not further discussed 
(Oguchi et al., 2000). As the amorphous form of the drug is highly unstable and no 
previous attempts have been made to minimize he amorphous formation during milling, 
the authors hypothesize that co-milling with crystalline additives could minimize 
amorphization of an API by selecting SS as the model compound. Thus, The objective of 
this research work was to evaluate the feasibility of retaining the crystalline form of 
milled SS by co-milling with crystalline excipients namely, lactose (LAC) or adipic acid 
(AA) or magnesium stearate (MgSt). The minimization of amorphous content and 
retention of the crystallinity of the drug in co-milled mixtures were evaluated using 
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XRPD, high sensitivity differential scanning calorimetry (HSDSC) and DVS 
respectively. Fourier transformed infrared spectroscopy (FT-IR) was used to study 
possible chemical interactions between the drug and each excipient. Scanning electron 
microscopy (SEM) of co-milled mixtures kept under ambient and elevated humidity 
conditions of 75 %RH was conducted to study the effect of re-crystallization on particle 
agglomeration and morphological changes. The content of SS in freshly co-milled and 
stored mixtures was evaluated using high pressure liquid chromatography (HPLC). 
1.8.2 Stabilization of a Milled Amorphous Form of SS  
Our second hypothesis is that a stable and homogeneous dispersion of a milled API 
could be obtained in the presence of an amorphous excipient. To test our hypothesis, 
stabilization of the amorphous SS was attempted with the use of an amorphous excipient, 
polyvinyl pyrrolidone (PVP). PVP has been found to inhibit re-crystallization and 
stabilize amorphous dispersions (Aso et al., 1996; Cirri et al., 2004). At the same time, 
PVP is highly hygroscopic (Umprayn and Mendes, 1987) which could be detrimental 
when used to stabilize amorphous dispersions. The minimum ratio of PVP required for 
stabilizing the amorphous form of milled pharmaceutical actives has not been elucidated. 
Thus, the objective of the study was to understand the influence of the proportion of PVP 
for stabilizing amorphous co-milled SS before and after storage under ambient and 
elevated humidity conditions. In addition to the analytical procedures used in the first 
objective, Raman microscopy (RM) was applied to map the spatial distribution of the 
drug and the excipient in the co-milled mixtures.  
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1.8.3 Investigation on Electrostatic Properties of Milled and Co-milled APIs  
Our third and fourth hypothesis is that stable amorphous mixture of charged APIs 
with suitable additives can be prepared and these amorphous mixtures can aid in reducing 
their chargeability in comparison to crystalline co-milled mixtures. To test this 
hypothesis, Clarithromycin (CAM) and Ibuprofen (IB), crystalline and readily chargeable 
pharmaceutical actives were selected as the model compounds. CAM has been reported 
to have a negatively charged surface plane (Bele et al., 2005) and can form charged 
transfer complexes with strong electron acceptors such as iodine and tetracyanoethylene 
(Zaria and Etaiw, 2007). IB, a non-steroidal anti-inflammatory drug, possesses poor flow 
properties due to high cohesivity and adhesivity during handling (Rasenack and Muller, 
2002).  The use of flow additives or glidants on blending with micronized pharmaceutical 
actives has been found to reduce the electrostatic charges (Pingali et al., 2009a). Thus, the 
objective of this study was to evaluate the use of co-milling with amorphous excipients in 
preparing stable amorphous dispersions of CAM and modifying the electrostatic 
properties. In addition, to understand whether crystalline co-milled mixtures have 
different electrostatic properties, co-milling of IB with a crystalline and an amorphous 
excipient is also carried out. Milling and co-milling of CAM with amorphous 
polymethacrylate polymer (Eudragit EPO) and co-povidone (Kollidon VA 64) were 
carried out using a planetary ball mill and a cryogenic ball mill. The milled fractions of 
CAM were characterized for net electrostatic charge measurements (Faraday’s Cage and 
Electrometer), particle size (Laser Diffraction), surface area (Brunauer-Emmett-Teller 
(BET) method), and moisture content (Karl Fischer Titration). In addition, electron 
donating and accepting properties were measured as acid-base parameters by using 
Chapter 1                                                                                                       Introduction  
 33 
inverse gas chromatography (IGC). The co-milled mixtures were analyzed for 
electrostatic charge and IGC measurements, amorphous contents using XRPD and DSC 
and inter-molecular interactions between CAM and excipients using FT-IR.  
Co-milling of IB with a crystalline excipient, MgSt and an amorphous excipient, 
colloidal silicon dioxide (colloidal SiO2) was carried out using a planetary ball mill. The 
co-milled mixtures were characterized for particle size (laser diffraction) and electrostatic 
charge measurements (Faraday’s Cage and Electrometer). 
 
The experimental approach and results obtained to achieve each of these research 
objectives are elaborated in chapters 3, 4 and 5.  
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CHAPTER 2  
 
EXPERIMENTAL METHODS AND ANALYTICAL TECHNIQUES 
 
2.1 Model APIs 
 
2.1.1 Salbutamol Sulphate (SS) 
 
Salbutamol Sulphate (SS) (1-(4-hydroxy-3-hydroxymethylphenyl)-2-(t-
butylamino) ethanol sulphate) is a β-2-sympathomimetic agent and treats asthma and 
chronic obstructive pulmonary diseases by relieving smooth muscle contraction (Brodka-







Figure 2.1 Chemical Structure of SS 
In a DPI, it is formulated with coarser carrier α-lactose monohydrate (LAC) with 
particle size of 30 - 90 μm. The larger lactose particles deposit in the oropharyngeal 
region, while the drug penetrates the deep lung. The particle size of SS has to be less than 
aerodynamic diameter of 6.4 μm to achieve effective penetration. More information about 
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Drug SS CAM IB 
1) Marketed Name  
2) Dosage form  
 
 
3) Need for particle size   






a) Solubility  
 Water 
 




b) Melting point (ºC) 
 
c)  Acidity/basicity  (pKa)       
d) Molecular weight 
e) References 
Ventolin® 
MDI s and DPIs 
 
Particle size range 
of 1 - 5µm required 







Soluble as 1 in 70 
parts of water 
 
1 in 25 parts of 
ethanol, slightly 
soluble in ether and 
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576.7 
(Aboul-Enein et al., 





















Soluble in acetone 



























 (0.37 mg/L) 
 
Readily soluble in 
 alcohol, chlorinated 
 hyrdrocarbons and 








(Higgins et al., 2001; 
Rasenack and Muller, 
2002) 
 
Table 2.1 Information of SS, CAM and IB 
2.1.2 Clarithromycin (CAM) 
Clarithromycin (6-O-methylerythromcyin) is a semi-synthetic 14-membered 
macrolide antibiotic exhibiting broad in vitro antibacterial spectrum. It was discovered 
and patented by Taisho Pharmaceutical Co. Ltd, Japan (Salem, 1996). The macrolide was 
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developed in order to overcome acid-instability associated with erythromycin. The 
physico-chemical properties of CAM are summarized in Table 2.1. CAM is used for 







Figure 2.2 Chemical Structure of CAM 
against respiratory pathogens such as penicillin-susceptible and intermediate 
pneumococci. CAM possesses poor aqueous solubility (< 1mg/mL) (Inoue et al., 2007), 
poor absorption and low oral bioavailability (Log P = 2.69). FDA has set daily dose 
requirements of 250 - 1000 mg with higher amounts given in multiple doses 
(Clarithromycin, 2008). Information about CAM is summarized in Table 2.1.  
2.1.3 Ibuprofen (IB) 
Ibuprofen (IB), (2-(4-isobutylphenyl) propionic acid), is a non-steroidal anti-
inflammatory drug (NSAID) that is commonly used in various medicinal formulations for 
its analgesic, anti-inflammatory and antipyretic effects (Adams et al., 1969). IB is fairly 
lipophilic in its un-ionized form (Log P = 3.5) (Mannila et al., 2005). Further information 
about IB is summarized in Table 2.1. 
 







Figure 2.3 Chemical Structure of IB 
2.2 Studies on SS  
2.2.1 Characterization of Unmilled SS  
SS (≥ 99% purity) was purchased from Junda Pharmaceutical Co. Ltd (Jiangsu, 
PR China). Table 2.2 summarizes the properties of SS that were characterized. 
 
Table 2.2 Characterization of SS 
2.2.1.1 Bulk Density 
Approximately 10 g of SS that is sufficient to fill a volume between 50 - 100 mL was 
placed into a 100 mL graduated cylinder. Bulk density was derived from Eq 2.1: 
Bulk density (g/mL) = weight (g)/unsettled apparent volume (mL)               (2.1) 
 
 
No Properties Procedures References 
1 Density  
- Bulk 
- Tapped 
- True  
 
Graduated cylinder 
Tapped density tester  
Helium pycnometry  
 
Method 1, USP 26-NF 21, 2003a 
Method 1, USP 26-NF 21, 2003a 
Gas pycnometry  
Method 1, USP 26-NF 21, 2003a 
2 Powder compressibility 
- Compressibility 
index 
- Hausner’s ratio   
 
Graduated cylinder 
Tapped density tester  
 
 
Method 1, USP 26-NF 21, 2003a 
Method 1, USP 26-NF 21, 2003a 
 
3 Moisture Content  Karl Fischer coulometry Method 1c, USP 26-NF 21, 2003b 
4 Particle size Malvern mastersizer Young et al., 2005 
5 Crystallinity  XRPD
 
Columbano et al., 2002 
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2.2.1.2 Tapped Density 
    The unsettled apparent volume was mechanically tapped at a nominal rate of 300 
taps per min using the tapped density tester (Quantachrome Inc., USA). The cylinder was 
initially tapped for 500 times and the volume recorded. The procedure was repeated for 
750 and 1250 taps, respectively. The final volume after 1250 taps was recorded. Tapped 
density was calculated using Eq 2.2: 
    Tapped density (g/mL) = weight (g)/final tapped volume                                        (2.2) 
 
2.2.1.3 True Density 
   Approximately 1 g of weighed sample, enough to occupy more than two-third of 
the sample holder, was added into the sample holder of a gas (helium) pycnometer 
(Quantachrome Inc., USA). Readings were taken under the following conditions in tripli- 
cate. 
Purging of helium gas (time): 30 min                               
Maximum runs: 20 
Temperature: 25°C 
Pressure of helium gas: 20 - 22 pounds per square inch 
Error: 0.010%                                                                    
2.2.1.4 Powder Compressibility 
 
Compressibility index (CI) (%) = 100 X (tapped density-bulk density/tapped density) (2.3)
             
Hausner’s ratio = tapped density/bulk density                                                               (2.4) 
                                                                  
2.2.1.5 Moisture Content  
 
An accurately weighed 100 mg of SS was added to a constantly stirred Coulomat 
reagent. Moisture content was then calculated using Eq. 2.5: 
 Moisture content = weight of water (g)/weight of sample (g) X 100%                       (2.5) 
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2.2.1.6 Particle Size Measurement  
 
Particle size analysis was determined by laser light scattering (Mastersizer 2000; 
Malvern Instruments, UK), using wet dispersion method. Approximately 100 mg of 
powder was added into cyclohexane solution containing 0.1% w/v lecithin and ultrasoni- 
cated prior to and during analysis. The ultrasonication was done to fully deagglomerate 
the powder. Each sample was measured in triplicates. The particle size distribution was 
described using volume equivalent diameters at 10% (d0.1), 50% (d0.5) and 90% (d0.9) 
cumulative volume.  
2.2.1.7 X-ray Powder Diffraction (XRPD) 
 
Diffraction pattern of crystalline SS was obtained using X-Ray powder diffractometer 
equipped with PSD Vantec-1 detector. Measurements were performed with CuK 
radiation over the reported (Columbano et al., 2002) angular range for SS from 2 < 2 < 
40° in step scan mode (step width 0.017°, scan rate 1°/min). Crystalline structure of the 
sample was verified by comparing to the standard reported in the Cambridge Structural 
Database. 
2.2.2 Sieved (unmilled) Fractions of SS 
Sieved fractions of SS were obtained using a set of sieves (710, 500, 250, 106 or 75 
μm) with the Retsch® Sieve Shaker (Retsch GmbH, Rheinische Straße, Haan, Germany) 
set at amplitude of 2.5 mm for 10 min. Two particle size ranges (75 - 250 and 250 - 500 
μm) were used to select a suitable size of SS for co-milling. The sieved fractions were 
subsequently jet-milled and particle morphology of each fraction was examined using 
SEM. The specific surface area of each fraction was analyzed using BET. SEM and BET 
analysis were used to select the sieved fraction for milling and co-milling.  
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2.2.2.1 Jet Milling of SS 
The sieved fractions (75 - 250 and 250 - 500 μm) were micronized using a spiral jet 
mill (50 AS, Hosokawa, Augsburg, Germany) with compressed air as the gas stream. 
Optimization of jet milling conditions to get desired particle size was done using 
following parameters: 
Feed rate = 50 - 60 g/h                 
Feed pressure = 5 - 5.5 bar 
Grinding pressure = 6 - 7 bar     
Vibrating feed amplitude = 70 - 80 
The particle size of SS after jet-milling was analyzed by wet dispersion method using 
conditions as mentioned in section 2.2.1.6. 
2.2.2.2 Scanning Electron Microscopy (SEM) 
 
The morphology of the jet-milled SS particles of each fraction was examined using 
high resolution SEM (JSM-6700F, JEOL, Japan) operating at 5 keV. The samples were 
mounted on carbon sticky tabs and sputter coated with platinum for 1 min (Cressington 
Sputter Coater 208HR, UK). 
2.2.2.3 Brunauer-Emmett-Teller (BET)  
 
Nitrogen adsorption/desorption isotherm of unmilled, sieved and jet-milled fractions 
were measured by using an Autosorb-6B gas adsorption analyzer (Quantachrome 
instruments, Boynton  Beach, FL) at the temperature of -196°C. Before nitrogen 
adsorption-desorption measurements, each sample was degassed at 25°C under vacuum 
for 24 hrs. The specific surface areas of the samples were determined from the linear 
BET plots. 
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2.2.3 Particle Size of Excipient for Co-milling  
All excipients used in the study were purchased from Sigma Aldrich. LAC, (Mw = 
360.31, 99% purity) was the first excipient selected to carry out co-milling studies with 
SS. As lactose is the most widely used carrier in DPI’s (Zeng et al., 1999), preliminary 
studies to select the appropriate particle size for co-milling were initiated. LAC was 
sieved and subsequently jet milled. 
2.2.3.1 Sieving of LAC  
Sieved fractions of LAC were obtained using a set of sieves (710, 500, 250, 106, 75 
or 38 μm) under similar conditions as mentioned in the section 2.2.2. 
2.2.3.2 Jet Milling of LAC 
The sieved fraction (< 106 µm) was micronized using a spiral jet mill (50 AS, 
Hosokawa, Augsburg, Germany) with compressed air as the gas stream. Optimization of 
jet milling conditions to get desired particle size was done using following parameters: 
Feed rate = 50 - 60 g/h     
Feed pressure = 5 - 8.5 bar 
Grinding pressure = 3 - 7 bar    
Vibrating feed amplitude = 50 - 80 
The particle size of LAC after jet milling was analyzed by wet dispersion and dry disper- 
sion methods. 
2.2.3.3 Wet Dispersion Method 
  
Particle size analysis was conducted using laser light scattering (Mastersizer 2000; 
Malvern Instruments, UK). Approximately 100 mg of jet-milled LAC was dispersed in 
ethanol and ultrasonicated during analysis for 1.5 min. The ultrasonication was done to 
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fully deagglomerate the powder. Obscuration value of 0.1 - 0.2 was obtained before 
measuring each sample in triplicates. The size distribution was described using volume 
equivalent diameters at 10% (d0.1), 50% (d0.5) and 90% (d0.9) cumulative volume. 
2.2.3.4 Dry Dispersion Method  
 
Particle size analysis was conducted using laser light scattering (Mastersizer 2000; 
Malvern Instruments, UK), with dry powder dispersing system Scirocco 2000 at 2 and 3 
bar. Approximately 1 g of jet-milled LAC was placed in the tray with a small orifice. 
Depending on the different vibration feed rates at 50, 75 and 90%; the powder is fed into 
the Mastersizer through the orifice with aid of compressed air. The obscuration value is 
kept between 0.1 - 0.2. Each sample was measured in triplicates. The particle size 
distribution is described using volume equivalent diameters at 10% (d0.1), 50% (d0.5) and 
90% (d0.9) cumulative volume. 
2.2.3.5 Ball Milling of LAC  
Ball milling of sieved fraction of LAC (< 106 μm) was carried out using a planetary 
ball mill equipped with stainless steel jar and balls of diameter 10 mm (Fritsch 
Pulverisette 5 FRITSCH GmbH, Idar-Oberstein Germany). The mass ratio of ball to 
sample was kept at 50:1. The rotation speed was set at 300 rev min
-1 
and a milling 
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Type of Mixtures Excipients Equipment Process  
1) Physical 
   A1 -  Ball-milled SS 
   B2  -  Ball-milled SS 
   C3 -  Ball-milled SS 




   E1 - SS  (75 - 250 µm) 
 
    
 
    
 
 F2  - SS (75 - 250 µm) 
 G3 - SS (75 - 250 µm) 
 H4 - SS (75 - 250 µm) 
 I5  - SS (75 - 250 µm) 
 J6  - SS (75 - 250 µm) 
 
 
3) Cryo co-milled  
 K1 - SS (75 - 250 µm) 
 
Ball-milled LAC 
Ball-milled AA  
Ball-milled MgSt 










Ball-milled LAC        
Ball-milled AA  
Ball-milled MgSt 
      PVP 
Ball-milled LAC   


























 mixer mill  
 
Ball-milled SS was prepared 
at conditions mentioned in 
section 2.2.3.5. Ball-milled 
SS-excipient physical 
mixtures were prepared by 
mixing at 49 rpm for 20 min.  
 
SS-jet-milled LAC co-milled 
mixtures were prepared by 
mixing at 49 rpm for 20 min.  
The resultant mixtures were 
jet-milled at conditions 
mentioned in section 2.2.2.1 
 
SS-excipient co-milled 
mixtures were prepared by 
mixing at 49 rpm for 20 min. 
The resultant mixtures were 
ball-milled at conditions 
mentioned in section 2.2.3.5 
SS-excipient cryo co-milled 
mixtures were prepared by 
mixing at 49 rpm for 20 min. 
The resultant mixtures were 
cryo-milled at conditions 
mentioned in section 2.2.4.3 
 
Table 2.3 Preparation of physical and co-milled mixtures  
2.2.3.6 Sonic Sifting and SEM of Milled LAC   
Milled fractions (jet-milled LAC and ball-milled LAC) were sifted using a sonic sifter 
on a sift/pulse mode set at amplitude of 7 mm for 10 min. Following set of sieves viz: 
500, 250, 63, 53 or 38 μm were used.  The agglomeration tendency, changes in particle 
size and morphology of ball-milled and jet-milled samples were examined using SEM at 
conditions mentioned under section 2.2.2.2. 
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2.2.4 Co-milling  
Table 2.3 summarizes the preparation of co-milled and physical mixtures of SS with 
different excipients. 
2.2.4.1 Preparation of Co-milled Mixtures with Jet-milled LAC 
Two different drug-excipient ratios (1:1, 1:2 w/w) of E1 (Table 2.3) were prepared. 
The co-milled mixtures were characterized immediately after extracting the sample from 
the collection bag at the end of the milling process.  
2.2.4.2 Preparation of Co-milled and Physical Mixtures with Ball-milled LAC  
       Different ratios (1:1, 1:2, 1:3, 1:4, 2:1, 3:1 w/w) of F2 (Table 2.3) were prepared. 
Mixtures of mass ratio of SS-ball-milled LAC (1:1) were milled at time intervals of 15, 
30, 45 and 60 min before setting the duration of milling at 60 min for all combinations of 
SS and LAC. The co-milled mixtures were characterized immediately after extracting the 
sample from the milling jars at the end of the milling process. Immediate characterization 
was needed due to the unstable nature of the milled form of the materials. Physical 
mixtures of A1 were prepared at similar SS - LAC ratios as used for co-milled mixtures. 
The physical mixtures were characterized immediately after sample was obtained from 
turbula mixer. 
2.2.4.3 Preparation of Cryo co-milled Mixture  
The physical mixture of K2 (Table 2.3) at 1:1 w/w was prepared using a mixer 
mill (Retsch Mixer mill MM 301, Rheinische Straße, Haan, Germany) equipped with a 
stainless steel jar and a grinding ball of diameter 20 mm. The mixture (2g) and the 
grinding ball placed inside the jar were pre-cooled in liquid nitrogen for a few min and 
milled for duration of 5 min at 10 Hz. The cryo co-milled mixture was characterized 
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immediately after extracting the sample from the milling jars at the end of the milling 
process.  
2.2.4.4 Milling of Other Excipients  
Sieved fractions of crystalline AA (Mw  = 146.14, ≥ 99% purity, 250 - 500 µm) were 
prepared using conditions mentioned in section 2.2.2. Crystalline MgSt (Mw = 591.24, ≥ 
90% stearic and palmitic acid basis) and PVP (Mw range of 29,000 - 55,000, 99% pure) 
were used as received. Milling of all excipients except PVP was carried out using 
conditions mentioned in section 2.2.3. As PVP is amorphous in nature, no prior milling 
was required. The milled form of excipients (ball-milled AA, ball-milled MgSt) was 
characterized immediately after extracting the sample from the milling jars at the end of 
the milling process.  
2.2.4.5 Preparation of Co-milled Mixtures with Excipients 
Co-milled (G3, H4, & I5) and physical mixtures (B2, C3 & D4) were prepared (Table 
2.3) at similar drug-excipient ratios as done for co-milled mixture F2. The co-milled 
mixtures were characterized immediately after extracting the co-milled sample from the 
milling jars at the end of the milling process while the physical mixtures were 
characterized immediately after sample was obtained from turbula mixer. 
2.2.4.6 Preparation of Co-milled Mixtures with LAC and PVP  
Co-milled mixture of J6 at 1:1:0.4 and 1:0.5:0.5 w/w ratios were prepared (Table 2.3). 
The co-milled mixtures were characterized immediately after extracting the co-milled 
sample from the milling jars at the end of the milling process. 
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2.2.5 Physical Stability of Stored Samples  
 
Ball-milled SS, co-milled (F2, G3, H4 & I5) and physical mixtures (A1, B2, C3 & D4) 
were stored in desiccators at approximately 22°C for 7 days. Storage humidity conditions 
of 15 and 75% RH were prepared using phosphorus pentoxide and standard hygrostatic 
NaCl solutions (OIML, 1996). XRPD of the co-milled and physical mixtures prior and 
after storage were conducted to evaluate changes in crystallinity. Additionally, co-milled 
(F2 & I5) and physical (A1 & D4) mixtures were evaluated for changes in morphology 
using SEM. The conditions for XRPD and SEM are mentioned in section 2.2.6. 
2.2.6 Analysis of Co-milled and Physical Mixtures  
2.2.6.1 X-ray Powder Diffraction (XRPD) 
Diffraction patterns of SS, ball-milled SS, ball-milled LAC, ball-milled AA, ball-
milled ball-milled MgSt, PVP, co-milled (F2, G3, H4 & I5) and physical mixtures (A1, B2, 
C3 & D4) were obtained using conditions mentioned in the section 2.2.1.7.  
2.2.6.2 Dynamic Vapor Sorption (DVS) 
Sorption isotherms of ball-milled SS, ball-milled LAC, ball-milled AA, ball-milled 
ball-milled MgSt, co-milled (F2, G3, H4 & I5) and physical mixtures (A1, B2, C3 & D4) 
were obtained using DVS (Advantage, Surface Measurement Systems, Alperton, UK). 
The initial drying phase of 3 h at 0% RH was carried out. The humidity range was then 
varied from 0 to 90% RH in steps of 10% RH at 22°C. The humidity was run in dm/dt 
mode to arrive at equilibrium with a reported dm/dt set at 0.002% per min within an 
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2.2.6.3 High Senstivity Differential Scanning Calorimetry (HSDSC) 
Thermograms of ball-milled SS, ball-milled LAC, ball-milled AA, ball-milled MgSt, 
PVP, co-milled (F2, G3, H4 & I5) and physical mixtures (A1, B2, C3 & D4) were analyzed 
using a Micro-DSC (Setaram, Caluire, France). Approximately 20 mg of each sample 
was loaded into Hastelloy-made vessels (1 cm
3
). Scanning was performed from 40 to 
110°C at a heating rate of 1°C/min. 
2.2.6.4 Scanning Electron Microscopy (SEM) 
The particle morphology of co-milled (F2) and physical (A1) mixtures were further 
examined at 10 KeV using SEM. Samples were prepared as mentioned under section 
2.2.2.2. 
2.2.6.5 High Performance Liquid Chromatography (HPLC) 
The SS contents in co-milled (F2) mixtures were analyzed by HPLC using the method 
developed by Zhu and co-workers (2008). The measured retention time for SS was 
approximately 3.9 min. Standard solutions were prepared for drug concentrations ranging 
from 0.5 - 15 µg/ml, in order to construct a calibration curve of drug concentration 
against the peak area. The calibration was considered to be acceptable when R
2 
> 99.9%. 
2.2.6.6 Infra-red Spectroscopy (FT-IR) 
Absorbance spectra of SS, ball-milled SS, PVP, co-milled (F2 & I5) and physical 
mixtures (A1 & D4) were obtained by a FT-IR spectrometer (Perkin-Elmer 2000, 
Massachusetts, USA). Samples were prepared as a pellet in a KBR matrix. Thirty-two 
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2.2.6.7 In situ Raman Spectroscopy  
Crystalline and amorphous phases in co-milled (F2) and physical (A1) mixtures at 1:3 
w/w ratio were analyzed using DVS with integrated Raman probe. The Raman probe is 
130 mm in length and the wavelength of the laser used was 785 nm. The initial drying 
phase of several hours at 0% RH was carried out. The humidity range was then varied 
from 0 to 90% RH in steps of 10% RH at 25°C.  The instrument was runned in dm/dt set 
at 0.002% per min with interval of 5 min. A sample of 10-15 mg was used.  
2.2.6.8 Raman Microscopy (RM) 
      Raman spectra of co-milled mixtures of I5 at ratios of 1:3 , 1:5, 3:1 and 5:1 (w/w) as 
well as physical mixtures of D4 at ratio of 1:5 were measured using a Raman microscope 
(InVia Reflex, Renishaw) equipped with near infrared enhanced deep-depleted 
thermoelectrically Peltier cooled CCD array detector (576 X 384 pixels) and a high grade 
Leica microscope. The Raman scattering was excited with a 785 nm near infrared diode 
laser. A 50x objective lens was used to collect the backscattered light. Raman point-by-
point mapping with a step size of 5 µm in both the x and y directions was performed in an 
area of 100 µm X 100 µm. Measurement scans were collected using a static 1800 groove 
per mm dispersive grating in a spectral window from 700 to 1800 cm
-1
. Since the 
collected raw Raman spectra were a combination of Raman scattering signals, spikes due 
to cosmic rays, and some autofluorescence background, spectral preprocessing was then 
carried out first in order to generate Raman spectral alone. Spikes were removed in the 
first step followed by baseline correction. The preprocessed Raman mapping data was 
then analyzed using the band-target entropy minimization (BTEM) algorithm (Widjaja et 
al., 2003) to reconstruct the pure component spectra (i.e. SS and PVP) from the spectra of 
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the co-milled and the physical mixtures. BTEM algorithm is one of the self-modeling 
curve resolution (SMCR) techniques, which was developed to recover the pure 
component spectra of underlying constituents from a set of mixture spectra without 
recourse to any a priori known spectral libraries. It can reconstruct pure component 
spectra of minor components (Li et al., 2002; Widjaja and Seah, 2008).   
2.3 Studies on CAM and IB  
2.3.1 Characterization of Unmilled CAM  
Crystalline CAM, the model API, was purchased from Nexchem Pharmaceutical Co., 
Ltd, China. The identity was verified by carrying out XRPD and thermal analysis using 
DSC as follows.  
2.3.1.1 X-ray Powder Diffraction (XRPD) 
Powder diffraction of CAM was obtained using X-Ray powder diffractometer 
equipped with PSD Vantec-1 detector. Measurements were performed with CuK 
radiation over the angular range from 2 < 2 < 40° in step scan mode (step width 0.067°, 
scan rate 1.9°/min).  Crystalline structure of the sample was verified by comparing to the 
standard reported in the Cambridge Structural Database. 
2.3.1.2 Differential Scanning Calorimetry (DSC) 
Thermogram of crystalline CAM was analyzed using a HyperDSC (Diamond Series 
DSC, Perkin-Elmer Ltd, USA). Approximately 5 mg of sample was placed inside an 
aluminium pan which was subsequently sealed hermetically. Scanning was performed 
from 40 - 230°C at a heating rate of 5°C/min under nitrogen purge rate of 20 mL/min.  
2.3.1.3 Determination of Tg 
The amorphous CAM samples were prepared by melt quenching in the cell of DSC 
which involved sealing an approximately 5 mg of crystalline CAM inside an aluminium 
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pan, heating to 230°C at different heating rates of 5°C/min, 10°C/min and 50°C/min 
respectively, holding at 230°C for 2 min and then immediately cooling to 25°C at 
50°C/min under nitrogen purge rate of 20 mL/min. The sample was re-heated again at 
respective heating rates to determine the Tg of amorphous CAM.  
2.3.2 Sieving of IB 
Sieved fractions of crystalline IB using sieves of 212, 150, 250, 106, 63 or 38 μm 
were obtained with Retsch Sieve Shaker (Retsch GmbH, Rheinische Straße, Haan, 
Germany) set at amplitude of 2.0 mm for 10 min. Sieved fraction of 63 - 106 µm was 
used for the co-milling studies. 
2.3.3 Milling and Cryomilling  
2.3.3.1 Ball Milling of CAM and IB 
Ball milling of CAM and IB (63 - 106 μm) was carried out at 25ºC in the planetary 
ball mill using conditions mentioned in section 2.2.3.5. Milling of CAM was carried out 
at intervals of 30, 45 and 60 min, while that of IB (63 - 106 μm) was carried out with 
different rotation speed of 100 rev min
-1
 and the milling duration was adjusted to 15 min. 
2.3.3.2 Cryomilling of CAM  
Cryomilling of CAM was carried out using a Retsch
®
 vibration cryomill (Rheinische 
Straße, Haan, Germany), equipped with a stainless steel jar and a grinding ball of 
diameter 20 mm. This enabled continuous milling at liquid nitrogen temperature. 
Approximately 2 g of the mixture and the grinding ball placed inside the jar were pre-
milled for duration of 5 min at 10 s
-1
. Followed by pre-milling, milling was further 
carried out for intervals of 10, 20, 30, 45, 60 and 75 min at vibration speed of 20 s
-1 
at  
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-196°C. The mass ratio of ball to sample was kept at 16:1. After milling, the milled 
material was warmed up to 25 ºC and was characterized immediately after extracting the 
sample from the milling jar. 
2.3.3.3 Preparation of Co-milled and Physical Mixtures with Excipients 
Non-ionic polymer such as co-povidone (Kollidon VA 64, Ph.Eur., Mw range of 
45,000 - 70,000), and an ionic polymer, polymethacrylate (Eudragit EPO, Ph.Eur., Mw - 
47,000), purchased from Evonik (Singapore) were selected as amorphous excipients for 
co-milling with CAM. The excipients were used as received for co-milling process. 
Commonly used tablet excipients such as MgSt (also used for co-milling studies with 
SS), colloidal SiO2 (Mw - 60, 99% pure) were used as received for co-milling studies with 
IB. Table 2.4 summarizes the preparation of co-milled and physical mixtures of CAM 
and IB with respective excipients. Different ratios of 1:1, 1:2, 1:3, 1:4, 2:1, 3:1 w/w of C1 
and D2 and a fixed ratio of 19:1 w/w of I1 and J2 were prepared (Table 2.4). Immediate 
characterization was needed due to the unstable nature of the milled form of the 
materials. Selected drug - excipient mixtures of A1 at ratio of 1:1 w/w, B2 (Table 2.4) at 
ratios of 1:4 and 1:5 w/w, G1and H2 at a fixed ratio of 19:1 were prepared and compared 
with results obtained for co-milled mixtures. The physical mixtures were characterized 
immediately after the samples were obtained from turbula mixer. In addition, co-milled 
mixtures of D2 at ratios (1:1 - 1:4 w/w) were also prepared by co-milling for duration of 
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Type of Mixtures Excipients Equipment Process 
A) CAM 
1) Physical 
   A1 -  Ball-milled CAM 
   B2  -  Ball-milled CAM 
    





   C1  - CAM 
   D2  - CAM 
    






3) Cryo co-milled  
   E1 - CAM 










1) Physical  
   G1  - Ball-milled IB 
   H2  - Ball-milled IB 
 
2) Co-milled  
    I1  - Sieved IB   
    J2   - Sieved IB 
 
 
           
 
 
      
 
  Ball-milled Kollidon VA 64 







    
Kollidon VA 64 




















   
  MgSt  
colloidal SiO2  
 
 
  MgSt  




            
  










































Ball-milled CAM and 
excipients prepared at 
milling interval of 45 min 
were used. Ball-milled 
CAM-excipient physical 
mixtures were prepared by 




mixtures were prepared by 
mixing at 49 rpm for 20 
min. 
 The resultant mixtures were 
ball-milled at conditions 
mentioned in section 2.2.3.5 
with milling duration 
adjusted to 45 min 
 
CAM-excipient cryo co-
milled mixtures were 
prepared by mixing at 49 
rpm for 20 min.  
The resultant mixtures were 
cryo-milled at conditions 
mentioned in section 2.3.2.2 
with milling duration 
adjusted to 45 min 
 
Ball-milled IB -excipient 
physical mixtures were 
prepared by mixing at 49 
rpm for 20 min.  
 
IB-excipient co-milled 
mixtures were prepared by 
mixing at 49 rpm for 20 
min.  
The resultant mixtures were 
ball-milled at conditions 
mentioned in section 2.3.3.1 
with milling duration 
adjusted to 15 min 
 
Table 2.4 Preparation of physical and co-milled mixtures of CAM and IB  
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2.3.3.4 Preparation of Cryo co-milled Mixtures with Excipients 
Different ratios (1:1, 1:2 and 1:3 w/w) of E1 and 1:1 w/w of F1 were prepared (Table 
2.4). After milling, the milled material was warmed up to room temperature and was 
characterized immediately after extracting the sample from the milling jar. Additionally 
co-milled mixture F1 at 1:1 w/w ratio was also prepared at a milling duration of 75 min. 
2.3.4 Physical Stability of Stored Samples  
Ball-milled CAM, cryo-milled CAM, co-milled mixtures (C1 & D2), physical 
mixtures (A1, & B2) and cryo co-milled mixtures (E1 & F2) were stored in a humidity and 
temperature controlled oven for 90 days at 40°C /75% RH. Samples were analyzed using 
XRPD at pre-determined time intervals of 7, 14, 21, 30, 60 and 90 days to evaluate 
changes in crystallinity. Additionally, DSC was used to analyze thermal changes in 
mixtures stored under accelerated stress conditions. The conditions for XRPD and DSC 
are described in the following section. 
2.3.5 Analysis of Mixtures and Excipients  
Table 2.5 summarizes the methods used for analysis of milled CAM, excipient and 
CAM-excipient mixtures. 
2.3.5.1 Scanning Electron Microscopy (SEM) 
Particle morphology of CAM, milled samples (M1, M2, M5 & M6) (Table 2.5) were 
further examined at SEM conditions mentioned in section 2.2.2.2. Operating condition at 
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Table 2.5 Analysis of milled CAM and CAM-excipient mixtures 
 
2.3.5.2 Particle Size Analysis  
  
Particle size analysis of CAM, milled samples (M1 – M6), (Table 2.5) were carried out 
at conditions mentioned in section 2.2.3.3, with water replacing ethanol was used as a 
dispersant. Particle size analysis of M7 sample, colloidal SiO2, co-milled mixtures (I1 & 
J2), physical mixtures (G1 & H2) (Table 2.5) were carried out at conditions mentioned in 
section 2.2.3.3, with water containing 2 wt% Tween 20 (surfactant) replacing ethanol as a 
dispersant. Particle size analysis of MgSt was carried out at conditions mentioned in 
section 2.2.3.3 with ethanol as a dispersant. 
 
Type of Samples Analysis 
1) Milled  
 M1- 45-min Ball-milled CAM 
 M2- 45-min Cryo-milled CAM 
 M3- 60-min Cryo-milled CAM 
 M4 - 75-min Cryo-milled CAM 
 M5 - Stored (40°C/75%RH/7days) 45-min Ball-milled CAM 
 M6 - Stored (40°C/75%RH/7days) 45-min Cryo-milled CAM 




 Particle Size Analysis  
 BET 
 Moisture Content 





2) Co-milled mixtures(C1 & D2) 
 






3) Physical mixtures (A1 & B2)  Electrostatic Measurement 
 XRPD 
 IGC 
4) Cryo co-milled mixtures (E1 & F2)  XRPD 
5) Co-milled mixtures (I1 & J2)  Electrostatic Measurement 
 XRPD 
 Particle Size Analysis  
6) Physical mixtures (G1 & H2)  Electrostatic Measurement 
 XRPD 
 Particle Size Analysis 
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2.3.5.3 Brunauer-Emmett-Teller (BET) 
 
Nitrogen adsorption/desorption isotherm of CAM, milled samples (M1 – M6) (Table 
2.5) were measured by using an Autosorb-6B gas adsorption analyzer (Quantachrome 
instruments, Boynton Beach, FL) at the conditions mentioned in section 2.2.2.3. 
2.3.5.4 Moisture Content  
Moisture contents of CAM, milled samples (M1 – M6) (Table 2.5) were determined 
using the Karl Fischer Coulometry method Ic (USP26-NF21, 2003b). A similar 
procedure was used as under section 2.2.1.5. 
2.3.5.5 Electrostatic Measurement 
The triboelectrification of CAM, milled samples (M1 – M7), Eudragit EPO, co-milled 
mixture (D2), physical mixture (B2), co-milled mixtures (I1 & J2) and physical mixtures 
(G1 & H2) (Table 2.5) were measured using a Faraday cage (model TR8031) attached to 
an electrometer (Keithley 6517A, Keithley Instruments, Cleveland, OH, U.S.A.). The 
electrometer was connected to a computer via the GPIB interface for data acquisition. 
The sample was weighed in a separate metallic cup. The Faraday pail was kept closed 
with a lid while sample was being weighed separately on a balance. The sample was then 
introduced in the Faraday pail from metallic cup by opening the lid. The lid was 
immediately placed after the sample was introduced. The specific charges (nC/g) of the 
samples were obtained by dividing the net charge obtained by the mass of sample used in 
each measurement. All tests took place in a low RH (< 20%) environment at 22 – 24 °C.  
2.3.5.6 X-ray Powder Diffraction (XRPD) 
Powder diffraction patterns of milled samples (M1 – M6), Kollidon VA 64, Eudragit 
EPO, ball-milled Kollidon VA 64, ball-milled Eudragit EPO, co-milled mixtures (C1 & 
D2) and physical mixtures (A1 & B2), cryoco-milled mixtures (E1 & F2), M7 sample, 
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MgSt, colloidal SiO2, co-milled and physical mixture with MgSt, co-milled mixtures (I1 
& J2), physical mixtures (G1 & H2) (Table 2.5) were obtained using conditions mentioned 
in section 2.3.1.1.  
2.3.5.7 Differential Scanning Calorimetry (DSC) 
Thermograms of milled samples (M1 – M4), Kollidon VA 64, Eudragit EPO, ball-
milled Kollidon VA 64, ball-milled Eudragit EPO, co-milled mixtures (C1 & D2) and  
physical mixtures (A1 & B2) were analyzed using conditions mentioned in section 2.3.1.2. 
2.3.5.8 Infra-red Spectroscopy (FT-IR)  
Absorbance spectra of milled sample (M1), Kollidon VA 64, Eudragit EPO, ball-
milled Kollidon VA 64, ball-milled Eudragit EPO, co-milled mixtures (C1 & D2) and 
physical mixtures (A1 & B2) were obtained by a FT-IR spectrometer (Perkin-Elmer 2000, 
Massachusetts, USA) using conditions mentioned in section 2.2.6.6. 
2.3.5.9 High Performance Liquid Chromatography (HPLC) 
The CAM contents in co-milled mixtures (D2) at 1:4 w/w were analyzed by HPLC. 
The HPLC method developed by Yajima and team
 
(2002) was modified in order to obtain 
an acceptable calibration. The operating conditions used were: ultraviolet absorption 
wavelength of 210 nm, reverse-phase column (15cm X 3.5 mm i.d, Zorbax Extend), 
column temperature of 40°C, mobile phase mixture of 1/15 M monobasic potassium 
phosphate buffer and acetonitrile (65:35) at a flow rate of 0.8 mL/min. The retention time 
for CAM was 5 min. Standard solutions were prepared for drug concentrations ranging 
from 0 to 1000 µg/ml, in order to construct a calibration curve of drug concentration 
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2.3.5.10 Inverse Gas Chromatography (IGC) 
      Surface characteristics such as dispersive component of surface free energy and 
acidic-basic parameters of CAM, milled samples (M1 – M6), Eudragit EPO, ball-milled 
Eudragit EPO, co-milled mixture (D2) and physical mixture (B2) were calculated using a 
commercial IGC system (iGC, Surface Measurement Systems, London, UK). 
Approximately 500 - 800 mg of each sample was packed into a presilanated glass column 
with internal diameter of 3 mm, length of 30 cm by vertical tapping using a tapping 
machine for at least 15 min. Tapping was carried out until no visible cracks, hollow or 
channels could be seen in the body of the powder. The tapped column was then loosely 
stoppered at both ends using a silanised glass wool. The column was subsequently placed 
in the column oven of Agilent gas chromatograph maintained at 30ºC and conditioned for 
a period of 5 h at 0% RH using helium at a flow rate of 10 mL/min and a flame ionization 
detector. After the conditioning, the experiment was performed under similar conditions. 
An elution study was performed using a range of non polar probes such as n-decane, n-
nonane, n-octane, n-heptane, n-hexane with methane as the reference probe and polar 
probes such as ethanol, acetone, ethyl acetate and chloroform. The concentration of the 
probes was set at 0.075 p/p
0
. The selection of the non-polar probes varied for different 
samples and 3 non-polar probes providing the best correlation coefficient of 0.999 were 
further considered for calculation of dispersive component of surface energy. The polar 
probes were used to determine the acidic or electron accepting parameter (KA) and basic 








MITIGATING MILLING-INDUCED AMORPHIZATION OR STRUCTURAL 
DISORDER OF A CRYSTALLINE PHARMACEUTICAL ACTIVE 
 
Amorphization is conventionally considered as an often undesirable but also 
unavoidable side-effect of milling. Hence, methods like co-milling or co-grinding with 
amorphous excipients such as PVP, Neusilin US2, and others to stabilize the unstable 
amorphous form, have been employed (Shakhtshneider, 2007b; Bahl and Bogner, 2006). 
However, there has been no reported attempt to avoid the formation of the amorphous 
state during milling. The first report of crystallinity retained in a milled API in the 
XRPD patterns of ursodeoxycholic acid co-milled with various additives was made but 
the effect was not discussed and the amorphous content was not quantified (Oguchi et 
al., 2000). A recent report revealed that some form of re-crystallization or defect re-
arrangement can take place by heating below the glass transition temperature of 
griseofulvin (Feng et al., 2008).  
This study investigated the feasibility of retaining the crystalline form of milled 
salbutamol sulphate (SS) by co-milling with crystalline excipients such as α-lactose 
monohydrate (LAC), adipic acid (AA) or magnesium stearate (MgSt). Co-milling with 
an amorphous excipient, polyvinyl pyrrolidone (PVP), was also carried out as a 
comparison to investigate the effect of the crystallinity of the excipient on the co-milled 
mixture. Co-milling was carried out by milling different ratios of SS and excipients 
using a planetary ball mill and a spiral jet mill. Finally, to test the usefulness of the new 
co-milling technique, a stability study was conducted to monitor the physical stability of 
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co-milled SS after 7-day storage at 75% RH compared to those of the milled SS alone 
and the physical mixture of SS with LAC. 
Salbutamol Sulphate (SS), the model pharmaceutical active, turns amorphous on ball 
milling and is unstable as described in the section 1.8. α- lactose monohydrate (LAC) is 
selected as one of the crystalline excipients as it has been widely used in the 
pharmaceutical industry as a carrier and diluent, especially in the formulation of powder 
mixtures for inhalation (Tee et al., 2000). Fine lactose has been reported as improving 
the aerosolization properties of a cohesive drug and controlling drug dispersion from 
drug-lactose mixtures of inhalation (Islam et al, 2004; Louey and Stewart, 2002). Adipic 
acid (AA) is a single polymorph (Chow et al., 1984) and a common pharmaceutical 
excipient used as an acidulent in effervescent tablets or lubricant in tablets. As it is a 
single polymorph, polymorphic transformation on milling is ruled out. Magnesium 
stearate (MgSt) is crystalline in nature and widely used as a lubricant in tablets 
(Leinonen et al., 1992). Polyvinyl pyrrolidone (PVP) is selected because it is an 
amorphous excipient, tolerated physiologically, widely used as a carrier for solid 
dispersions to increase the dissolution rate while suppressing re-crystallization (Akbuga 
et al., 1988; Kondo et al., 1994; Yagi et al., 1996; Margarit, et al., 2001).  
Amorphous content has been assessed using different techniques such as XRPD, 
DSC with limits of detectability down to 5% and Dynamic Vapor Sorption (DVS) which 
can detect extent of disorders as low as 0.5% (Mackin et al., 2002b). Dynamic Vapor 
Sorption has been found to be the method for producing the best correlation for 
amorphous content in lactose among seven techniques (Lehto, et al., 2006). For this 
study, the amorphous contents of the individual milled components, physical and co-
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milled mixtures were analyzed using XRPD, DVS and DSC. Amorphous content 
analysis by DVS was based on a reported method (Matthias, et al., 2007) where the 
change in mass of micronized SS at a given relative humidity was used to determine the 
amorphous content. Besides these methods, changes in particle morphology were studied 
using SEM for co-milled mixtures kept under ambient and elevated humidity conditions 
(75% RH) to observe any accompanying particle agglomeration and morphological 
changes. It is hoped that providing an in-depth understanding of retention of the 
crystallinity of substances on co-milling could open up new strategies to minimize 
amorphous phase formation during milling, stabilize the properties of a crystalline drug 
during storage and improve the batch-to-batch reproducibility.  
3.1 Characterization of Unmilled SS  
Table 3.1 summarizes the powder properties of unmilled SS. The compressibility index  
No Properties Results 
1 Density and compressibility 
 
Bulk Density = 0.18 g/cm
3
, Tapped Density = 0.25 
g/cm
3
, True Density  = 1.28 g/cm
3
, Compressibility 
Index = 28.33%, Hausner’s Ratio = 1.38 
2 Moisture  content 0.194 wt% 
3 Particle size Ultrasonication during analysis (a) d0.1 = 0.11 µm, d0.5 
= 0.738 µm, d0.9 = 296.90 µm 
 Ultrasonication before analysis (b) d0.1 = 0.1 µm, d0.1 
= 0.33 µm, d0.9 = 11.95 µm 
4 Crystallinity XRPD pattern (Fig. 3.3a) complied with the crystal 
structure in Cambridge structural database 
 
Table 3.1 Powder properties of unmilled SS 
 
and Hausner’s ratio indicates that SS has poor flowing properties. Hausner’s ratio is used 
to predict flow properties of powder. Powders with low inter-particle friction such as 
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coarse spheres have ratio of around 1.2, while those which are more cohesive and less 
free flowing such as flakes have a ratio of greater than 1.6 (Staniforth, 2002). SS lies in 
the mid range as per Table 3.1. It has more inter-particle adhesion and behaves as a 
cohesive powder. Cyclohexane with lecithin 0.1%, a reported dispersive medium (Young 
et al., 2005) for SS, was used for particle size analysis of SS. Particle size of SS varied 
depending on the method of analysis. Lecithin reduced the agglomeration between 
particles and as it is soluble in cyclohexane, it did not interfere with the measurements. It 
can be seen that ultrasonication before analysis (b) yielded a mixture with normal particle 
size distribution, probably due to deaggregation, while ultrasonication during analysis (a) 
gave a pronounced bimodal distribution. The moisture content was found to correlate to 
the reported value (Ashurst et al., 2000).  
3.2 Selection of Sieved (unmilled) Fractions of SS 
Salbutamol Sulphate (SS) is commonly formulated as a carrier based DPI 
formulation. Hence, sieving and milling were initially attempted in order to obtain a drug 
of fine particle size distribution (< 10 µm). Sieving of SS did not yield particles below 75 
µm hence two sieved fractions (75 - 250 and 250 -500 µm) were jet-milled. Particle 
morphology by SEM as well as the change in surface area by BET was used to select the 
sieve fraction. Although SEM photomicrographs (Fig. 3.1) indicate an agglomeration for 
both jet-milled fractions, BET results indicate that jet-milled fraction (75 - 250 µm) had a 
surface area of 14.74 m
2
/g, while jet milled fraction (250 - 500 µm) had a surface area of 
4.81 m
2
/g. The increase in surface area was indicative of decrease in particle size and 
hence the sieved fraction (75 - 250 µm) was used for the co-milling studies. 
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Jet-milled Fraction (75 - 250 µm)                             Jet-milled Fraction (250 - 500 µm) 
 
Figure 3.1 SEM photomicrographs of Jet-milled SS fractions 
 
3.3 Selection of Particle Size of Excipient for Co-milling 
Sieving of LAC gave a yield of 50% of sieved fraction (< 106 μm). Micronization 
using jet milling is an important step for the preparation of APIs for the processing of 
DPI formulations (Brodka-Pfeiffer et al., 2003a). Air-jet mills, causing size reduction 
through particle impact and attrition, are capable of producing super to ultrafine particles 
(1 - 15 μm) within a very narrow particle size distribution (Brodka-Pfeiffer et al., 2003b). 
The material to be ground and the feed gas (compressed air) were introduced into a 
circular grinding chamber where the inter-particle collisions occurred, resulting in finer 
fractions. The critical milling parameters, feed rate, feed or injector pressure and grinding 
pressure were each varied in the experimental trials to achieve the optimal particle size 
distribution. The application of fine lactose was described earlier. An initial attempt was 
made to obtain a yield of at least 90% of fine lactose less than 10 μm in size. Two sieved 
fractions (≤ 63 and ≤ 106 μm) were subsequently jet-milled based on the specifications 
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provided by the supplier (Hosokawa Alpine). The processing conditions and respective 
observations are given in Table 3.2. 
 
Table 3.2 Jet milling trials of LAC 
3.3.1 Particle Size Analysis  
Particle size analysis of Trial No. 1 and 4 samples were carried out using the wet 
dispersion method. Particle size analysis of Trial No. 2 and 3 samples was not done as 
sieve analysis after jet milling did not indicate a reduction in particle size. Reproducible 
results could not be obtained using the wet dispersion method therefore analysis was 
repeated using the dry dispersion method. Analysis of Trial No.5 sample was carried out 
















1 ≤ 106 60 6 6 50 - 80 Yield ≥ 70%, 
particles 
agglomerate 
2 ≤ 106 60 5-6 3-4 70 Yield ≥ 70%, 
particles 
agglomerate,  
1% < 106 µm 
3 ≤ 106  60 6 5.5 70 Particle still 
agglomerate 
4 ≤ 63 50 8.5 7 70 Particles 
agglomerate, fewer 
particles below 
original feed size 
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vibration feed rate gave the best results. It can be clearly seen that in all the trials, LAC 
showed a polydisperse particle size distribution. Volume equivalent diameters are given 
in the Table 3.3. To confirm that, particle size reduction was achieved on jet milling, 
SEM images of Trial 5 particles were taken (Fig. 3.2). As the milling conditions 
employed in Trial 5 gave an expected particle size distribution range, it was further 









Table 3.3 Particle size distribution of Jet-milled LAC 
 
3.3.2 Comparison of Ball-milled and Jet-milled LAC  
Ball milling of LAC yielded agglomerates. Sonic sifting of ball-milled LAC showed 
that 26% of the particles were less than 38 µm, whereas very few particles of jet- milled 
LAC was below 38 µm. SEM was also used to compare the particle morphology and size 
of ball-milled and jet-milled LAC. Fig. 3.2 shows the SEM photomicrographs of ball-
milled LAC and jet-milled LAC (Trial 5). As jet-milled LAC and ball-milled LAC were 
agglomerative in nature, both milling methods were further employed for co-milling 
studies. 
Trial No Volume Equivalent Diameters 
1            d0.1 = 0.9 µm, d0.5 = 5.4 µm, d0.9 = 150 µm 
4            d0.1 = 0.7 µm, d0.5 =  70 µm, d0.9= 225 µm 
5            d0.1 = 0.9 µm, d0.5 =  22 µm, d0.9= 101 µm 
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  Ball-milled LAC                                                      Jet-milled LAC 
Figure 3.2 SEM photomicrographs of Ball-milled LAC and Jet-milled LAC fractions 
3.4 Co-milling  
3.4.1 Co-milling of SS with Jet-milled LAC 
Co-milling of SS with jet-milled LAC was initially carried out. In Fig. 3.3, the XRPD 
of SS co-milled with jet-milled LAC was compared with those of jet milled SS, SS and 
jet-milled LAC. Jet milling resulted in reduction of the characteristic peaks of SS (Fig. 
3.3b) at 10.50°, 17.67° and 18.32° 2θ. The characteristic peaks of LAC at 19.61° and 
19.98° 2θ (Fig. 3.3c), though reduced in intensity, were present in jet-milled LAC. The 
random peaks observed at ~ 3° 2θ (Fig. 3.3b,c & f) was due to background interference. 
The characteristic peaks of crystalline SS at 17.67° and 18.32° 2θ were also observed 
when SS was co-milled with jet-milled LAC at 1:1 wt% ratio (Fig. 3.3d). Increasing the 
ratio of LAC in co-milled mixtures resulted in more peak counts of characteristic SS and 
LAC peaks (Fig. 3.3e). These observations suggest that jet milling at these parameters did 
not change SS fully to its amorphous form. A previous study (Brodka-Pfeiffer et al., 
2003b) suggested that jet milling of SS could be carried out at higher grinding and higher 
feed pressures, however it was not feasible in the available jet mill. Controlling the 
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pressures to a constant during milling was a challenge. Optimization of jet milling 
parameters could yield amorphous SS, with more passes of SS through the jet mill. 
Further, studies were carried out using a planetary ball mill to see whether fully 
amorphous form of SS could be obtained. 
 
 
Figure 3.3 Powder X-ray diffractograms of (a) SS, (b) jet-milled SS, (c) jet-milled LAC, 
(d) co-milled mixture of SS : jet-milled LAC 1:1, (e) co-milled mixture of SS : jet-milled 
LAC 1:2 
 
3.4.2 Co-milling of SS with Ball-milled LAC  
In Fig. 3.4, the XRPD of SS co-milled with ball-milled LAC was compared with 
those of ball-milled SS, ball-milled LAC, physical mixture of ball-milled SS and ball-
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milled LAC. A broad halo confirming the X-ray amorphous state (Fig. 3.4a) was obtained 
on ball milling. The characteristic peaks of crystalline LAC at 19.61° and 19.98° 2θ  
  
Figure 3.4 Powder X-ray diffractograms of (a) ball-milled SS, (b) SS, (c) ball-milled 
LAC, (d) co-milled mixture of SS : ball-milled LAC  1:1, (e) co-milled mixture of SS : 
ball-milled LAC 2:1, (f) physical mixture of ball-milled SS : ball-milled LAC  1:1 
 
(Fig. 3.4c) though reduced in intensity, were still present in ball-milled LAC. This agreed 
with a recent study showing that at least 12 h of ball milling was required to fully 
amorphize LAC (Willart et al., 2006). Interestingly, the characteristic peaks of crystalline 
SS at 17.67° and 18.32° 2θ were observed when crystalline SS was co-milled with ball-
milled LAC (Fig. 3.4d). The retention of characteristic peaks suggested that the degree of 
amorphization has been reduced in the presence of LAC. When the mass ratio of SS : 
ball-milled LAC was greater than 1,  XRPD pattern was predominantly amorphous with 
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low intensity crystalline peaks of  LAC and minute peaks of SS seen, suggesting a 
minimum ratio of LAC was needed in retaining the crystalline form of SS on co-milling 
(Fig. 3.4e). In comparison, these characteristic peaks of SS were also absent in all 
physical mixtures including ball milled SS : ball-milled LAC  1:1 (Fig. 3.4f). In addition, 
the random peak observed at ~ 3° 2θ (Fig. 3.4f) was due to background interference. The 
use of other grinding techniques such as cone or hammer mill with shorter milling 
durations could result similar particle size range with less potential amorphization. 
 
Figure 3.5 Sorption isotherms of ball-milled SS, co-milled mixtures of SS : ball-milled 
LAC (1:1, 1:3 and 1:4) and co-milled mixture of ball-milled SS : ball-milled LAC 1:1   
 
To quantify the amorphous content in milled and co-milled samples, the individual 
components, physical mixtures and co-milled mixtures were analyzed using DVS. The 
moisture sorption isotherms of SS with ball-milled LAC at co-milled ratios 1:1, 1:3 and 
1:4 were measured and plotted in Fig. 3.5. As expected, a mass loss was observed 
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between the first and second sorption isotherms of milled SS with a steep mass loss 
between 60-70% RH (Young and Price, 2004) due to the re-crystallization of amorphous 
regions. Interestingly, this hysteresis occurrence was clearly absent in co-milled mixtures 
at mass ratios of 1:3 and 1:4, which suggests the absence of amorphous content. Physical 
mixtures of ball-milled SS with ball-milled LAC showed mass loss similar to ball-milled 
SS. It should be noted that in order to improve the clarity in Figs. 3.5 and 3.11, second 
sorption isotherms of all samples except ball-milled SS were excluded. Using the method 
reported by Matthias and researchers (2007), the amorphous content was estimated using 
Eq. 3.1 and shown in Table 3.4.  
          Amorphous content = Δm.ms.  1   . 100%                                               (3.1)                                          
                                                   md   Δm100                                                                                                                                                                                                                                                                   
whereby Δm is the difference in change in mass between first and second sorption cycles 
at 30% RH [%], ms the sample mass [kg], md the dry mass of SS [kg] and Δm100 the 
difference in change in mass between first sorption and second sorption cycle of ball 
milled X-ray amorphous SS at 30% RH [%]. Crystalline SS and ball-milled X-ray 
amorphous SS were used as reference points for 0% and 100% amorphous contents 
respectively. The contribution of varying excipient contents to the isotherms has been 
deducted. As indicated in Table 3.4, the co-milled ratio (SS : ball-milled LAC 1:1) 
contained significant amorphous content with small difference of 19% in comparison 
with the physical mixture (ball-milled SS : ball-milled LAC 1:1). The additional water 
sorption, which provides a percentage of amorphous greater than 100, is probably due to 
amorphous lactose. The standards used are pure SS and do not contain lactose. Hence, the 
amorphous content quantification by DVS may not be precise. On the other hand, no 
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detection of amorphous content below the reported detectable limit (< 0.5%) could be 
seen in the co-milled ratios of SS with ball-milled LAC at 1:3 and 1:4.  
*- Reference Values  
Table 3.4 Amorphous contents of SS, physical mixture and co-milled SS with excipients 
 
To verify the absence of amorphous content in co-milled mixtures at 1:3 and 1:4 mass 
ratios, a highly sensitive technique, HSDSC, was applied to probe the amorphous content. 
Fig. 3.6 shows the HSDSC thermograms of ball-milled SS, ball-milled LAC, physical 
and co-milled mixtures of SS with LAC. The HSDSC thermograms of ball-milled SS 
(Fig. 3.6a), physical (Fig. 3.6c) and co-milled (Fig. 3.6d) mixtures except co-milled ratios 
of SS : ball-milled LAC 1:3 (Fig. 3.6e) and 1:4 (Fig. 3.6f)) showed a characteristic Tg 
between 60 and 65°C due to amorphous SS (Dhumal et al., 2009). A re-crystallization 
exotherm was also observed but at a higher temperature range of 100-105°C instead of 
82°C reported previously (Brodka-Pfeiffer et al., 2003b). 
The observation of Tg and re-crystallization is attributed to the amorphous content 
generated by milling. Neither Tg nor crystallization exotherms were observed for the co-
Components Difference in mass 







Ball-milled SS  
Co-milled SS : ball-milled LAC  (1:1)  
Co-milled ball-milled SS : ball-milled LAC  (1:1) 
Co-milled SS : ball-milled LAC  (1:3) 
Co-milled SS : ball-milled LAC  (1:4) 
Co-milled SS : ball-milled AA (1:1) 
Co-milled SS : ball-milled MgSt (1:1) 
Physical mixture ball-milled SS : ball-milled LAC (1:1)  
Physical mixture ball-milled SS : ball-milled LAC (1:3)  
Physical mixture ball-milled SS : ball-milled LAC (1:4)  
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milled ratios of SS : ball-milled LAC 1:3 (Fig. 3.6e) and 1:4 (Fig. 3.6f). Additionally, 
DVS coupled with a Raman probe was also used to differentiate amorphous and 
crystalline phases in physical and co-milled mixtures at ratios of SS : ball-milled LAC 
1:3. As seen in Fig. 3.7 a-b, the broadening of spectra at different RH suggests the 
presence of amorphous material in the physical mixture ratio of ball-milled SS : ball-
milled LAC 1:3. The crystalline spectra of co-milled mixture SS : ball-milled LAC 1:3 
 
Figure 3.6 HSDSC thermograms of (a) ball-milled SS, (b) ball-milled LAC, (c) physical 
mixture of ball-milled SS : ball-milled LAC 1:1, (d) co-milled mixture of SS : ball-milled 
LAC 1:1, (e) co-milled mixture of SS : ball-milled LAC 1:3, (f) co-milled mixture of SS : 
ball-milled LAC 1:4 
 
had lower intensities and features far more clearer than the amorphous spectra. Thus, in- 
 
 






















Figure 3.7 In-situ Raman spectra of (a) physical mixture of ball-milled SS : ball-milled 
LAC 1:3, (b) co-milled mixture of SS : ball-milled LAC 1:3 at increasing RH values 
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situ Raman spectroscopy along with DVS and HSDSC data provided evidence to support 
the notion that co-milling of SS with ball-milled LAC at mass ratios of 1:3 and 1:4 
















Figure 3.8 FT-IR spectra of (a) ball-milled SS, (b) SS, (c) ball-milled LAC, (d) physical 
mixture of ball-milled SS : ball-milled LAC 1:1, (e) co-milled mixture of SS : ball-milled 
LAC 1:1 
 
3.5 Understanding of Amorphization Reduction   
H-bonding interactions upon mechanical activation with polymers and inorganic 
additives such as silicates
 
have been studied (Telang et al., 2009). H-bonding interactions 
have also contributed in confirming co-crystal formation after co-grinding (Jayasankar et 
al., 2006). To decipher the mechanism behind the retention of crystalline SS on co-
milling; the spectra of individual components, physical mixtures and co-milled mixtures 
were recorded using FT-IR. Figure 3.8 shows the FT-IR of ball-milled SS, ball-milled 
LAC, physical mixtures and co-milled mixtures of SS with LAC (1:1). FT-IR of 
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crystalline SS (Fig. 3.8b) characterized by presence of peaks corresponding to secondary 
amine salt (C-N) stretch at 1616 cm
-1
 and 1509 cm
-1
 apart from phenolic C-O stretching 
and secondary alcoholic C-O stretching at 1209 and 1085 cm
-1
 respectively (Hyvönen et 
al., 2005; Geeta and Baggi, 1989). After milling, these peaks decreased in intensity as 
seen in spectra of ball-milled SS (Fig. 3.8a). Ball-milled LAC (Fig. 3.8c) displayed low 
intensity peaks within 1040 to 1160 cm
-1
 attributed to the asymmetrical stretching 
vibrations of C-O-C ether unit bonds (glucose and galactose) (Drapier-Beche et al., 
1999). The peaks in the range of 1600 cm
-1
 and 1700 cm
-1
, of around 1654 cm
-1
 
correspond to the stretching vibrations of water from crystallization of O-H bonds and of 
water adsorbed to the surface of milled LAC (Kirk et al., 2007). The peaks did not shift to 
higher or lower wavenumbers as seen in spectra of both co-milled (Fig. 3.8e) and 
physical mixtures (Fig. 3.8d) of ball milled SS : ball-milled LAC at 1:1 ratio. At the same 
time, no significant change in absorbance of principal peaks of SS and LAC could be 
noted. The presence of H-bonding was also not detected. There was no significant shift in 
N-H and O-H stretching broad peaks (> 3000 cm
-1
) to a lower wavenumber. Thus, FT-IR 
results suggested that inter-molecular interactions between APIs and crystalline 
excipients are not likely to account for the appearance of the characteristic SS crystalline 
peaks in the co-milled mixtures. 
One of the processes involving transformation from crystal to crystal on milling could 
involve an intermediate stage of transient amorphization followed by a rapid re-
crystallization process. It has been difficult to analyze this transient amorphous fraction 
because amorphization ceases when milling is stopped but re-crystallization does not. 
Therefore, when the sample is analyzed using DSC or XRPD, the amorphous fraction is 
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not present (De Gusseme et al., 2008). The presence of transient amorphous fraction has 
been difficult to observe directly but suspected in the polymorphic transformation of 
sorbitol induced on milling (Willart et al., 2005). In this study, the microstructural 
analysis by XRPD showed an increase in crystal size of the milled product. To 
investigate the possibility of the formation of a transient amorphous fraction during co-
milling of SS and ball-milled LAC, samples at ratio of 1:1 were taken at different milling 
intervals of 15, 30, 45 and 60 min. The mixtures at the end of each time interval were 
analyzed using XRPD and plotted in Fig. 3.9. 
 
Figure 3.9 Effect of ball-milling time [(a) LAC, (b)15 min, (c) 30 min, (d) 45 min, (e) 60 
min], temperature (f) cryo co-milled mixture of SS : ball-milled LAC 1:1, (g) co-milled 
mixture of ball-milled SS : ball-milled LAC  1:1. 
 
Little change in crystallinity was observed after 15 min (Fig. 3.9b). An increase in 
peak counts for SS and LAC in co-milled mixture after 30 min (Fig. 3.9c) suggesting the 
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increase in crystallinity as for sorbitol (Willart et al., 2005). After 45 min, the amorphous 
halo in the XRPD pattern (Fig. 3.9d) indicated an almost complete crystalline-amorphous 
transition, which reverted back to the crystalline state after 60 min (Fig. 3.9e). These data 
showed that amorphization of SS took place during the initial phase of co-milling with 
ball-milled LAC. After co-milling for more than 45 min, SS amorphous phase underwent 
re-crystallization. This confirmed the presence of a transient amorphous phase followed 
by re-crystallization after 60 min. Thus, re-crystallization was evident in the presence of 
residual crystalline peaks of LAC (as in Fig. 3.4d) unaffected by mechanical activation. 
This observation aligns with a recent report on fananserine where partially amorphous 
sample produced on milling tended to reverted to the stable crystalline state in the 
presence of residue crystalline particles of the same material (De Gusseme et al., 2008).  
To verify whether the role of “residue” crystalline particles of LAC enhanced the 
process of re-crystallization or minimize amorphization during co-milling, a mixture of 
milled amorphous SS and milled LAC was co-milled at 1:1 ratio for 1 h. Characteristic 
crystalline peaks of SS were clearly visible in the XRPD of the co-milled mixture (Fig. 
3.9g), showing that the amorphous SS has been re-crystallised. XRPD results were also 
supported by DVS results (Fig. 3.5) with amorphous content below the detection limits 
(Table 3.4). 
This finding confirms that crystalline LAC served as seed crystals to re-crystallize 
any form of starting API (i.e. crystalline or amorphous) upon co-milling for 1 h. In 
support of this hypothesis, Brodka-Pfeiffer and team (2003b) suggested that possible re-
crystallization could occur during prolonged milling, accounting for increase in particle 
size and agglomeration of SS. The possible role of nucleation seeds (seed crystals) in 
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suppressing complete amorphization of co-milled indomethacin with Aerosil 200 was 
also suggested by Watanabe and co-workers (2001). This was supported by theoretical 
calculations of the lowest n value for the co-ground mixture in Kolmogoro-Johnson-
Mehl-Avrami (KJMA) equation (Watanabe et al., 2001). In addition, the role of seed 
crystals in polymorphic transformation of chloramphenicol palmitate during grinding has 
been reported (Otsuka and Kaneniwa, 1986). Acceleration of polymorphic transformation 
from one form to another form was observed in the presence of seed crystals of particular 
Form II, with amorphous content below the detection limits (Table 3.4).  
The readily accepted hypothesis behind “amorphization” upon milling of a single 
compound suggests the creation of local hot points due to an increase in temperature 
induced by collisions of the milling balls. These local hot points may exceed the melting 
temperature of the compound. The rapid return to room temperature after the impact 
would then act as a quench mechanism. The amorphization process is thus believed to be 
governed by local “melt/quench” events (De Gusseme et al., 2008). However this 
hypothesis is debatable as suggested in milling studies with compounds such as 
fananserine (De Gusseme et al., 2008), glucose (Dujardin, et al., 2008), lactose (Willart et 
al., 2004) and indomethacin (Crowley and Zografi, 2002). These compounds underwent 
amorphization when milled at temperatures lower than their melting points, increasing 
the gap between the milling and melting temperatures. Although, different results make it 
difficult to understand the process of amorphization, milling temperature is certainly one 
of the crucial factors governing the nature of the milled product. To understand whether 
the “milling temperature” plays a role in mitigating the amorphization process during co-
milling, cryogenic co-milling was carried out on SS : ball-milled LAC ratio of 1:1. 
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Cryomilling is a cryogenic comminution technique that grinds at liquid nitrogen 
temperatures (Crowley and Zografi, 2002). If re-crystallization of amorphous SS 
mitigates amorphization, co-milling at temperatures far below the Tg would suppress the 
re-crystallization process leading to an amorphous sample. As shown in Fig. 3.9f, 
characteristic crystalline peaks of SS were not observed on cryo co-milling. At room 
temperature, re-crystallization of amorphous SS during co-milling was probably 
facilitated by localized heating in the ball mill as with fananserine (De Gusseme et al., 
2008). In previous reports, the temperature of the mill container was correlated to 
temperature rise in metallic powder at collision site of balls and found to be less than 
150°C under normal milling conditions (Xi et al., 2007).  High energy ball-milling could 
lead to the rise of average environmental temperature of more than 100°C (Ren et al., 
2000) that is beyond the Tg of SS (60-65°C). Descamps’s group (2007) explained that 
when milling at temperatures above Tg, where an amorphous state can exist as a 
metastable liquid, the molecular mobility is known to be much higher and increases 
rapidly with temperature. Because of this higher mobility, the restoration of a 
crystallographic order upon milling is expected to be more efficient. Thus, the presence 
of nucleation seeds along with a temperature rise of powder (above Tg of SS) during 
room temperature milling could have been the plausible mechanism behind retention of 
crystalline SS on co-milling. It should be further noted that the increase in temperature 
did not lead to drug degradation as suggested by drug content of 93 ± 2% (assay by 
HPLC; n = 3) and absence of any additional peak in HPLC chromatogram of co-milled 
SS : ball-milled LAC at the ratio of 1:3.  
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When used as an excipient for co-milling, LAC has been shown to be effective in 
mitigating the amorphization of SS. To further study how crystalline seeds induce re-
crystallization of ball-milled SS, crystalline excipients (AA, MgSt), amorphous PVP 
were separately co-milled under similar conditions. 
Results in Fig. 3.10 showed that the characteristic crystalline peaks of SS were also 
retained on co-milling with ball-milled AA (Fig. 3.10c) and ball-milled MgSt (Fig. 3.10g) 
respectively. A distinct observation was that all AA : SS ratios (not shown) displayed 
similar peak counts of SS suggesting that a low ratio of AA : SS was sufficient for SS to 
retain some degree of crystallinity on co-milling. The emergence of unknown peak at ~ 
20° 2θ (Fig. 3.10d) was due to background interference. Co-milling of SS with PVP 
showed an amorphous mixture in Fig. 3.10i.  
 
Figure 3.10 Powder X-ray diffractograms of (a) ball-milled AA, (b) SS, (c) co-milled 
mixture of  SS : ball-milled AA, (d) physical mixture of ball-milled SS : ball-milled AA 
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1:1, (e) ball-milled MgSt, (f) physical mixture of ball-milled SS : ball-milled MgSt 1:1,  
(g) co-milled mixture of SS : ball-milled MgSt 1:1, (h) physical mixture of ball-milled SS 
: PVP 1:1, (i) co-milled mixture of SS : PVP 1:1, (j) co-milled mixture of SS : ball-milled 
LAC : PVP 1:1:0.4, (k) co-milled mixture of SS : ball-milled LAC : PVP 1:0.5:0.5 
 
It could be said that the amorphous PVP did not minimize amorphization of SS during 
co-milling. Additionally, the glass transition of amorphous mixtures of SS with LAC or 
PVP calculated theoretically using the Gordon- Taylor equation are 77°C for SS : LAC 
(1:1) and 92°C for SS : PVP (1:1). Further co-milling in presence of both LAC and PVP 
at different ratios did not retain the crystalline SS peaks (Fig. 3.10j, k). The amorphous 
nature of PVP could have prevented the minimization of amorphization of SS on co-
milling. These results strongly suggest that the crystallinity of the excipient along with 
milling temperature are important factors in minimizing amorphization during co-milling.  
 
 
Figure 3.11 Sorption isotherms of ball-milled SS, physical mixture of ball-milled SS : 
ball-milled AA 1:1 and co-milled mixture of SS: ball-milled AA 1:1, co-milled mixture 
of SS : ball-milled MgSt 1:1 
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Using the same method described by Matthias and researchers (2007), the amorphous 
content of co-milled mixtures of SS with ball-milled AA and ball-milled MgSt, the 
physical mixtures and the individual components were estimated by DVS. Fig. 3.11 and 
Table 3.4 showed that co-milling of SS with ball-milled AA resulted in minimizing the 
amorphous content of SS, to a lesser extent than with ball-milled LAC. On the other 
hand, co-milling with ball-milled MgSt at a lower excipient ratio (1:1) in comparison to 
ball-milled LAC (1:3) was found to be the more effective in reducing the amorphous 
content to below detection limits.
 
3.6 Stability Studies of Mixtures of SS and LAC  
To study if co-milling can improve the physical stability of milled SS, ball-milled SS, 
co-milled and physical mixture of SS : LAC at ratios 1:1 and 1:3 wt% were stored for 7  
 
Figure 3.12 Powder X-Ray diffraction patterns of stability samples (a) ball-milled SS 
(22°C/15%RH), (b) ball-milled SS (22°C/75% RH), (c) co-milled mixture of SS : ball-
milled LAC  1:1 (22°C/15% RH), (d) co-milled mixture of SS : ball-milled LAC 1:1 
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(22°C/75% RH), (e) physical mixture of ball-milled SS : ball-milled LAC 1:1(22°C/15% 
RH), (f) physical mixture of ball-milled SS : ball-milled LAC  1:1 (22°C/75% RH)  
 
days at 22°C and 15 % RH or 75% RH. The crystallinity and morphology of the samples 
were analyzed prior to and after storage. Figure 3.12 shows the XRPD patterns. Ball-
milled SS remained amorphous at 15% RH (Fig. 3.12a). As reported in case of 
amorphous SS (Buckton et al., 1995; Columbano et al., 2002), vapor induced re-
crystallization was clearly evident as indicated by the presence of crystalline peaks in 
XRPD pattern of ball-milled SS at 75% RH. At 75% RH, increases in peak counts in the 
diffractograms were observed in physical mixture of ball-milled SS : ball-milled LAC 
(1:1) (Fig. 3.12f) and co-milled mixture of SS : ball-milled LAC (1:1) (Fig. 3.12d), 
showing that the occurrence of re-crystallization under these storage conditions. The 
random peaks observed at ~ 3° 2θ (Fig. 3.12b,c & f) was due to background interference. 
 Apart from XRPD, SEM is a useful technique for visualizing changes in particle 
shape and surface with respect to milling time (Glushenkov et al., 2008) and storage 
period of the milled material (Ng et al., 2008). Fig. 3.13a-f illustrates the SEM images of 
ball-milled SS, physical mixtures and co-milled samples under the storage conditions. 
Ball-milled SS (Fig. 3.13a) which has similar morphology reported for spray dried SS 
(Corrigan, et al., 2006) appeared close to spherical on storage at 15% RH for 7 days. The 
spherical-like shape of ball-milled SS (Fig. 3.13b) was not retained after 7-day storage at 
75% RH. Fines appeared to agglomerate on irregularly shaped block-like structures, 
which tallied with the occurrence of re-crystallization shown in earlier XRPD results. The 
SEM photomicrograph of co-milled mixture of SS and ball-milled LAC (1:1) stored 
under 15% RH (Fig. 3.13c) showed particle agglomeration with some of the SS particles 
retaining the spherical-like shape rather similar to ball-milled SS (Fig. 3.13a). Particle 









































Figure 3.13 SEM images of stability samples (a) ball-milled SS (22°C/15% RH), (b) 
ball-milled SS (22°C/75% RH), (c) co-milled mixture of SS : ball-milled LAC 1:1  
(22°C/15% RH), (d) co-milled mixture of SS : ball-milled LAC  1:1 (22°C/75% RH), (e) 
physical mixture of ball-milled SS : ball-milled LAC 1:1 (22°C/15% RH), (f) physical 
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agglomeration and subsequent re-crystallization were evident in the SEM 
photomicrograph of co-milled mixture of SS : ball-milled LAC (1:1) stored under 75% 
RH (Fig. 3.13d).  As expected, spherical shape of the SS was relatively well-retained in 
the physical mixture of ball-milled SS : ball-milled LAC (1:1) (Fig. 3.13e) stored at 15% 
RH. However, no retention of the spherical shape was seen in the sample stored under 
75% RH (Fig. 3.13f) with presence of agglomerated particles resembling to Fig. 3.13b. 
This absence of fused spherical SS particles agrees with a re-crystallization process to a 
stable state, which was evident during the milling process.  No significant changes in the 
XRPD and SEM analyses of the co-milled mixtures SS : ball-milled LAC (1:3) and 
higher ratios were observed.  
3.7 Summary      
The work sets out to investigate the effect of some pharmaceutical excipients for 
mitigating amorphization in SS. The use of jet mill was inefficient in achieving an X-ray 
amorphous form of SS. On the other hand, co-milling of SS with ball-milled LAC at 1:3 
and 1:4 ratios using a planetary ball mill minimized the amorphization below the 
detection level of DVS (0.5%), DSC (5%) and XRPD (5%). The physical mixtures in the 
same ratios served as the control and these did not improve the crystallinity of milled SS. 
To the best of our knowledge, the use of crystalline excipients to mitigate the amorphous 
content of an API to such low levels by co-milling has not been reported before. By 
investigating the effects of the nature of excipients, milling time and temperature, it was 
found that the presence of crystalline excipient aided by the temperature rise during 
milling (> Tg) led to re-crystallization of SS upon co-milling for 1 h. Co-milled SS : ball-
milled LAC at 1:3 ratio showed no change in crystallinity nor morphology upon storage 
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at 75% RH (elevated humidity level) for 7 days as compared to both milled SS and 
physical mixtures. The results reveal that co-milling with a crystalline excipient has 
potential in achieving a crystalline form of a milled API. As milling alone leads to a 
thermodynamically unstable and dynamic amorphous state, (Martin and Bellon, 1997) 
this application offers a novel solution to tackle the challenges of handling the unstable 
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     CHAPTER 4  
 
STABILIZATION OF MILLED AMORPHOUS FORM OF  
SALBUTAMOL SULPHATE 
 
One of the major challenges of the pharmaceutical industry is to improve the water 
solubility of NCEs under development. This necessitates the use of highly soluble 
amorphous form of the drug. However, the amorphous form of the drug is 
thermodynamically unstable and tends to re-crystallize to the stable but less soluble 
crystals under temperature and humidity stress encountered during accelerated storage 
conditions designed for testing pharmaceutical preparations (Vasconcelos et al., 2007). 
Thus, stabilization of the amorphous form of drug is particularly desirable for 
pharmaceutical products. For practical purposes, it is important to find a subtle balance 
between amorphization and stabilization (Watanabe et al., 2001) by application of 
techniques such as melt quenching, spray drying, melt extrusion to formulate stable 
amorphous drug-excipient dispersions (Miyazaki et al., 2004; Ghebremeskel et al., 2006; 
Pokharkar et al., 2006). 
      Studies have shown that the higher Tg and greater viscosity of polymers gave rise to a 
more stable amorphous drug mixture (Hancock et al., 1995; Hancock and Zografi, 1997). 
Polyvinyl pyrrolidone (PVP), a hydrophilic polymer, inhibits re-crystallization and has 
been reported to stabilize amorphous dispersions. (Aso et al., 1996; Watanabe et al., 
2003; Cirri et al., 2004). However, a major concern with the use of PVP is its 
hygroscopic nature. PVP has been reported to have an equilibrium moisture content of 
27.8 wt% at 25°C/75% RH and classified as “very hygroscopic” (Umprayn and Mendes, 
1987).  The hygroscopic nature of PVP could be detrimental when it is used to stabilize 
dispersions. Marsac and co-workers (2008) observed that 25 wt% PVP in the presence of 
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water increased the nucleation rate of the solvent evaporated amorphous nifedipine-PVP 
molecular dispersions leading to re-crystallization. Vapor sorption studies indicated that 
pure amorphous nifedipine with a moisture uptake of around 1-2 wt% showed a 
significant increase in moisture uptake up to 6 wt% when PVP content was increased 
from 0 to 25 wt%. In an atomic force microscopy study, Mahlin and team (2006) found 
that when more PVP was present in spray-dried lactose-PVP, the propensity of moisture-
induced re-crystallization increased. The Tg of pure amorphous lactose was below 25°C 
at 40% RH. This RH referred to as the critical crystallization RH increased steadily with 
more PVP in the composite mixture. PVP when used at high concentrations impaired the 
stability of co-formulated amorphous phase. On the other hand, Shakhtshneider’s group 
(2007b) reported that lower PVP content resulted in less stable cryogenic co-ground 
mixture of indomethacin and PVP. Concentrations of PVP above 50 wt% were required 
to keep amorphous indomethacin stable for 300 days. However, indomethacin-PVP solid 
dispersions prepared by solvent evaporation technique did not show any re-crystallization 
even at 20 wt% PVP. The authors suggested that amorphous forms prepared by grinding 
may contain crystalline seeds or nuclei which facilitated re-crystallization at low PVP 
concentrations.  
The nature and content of the polymer plays significant roles when used to stabilize 
the amorphous forms of milled pharmaceutical actives. The stability of amorphous 
salbutamol sulphate (SS) is dependent on storage conditions as the Tg of SS is influenced 
by RH and temperature (Burnett et al., 2004). Therefore, the objective of this work is to 
study the influence of polymer content (PVP) for stabilizing amorphous co-milled SS 
before and after storage under ambient and elevated humidity conditions. The degree of 
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crystallinity, drug-polymer interactions and the re-crystallization tendency of the co-
milled mixtures were evaluated using XRPD, HSDSC, DVS, SEM and FT-IR. Raman 
Microscopy (RM) was utilized to map the spatial distributions of drug and excipient in 
the co-milled mixture.  
4.1 Effect of Co-milling on Crystallinity of SS 
4.1.1 X-ray Powder Diffraction (XRPD)  
As described in section 3.5, co-milling of SS with PVP at weight ratio of 1:1 resulted 
in an amorphous halo at around 20° 2θ for ball-milled SS confirming the X-ray 
amorphous state. As expected, the characteristic peaks of SS were absent in all physical 
mixtures of ball-milled SS : PVP. Absence of crystalline peaks of SS in the diffraction 
pattern confirmed the amorphous nature of the co-milled mixtures. The concentration of 
PVP (10-90 wt%) had little effect on the crystallinity of co-milled mixtures as all were 
found to be X-ray amorphous (Fig. 4.1 ). 
 
Figure 4.1 Comparative Powder X-ray diffraction patterns 
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4.1.2 High Sensitivity Differential Scanning Calorimetry (HSDSC) 
To study the thermal stability of co-milled samples, HSDSC analyses were 
conducted. The thermal characteristics of both ball-milled SS and PVP, and co-milled 
mixture of SS : PVP and physical mixture of ball-milled SS : PVP at the same weight 
ratio of 1:1 are shown in Fig. 4.2. As described previously, ball-milled SS showed a 
characteristic Tg within the range of 60-65°C. As the temperature increased, molecules in 
the amorphous region gained sufficient energy and molecular mobility to overcome the  
 
 Figure 4.2 HSDSC thermograms of ball-milled SS, PVP, physical mixture of ball-milled 
SS : PVP 1:1 and co-milled mixture of SS : PVP 1:1 
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activation energy barrier to re-crystallization. They rearranged themselves into their 
thermodynamically stable crystalline form (Burnett et al., 2004). The observed re-
crystallization-induced exothermal effect was shown with a peak at 104.15
o
C with an 
apparent total ∆Hcrystallization of 24.07 J/g. Brodka-Pfeiffer and team (2003b) also found a 
similar value for ∆Hcrystallization for an amorphous form of SS obtained upon ball milling 
for 5 h in a agate mortar. DSC thermogram of PVP alone did not show any heat 
transitions except for a small change in baseline in range of 60-65
o
C. This could be due 
to evaporation of absorbed water as previously reported for PVP (Friedrich et al., 2005). 
No shift in Tg of drug or presence of re-crystallization exotherm could be seen in the DSC 
thermogram of co-milled ratios of SS : PVP (1:1 to 1:5). However at lower PVP ratios of 
3:1 and 5:1 (SS : PVP) re-crystallization exotherms were observed.  
 
Components                                                     ∆Hcrystallization (J/g) 
Ball-milled SS                              24.07 
Co-milled SS : PVP (1:1)                                                             NO
a 
Co-milled SS : PVP (1:2)                     NO 
Co-milled SS : PVP (1:3)                                                            NO 
Co-milled SS : PVP (1:5)           NO 
Co-milled SS : PVP (2:1)                      NO 
Co-milled SS : PVP (3:1)             0.92 
Co-milled SS : PVP (5:1)            0.45 
Physical mixture ball-milled SS : PVP (1:1)                                                     38.80 
Physical mixture ball-milled SS : PVP (1:2)                                                               40.23 
Physical mixture ball-milled SS : PVP (1:3)            46.41                              
Physical mixture ball-milled SS : PVP (1:5)                 48.77 
Physical mixture ball-milled SS : PVP (2:1)                                       41.55 
Physical mixture ball-milled SS : PVP (3:1)                                                    39.50 
Physical mixture ball-milled SS : PVP (5:1)                             37.70 
 
a
Re-crystallization exotherm Not Observed  
Table 4.1 Re-crystallization energies 
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Re-crystallization exotherms, indicated by ∆Hcrystallization values, were present in all 
physical mixture ratios (Table 4.1). A distinct increase in the re-crystallization 
temperature in DSC thermogram of physical mixture ball-milled SS : PVP (1:1) (Fig. 4.2) 
and re-crystallization energy of physical mixture ball-milled SS : PVP (1:1) were 
observed (Table 4.1). The ∆Hcrystallization values increased with an increase in PVP content 
in all physical mixtures as seen in Table 4.1. A similar increase in crystallization 
temperature at PVP content of 20 wt% and below was reported for indomethacin-PVP 
co-precipitates (Yoshioka et al., 1995). However, at the same time ∆Hcrystallization values 
were found to decrease with increase in PVP content. It was also noted that increase in 
∆Hcrystallization values were not proportional to the content of ball-milled SS in the physical 
mixtures (Table 4.1). Although the reason for the increase in ∆Hcrystallization values in DSC 
thermograms of physical mixtures was not clear, it could be reasonably said that the 
presence of PVP did have an effect on increasing re-crystallization temperature in the 
DSC thermogram of physical mixture ball-milled SS : PVP (1:1). Additionally, glass 
transition of drug in physical mixtures showed adherence to the Gordon-Taylor predicted 
equation (data not shown) only at PVP content of 25 wt% and below. Shakhtshneider’s 
group (2007b) reported a similar observation in case of cryo-ground mixtures of 
indomethacin and PVP. The Tg was not found to increase with PVP content as predicted 
by Gordon-Taylor equation. The non-ideal mixing of the system was explained in terms 
of molecular size differences between a macromolecule (PVP) and drug (indomethacin). 
An excess free volume will be introduced in the system due to large molecular size of 
PVP. The DSC results showed that co-milling of SS with PVP attributed thermal stability  
 












Figure 4.3a-c FT-IR spectra of SS, ball-milled SS, PVP, physical mixture of ball-milled 
SS : PVP (1:1, 1:2, 1:3, 1:5) and co-milled mixtures of SS : PVP (1:1, 1:2, 1:3, 1:5, 3:1 
and 5:1) 
 
to the amorphous SS at ratio at PVP content of 33.3 wt% and above. Physical mixing 
with PVP at all ratios did not enhance the stability of the mixtures.   
4.1.3 Infra-red Spectroscopy (FT-IR) 
In order to evaluate possible intermolecular interactions in co-milled SS, the spectra 
of individual components, physical and co-milled mixtures were recorded using FT-IR 
(Fig. 4.3a-c). In the Fig. 4.3a, the FT-IR spectrum of SS was well characterized by the 





 apart from phenolic C-O stretching and secondary alcoholic C-O stretching at 
1209 cm
-1
 and 1085 cm
-1
 respectively (Geeta and Baggi, 1989; Hyvönen et al., 2005). 
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Under mechanical activation, these peaks decreased in intensity as seen in the spectra of 
milled SS. PVP showed the characteristic C=O stretching vibration at 1654 cm
-1
 
(Shakhtshneider, 1997). Similar peaks were observed in the physical mixture of ball-
milled SS : PVP (1:1), suggesting SS did not interact with PVP in the physical mixture. 
Co-milled mixture at similar ratio exhibited distinct changes in the IR spectra. The 
characteristic secondary alcoholic C-O stretching peak at 1085 cm
-1
 was almost absent in 
the co-milled mixture spectra. The peak was quite evident in the physical mixture at 
similar ratio. The -OH and -NH stretching vibrations (> 3000 cm
-1
) of SS, while still 
vaguely evident in physical mixture samples, could not be observed in the co-milled 
mixture with lower PVP (Fig. 4.3b). Moreover, the presence of a single peak at 1654 cm
-1
 
corresponding to the carbonyl of PVP (Fig. 4.3a) in comparison to two distinct peaks at 
1616 cm
-1
 and 1654 cm
-1 
in the physical mixture (Fig. 4.3a) suggests that chemical 
interaction between the components during co-milling occurred. Banchero and 
researchers (2009) have recently reported similar peak broadening in FT-IR spectra of 
PVP/piroxicam impregnated samples. Hydrogen bonds between the NH group of drug 
and the N or C=O functions of the PVP were strong enough to weaken the drug NH 
stretching resulting in a weak and broad peak that is completely covered by the bond 
stretches of the PVP. Our results for SS-PVP composites supported the earlier reports that 
amino (NH) stretch of SS formed hydrogen bonds with C=O group of the polymer 
(Shakhtshneider, 1997; Chen et al., 2008). At higher ratios of SS (≤ 50 wt% PVP), 
carbonyl peak of PVP at 1654 cm
-1
 (data not shown) the absorbance increased in co-
milled ratios compared to physical mixtures its position did not change. Although an 
increase in intensity of SS peaks was observed in co-milled mixtures with higher ratios of 
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SS, a change in peak broadening (> 3000 cm
-1
) as seen in Fig. 4.3b was not evident. This 
meant that, formation of a solid dispersion in co-milled ratios containing less than 50 
wt% of PVP might not have occurred. On the other hand, although increases in 
absorbance of SS peaks were less prominent in co-milled mixtures at higher ratios of 
PVP (≥ 50 wt%), the shifting of -NH stretch to lower wavenumber was quite notable 
compared to that physical mixture at similar ratios (Fig. 4.3c). The results support strong 
hydrogen bonding, similar to that of PVP-felodipine dispersions (Konno and Taylor, 
2006). Thus, FT-IR results support the DSC findings, indicating that the inter-molecular 
interactions between SS and PVP could have resulted in stable amorphous form of SS on 
co-milling with PVP (≥ 50 wt%). 
4.1.4 Raman Microscopy (RM) 
The collected Raman image data of co-milled mixtures of SS : PVP at ratios of 1:3, 1:5, 
3:1 and 5:1 (w/w) and physical mixture of ball-milled SS : PVP at ratio of 1:5 were 
preprocessed and analyzed using the Band-Target Entropy Minimization (BTEM) 
method. Unlike other self-modeling curve resolution (SMCR) techniques, BTEM was 
recently reported to be applicable for resolving pure component spectra of species present 
at sub-ppm levels both in non-reactive and reactive multicomponent liquid systems 
measured by FT-IR as well as for resolving pure component spectra of Raman data 
measured from solid-state chemical problems and biological materials (Widjaja and Seah, 
2008). Fig. 4.4 shows the pure component reference spectra of SS, PVP and the extracted 
reference spectra of physical mixture ball-milled SS : PVP (1:5) and co-milled mixture 
ratio of SS : PVP (1:5) estimated by BTEM. The extracted pure component spectra 
estimate of co-milled mixture of SS : PVP at ratio of 1:5 (Fig. 4.4d) exhibited combined 
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Figure 4.4  Pure component Raman spectral estimates of SS and PVP obtained via 
BTEM from SS, ball-milled SS, PVP, physical mixture of ball-milled SS : PVP 1:5 and 
co-milled mixture of SS : PVP 1:5 
 
peaks of SS and PVP which bore resemblance to Raman peaks for SS (Fig. 4.4a) and 
PVP (Fig. 4.4b) respectively. A distinct spectral variation in the extracted pure 
component spectrum estimate was not evident. This suggests that composition co-
linearity between the two components. On the other hand, BTEM analysis was able to 
resolve or separate out the pure component spectra of SS and PVP in the physical mixture 
of ball-milled SS : PVP at ratio of 1:5 (Fig. 4.4c). This indicates that physical blending 
did not produce homogeneous distribution of SS. To further understand the difference in 
distribution behavior of SS and PVP particles, spatial distributions of drug and polymer 
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in physical mixture and co-milled samples were generated using Raman point-by-point 




 Figure 4.5 Raman mapping score images obtained via BTEM from SS, ball-milled SS, 
PVP, physical mixture of ball-milled SS : PVP 1:5 and co-milled mixtures of SS : PVP 
(1:3, 1:5, 3:1 and 5:1). The axes of the score images are in pixels and can be directly 
correlated to distance by multiplying each pixel with 5 µm  
 
projecting the pure spectra reference of SS and PVP (measured from SS and PVP 
samples) onto the measured Raman mapping data. As seen in Fig. 4.5, SS and PVP on 
co-milling were found to be distributed very homogeneously in the mapped areas down 
to 5 µm resolution at all ratios of SS : PVP (3:1) and below. The mapping data of co-
milled ratio of SS : PVP (5:1) (Fig. 4.5e) indicate the presence of SS along with a mixture 
of ball-milled SS and PVP by the reconstruction of pure component spectrum of SS via 
BTEM analysis. The BTEM SS spectrum estimate is similar to the pure spectra reference 
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of SS (Fig. 4.4a). It should be noted that the BTEM estimate of SS (Fig. 4.4a) along with 
BTEM estimates of ball-milled SS and PVP (Fig. 4.4c) were combined together to 
generate spatial distribution of co-milled mixture of SS : PVP at ratio of 5:1 (Fig. 4.5e). 
The results suggested that the minute presence of crystalline SS could have contributed to 
the instability against re-crystallization. A distinct presence of SS clusters was observed 
in the mapping data of physical mixture of ball-milled SS : PVP at ratio of 1:5 (Fig. 
4.5b). The Raman results showed that at PVP concentrations of 25 wt% and above in co-
milled mixtures, SS and PVP were uniformly dispersed at 5 m  5 m scale, which 
supported the FT-IR results that interactions at molecular level were present. 
4.2 Stability Studies of Mixtures of SS and PVP  
To evaluate if co-milling improved the physical stability of amorphous SS, ball-
milled SS, co-milled and physical mixtures of SS and PVP at all ratios were stored for 7 
days at 22°C and 15 % RH or 75% RH. The crystallinity and morphology of the samples 
prior and after storage were analyzed. Fig. 4.6 summarizes the XRPD patterns. Ball-
milled SS remained amorphous when stored at 15% RH but re-crystallized at 75% RH as 
described earlier. At 75% RH, an expected occurrence of re-crystallization was noted for 
all ratios of physical mixtures. This appears as sharp crystalline peaks in the respective 
XRPD patterns. In contrast, co-milled mixtures at higher concentration of PVP i.e. ≥ 80 
wt% stored under elevated humidity conditions were found to be X-ray amorphous (Fig. 
4.6). This was in agreement with the indomethacin-PVP amorphous dispersions prepared 
by cryo-grinding (Shakhtshneider, 2007b) where more than 50% of PVP was required to 
stabilize the amorphous form of indomethacin-PVP cryo-ground mixtures stored for 300 
days at ambient conditions. Presence of PVP has been shown to suppress recrystallization 
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(Watanabe et al., 2003; Cirri et al., 2004).  Despite the earlier report that high 
concentration of hygroscopic PVP may not work as a stabilizer at elevated RH, the 
results demonstrated that stability of ball-milled SS at 75% RH was enhanced by PVP 
above 80 wt%. To evaluate the degree of crystallinity of co-milled ratios (1:1 and 1:3) 
stored at 75% RH, their XRPD diffractograms were compared with a X-ray amorphous 
physical mixture of SS : PVP (1:1) seeded with 1 wt% of crystalline SS. Fig. 4.6 shows 
 
Figure 4.6 Powder X-ray diffraction patterns of stability samples and a physical mixture 
of ball-milled SS : PVP (1:1) seeded with 1 wt% crystalline SS 
 
 the principal diffraction peaks of SS in physical mixture ratio seeded with 1 wt% 
crystalline SS were found to be sharper than in the co-milled ratio 1:1. This suggests that 
after storage at elevated humidity conditions, the co-milled mixture at PVP content of 50 
wt% had low crystallinity while higher PVP ratios led to more enhanced stabilization in 
the amorphous form. 
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Figs.4.7a-k illustrates the SEM images of ball-milled SS, physical and co-milled 







































Figure 4.7  SEM images of stability samples (a) ball-milled SS (22°C/15% RH), (b) PVP 
(22°C/15% RH), (c) ball-milled SS  (22°C/75% RH),  (d) co-milled mixture of SS : PVP 
1:1 (22°C/15% RH), (e) co-milled mixture of  SS : PVP (22°C/75% RH), (f) physical 
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milled SS : PVP 1:1 (22°C/75% RH), (h) co-milled mixture of  SS : PVP 1:4 (22°C/15% 
RH), (i) co-milled mixture of  SS : PVP 1:4 (22°C/75% RH), (j) physical mixture of  ball-
milled SS : PVP 1:4 (22°C/15% RH), (k) physical mixture of  ball-milled SS : PVP (1:4) 
(22°C/75% RH) 
 
milled SS (Fig. 4.7a & c), has been previously described under section 3.5. Amorphous
 
 nature of the PVP particles was clearly evident with a rough and undulated surface 
suggesting a lack of arrangement in the structure of PVP (Fig. 4.7b). The appearance was 
different from reported SEM images of an untreated PVP sample which is made up of 
round and smooth particles, characteristic of the glassy phase (Marini et al., 2003). SEM 
photomicrograph of co-milled mixture of SS : PVP (1:1) stored under 15% RH (Fig. 
4.7d) showed particle fusion with some of the SS particles retaining the spherical-like 
shape rather similar to ball-milled SS (Fig. 4.7a). Particle agglomeration and subsequent 
re-crystallization were evident in the SEM photomicrograph of co-milled mixture of SS : 
PVP (1:1) stored under 75% RH (Fig. 4.7e). As expected, the spherical shape of the SS 
was relatively well-retained in the physical mixture of ball-milled SS : PVP(1:1) (Fig. 
4.7f) stored at 15% RH, while particle agglomeration with no distinct retention of  the 
spherical shape was seen in the sample stored under 75% RH (Fig. 4.7g). SEM 
photomicrographs of a sample of co-milled SS : PVP at a ratio of 1:4 stored at both 15% 
(Fig. 4.7h) and 75% RH (Fig. 4.7i) did not indicate any distinct morphological 
differences. They appeared similar to PVP stored under 15% RH (Fig. 4.7b) with 
particles in agglomerated form. Absence of block-like structures as seen in SEM 
photomicrograph of ball-milled SS stored under 75% RH (Fig. 4.7c) suggests that co-
milled SS : PVP (at 1:4 ratio) could have formed a single solid phase. The spherical 
shape of the SS particles was found in the physical mixture of ball-milled SS : PVP (1: 4) 
(Fig. 4.7j) stored under 15% RH. The physical mixture of ball-milled SS : PVP (1:4) 
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stored under 75% RH (Fig. 4.7k) indicate the presence of block-like structures with a 
glassy appearance. The glassy appearance could be attributed to presence of PVP, which 
has tendency to absorb moisture at elevated humidity conditions. Conditioned PVP in a 
wet atmosphere for 3 h resulted in transformation of PVP into a glassy semisolid mass 
(Marini et al., 2003). This remained unchanged after an hour exposure at RH > 90%. The 
block-like structures bore resemblance to the SEM photomicrograph of milled SS stored 
under 75% RH (Fig. 4.7c) indicating possible occurrence of re-crystallization. This was 
found to be consistent with XRPD pattern of the similar ratio stored at 75% RH (Fig. 
4.6). SEM analysis was found to be consistent with XRPD results and further confirmed 
that co-milling of SS with 80 wt% or more PVP stabilized the amorphous form of SS 
even under elevated humidity conditions. 
Earlier Raman results confirmed homogeneous distributions of PVP and SS on 
particle surfaces. However, when only ball-milled SS was present in Fig 4.7a & c, the 
amorphous surfaces came into close contact with each other, formed solid bridges via re-
crystallization and led to particle fusion and growth (Young et al., 2007). Compared to 
Figs 4.7h and i, where PVP is present at 80 wt%, no evident changes in morphology 
occurred in the absence of re-crystallization. Interdispersion of PVP among the SS could 
have helped to reduce these bridge formations.   
To understand the role of moisture with respect to drug-polymer ratio in co-milled 
mixtures, DVS was used to estimate the moisture sorption behavior of co-milled 
mixtures. As indicated in Fig. 4.8, an increase in moisture content of the co-milled 
mixtures was evident with a corresponding increase in PVP content. However, high RH 
did not result in a steep mass loss, which typically represents a clear transition from 
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amorphous to crystalline in DVS sorption profiles. However at high SS : PVP ratios of 
(2:1 and 5:1), an inflexion is observed between 50 to 70% RH, which indicates some 
extent of re-crystallization. 
 
Figure 4.8 Sorption isotherms of co-milled mixtures 
This suggests that a minimum PVP content may be required to retain the amorphous 
character of co-milled mixture at elevated RH. An important consideration here is the 
minimum amount of excipient needed to stabilize the drug in the amorphous phase on co-
milling. As seen from XRPD results, co-milled ratios of 80 wt% or more of PVP stored 
under elevated humidity conditions for 7 days were found to be completely X-ray 
amorphous, with emergence of crystalline peaks in co-milled ratios of 75 wt% PVP. DVS 
profiles also registered some degree of re-crystallization at ratios containing less than 
33.3 wt% PVP. The difference is not surprising as XRPD is more sensitive to crystallinity 
while DVS is more accurate for detecting amorphous content. This was observed by 
Bhugra and his co-worker (2008), who explained that the stability to drug polymer 
amorphous dispersions was imparted by two different mechanisms based on the polymer 
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concentration. At higher concentrations of 25 wt%, polymer could act as a diluent 
whereby the nucleation rate was reduced as the drug was diluted in the polymer and the 
diffusion pathway for crystallization increased. In the present study, it could be 
reasonably inferred that the polymer acted as a diluent as the co-milled mixtures at higher 
ratios of PVP were found were found to be X-ray amorphous under elevated humidity 
conditions.  
4.3 Summary 
The influence of additive PVP concentration on stabilizing the amorphous form of an 
inhaled drug, salbutamol sulphate, upon milling was investigated. Co-milling of SS with 
PVP content ranging from 0 to 90 wt% resulted in fully amorphous materials. However, 
upon storage at 25°C and elevated RH of 75% RH after 7 days, XRPD analyses showed 
that only SS co-milled with at least 80 wt% PVP content remained X-ray amorphous. In 
comparison, physical blending of ball-milled SS with PVP did not hinder the re-
crystallization process. Even at lower PVP content between 50 and 75 wt%, the 
crystallinity of stored samples remained below that of 1 wt% crystalline SS added to an 
amorphous physical mixture. Thermal treatment using DSC, showed co-milled SS 
containing over 33 wt% or more PVP was thermally stable with no re-crystallization 
exotherm detected. Similar to DSC, DVS analysis using humidity treatment did not detect 
any re-crystallization tendency of the co-milled mixture with over 33 wt% or more PVP 
content. The differences in minimum PVP contents are attributed to firstly, XRPD 
samples were subjected to an extended exposure to elevated humidity of 7 days, which 
provided more time for re-crystallization to occur and  secondly, XRPD can detect low 
degree of crystallinity while DSC and DVS is sensitive to low amorphous content. At 
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crystallinity level of about 1%, XRPD is probably more sensitive in our study. In terms of 
particle morphology, SEM micrographs showed that no observable particle 
agglomeration or surface changes occurred at minimum PVP content of 80 wt%. FT-IR 
results supported the formation of hydrogen bonding between SS and PVP on co-milling. 
The extent of inter-molecular interactions increased with higher PVP content suggesting 
that they could contribute towards a stabilized amorphous phase even when stored at 
higher RH. RM showed that SS and PVP were homogeneously distributed at minimum 
PVP content of 25 wt% and could not be distinguished from each other even at 5 µm 
resolution. This evidence suggested that PVP could be dispersed in very fine clusters or 
at molecular interaction level resulting in a very stable solid dispersion. In summary, a 
good understanding of the drug-excipient interactions, their susceptibilities to heat and 
humidity treatments, as well as stabilities upon storage under accelerated ageing are 
important considerations for designing a stable amorphous formulation using co-milling.  
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CHAPTER 5  
 
INVESTIGATION ON ELECTROSTATIC PROPERTIES OF MILLED AND 
CO-MILLED APIs 
 
5.1 Introduction  
 Pharmaceutical materials being generally dielectric in nature, often induce 
electrostatic charges during the manufacturing process as a result of inter-particle and 
particle-wall collisions. Tribo or frictional charging as explained in section 1.7 is the 
most common form of electrostatic charging for pharmaceutical materials. Charges 
continue to reside on the material surface even after particle-particle separation (Kelly 
and Spottiswood, 1989). Milling can generate amorphous surfaces, which have an effect 
on the triboelectrification of materials. Murtomaa and Laine (2002) found that 
triboelectric charging increases as amorphous content increases on the surface of lactose. 
However, Carter and group (1992) found that micronized lactose showed a lower charge 
value than the theoretical maximum. This was attributed to the presence of particle 
asperities, agglomeration and contact surface roughness limiting particle to stainless steel 
surface contact.  
Additives have been found to stabilize the surface charge. Addition of lactose altered 
the charging behavior of glucose and improved powder flow (Murtomaa and Laine, 
2000). Blending with excipients such as lactose (Pu et al., 2008) and flow enhancing 
additives like magnesium stearate (MgSt) or colloidal silicon dioxide (colloidal SiO2) 
(Pingali et al., 2009a) were reported to improve blend uniformity as well as enhance 
flowability of pharmaceutical actives. The use of flow aids such as talc and titanium 
oxide could also improve flow properties of ibuprofen (IB) (Kato et al., 2005) by 
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reducing the adhesive forces between surface-modified IB particles. However, no attempt 
has been reported to incorporate the additives in co-milling to influence the electrostatic 
properties. This chapter evaluates the use of co-milling for stabilizing the milled 
amorphous form of a readily chargeable active, Clarithromycin (CAM) and modifying 
the electrostatic properties. Triboelectrification of co-milled mixtures is compared with 
those of crystalline and milled forms of CAM. As a preliminary comparison study, co-
milling is conducted using crystalline excipients on another readily chargeable active, IB 
to investigate whether a crystalline co-milled mixture has different electrostatic 
properties.  
Clarithromycin (CAM) is one of the most potent antibiotics used in the treatment of 
Helicobacter pylori which is a severe pathogen in chronic gastritis, peptic ulcers and 
gastric neoplasia. Being a weak base with one ionizable group having pKa of 9.2, CAM 
is ionized at neutral pH. However, it possesses poor water solubility and resists wetting 
by gastrointestinal fluids (Grübel and Cave, 1998). Table 5.1 summarizes the studies 
carried out in order to improve the solubility and efficacy of CAM. Other studies (Bele et 
al., 2005; Zaria and Etaiw, 2007) have reported the presence of surface charges on CAM.  
The presence of surface charge on CAM could affect its diffusion through glycoprotein  
 (mucin layer protecting H. pylori) include extent of interaction with the charged moieties 
on its surface. This is one of the factors that have been found to restrict movement of 
antibiotics due to electrostatic effects, hydration radius of the molecule and extent of 
hydrogen bonding (Allen et al., 1993).  
Ibuprofen (IB), a non-steroidal anti-inflammatory drug, has poor powder flow (angle 
of repose = 54.3°), a great tendency for sticking to the tablet punches and poor 
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Table 5.1 Studies on improving solubility and efficacy of CAM 
















































Inoue et al., (2007) 
        
Physico-chemical properties of ground and 







Effect of cyclodextrin-complexed and 
liposome encapsulated CAM on efficacy of 





Effect of βCD on solubility of CAM in 
presence of citric acid (CA) in water. 
Preparation of solid-state co-evaporated and 





Solubilization and nanoparticle formation of 
CAM in co-ground mixtures with L-
ascorbic acid 2-glucoside (AA-2G) 
Ground amorphous forms showed a 2-fold 
increase in the solubility parameter, which was 
attributed to the increase in polarity upon 
grinding. 
Ground and spray-dried amorphous forms re-
crystallized after 7-day storage at 40°C and 82% 
RH. 
 
700-fold improvement in solubility of 
cyclodextrin-complexed CAM.      
Modest enhancement of efficacy against 
Mycobacterium avium complex (MAC) in human 
macrophages for cyclodextrin-complexed and 
liposome-encapsulated CAM. 
 
104-fold increase in solubility of CAM-βCD 
complex in presence of 6mM CA compared to the 
intrinsic water solubility of CAM. 
CAM formed strong complex with CA and βCD 
on lyophilization and exists as a single phase 
amorphous form. 
 
Co-ground mixture completely solubilized in 
water compared to only 80% drug dissolved in a 
physical mixture of the same ratio. 
Increase in solubility of the drug was attributed to 
decrease in pH of the solution caused by strong 
interactions between N,N-dimethyl amino moiety 
of CAM and the hydroxyl group of AA-2G. 
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compaction behavior which requires granulation prior to tableting (Rasenack and Muller, 
2002; Nada et al., 2005). IB is essentially non-hygroscopic which eliminates the need to 
consider other factors such as surface wetting, caking and agglomeration (Rainsford, 
1999).  
Milling and co-milling of CAM were performed using a planetary and a cryogenic 
ball mill. As increases in moisture content may aid in dissipating the charges by forming 
a water film on particle surface (Young et al., 2004; Nomura et al., 2003), the milled 
fractions were stored in a controlled environment (under phosphorous pentoxide). They 
were subsequently characterized for particle size (laser diffraction), moisture content 
(Karl Fischer Titration), morphology (SEM), crystallinity (XRPD), surface energetics and 
acid-base contributions (IGC). Co-milling with selected excipients was then carried out in 
order to prepare a physically stable amorphous form of CAM.  
The amorphous contents of the physical and co-milled mixtures were analyzed using 
XRPD and DSC. Inter-molecular interactions were studied using FT-IR and surface 
contributions (IGC analysis) were also conducted. The specific electrostatic charge 
measurements of milled and co-milled CAM were carried out with the aid of a Faraday’s 
Cage connected to an electrometer (Kelly and Spottiswood, 1989). 
The Faraday’s cage consists of a metal cup surrounded by a metallic container 
whereby the outside wall of metal cup is connected to the electrometer, and is based on 
Gauss’s law whereby Q (surface charge) = ψ (electric flux). The free electrons flow from 
particle surface flow to the inner wall of the cup which subsequently induces an equal 
charge on the outside wall of the cup which is measured in the form of an electric current 
by the electrometer. The measured net charge on the particles is the sum of the total of all 
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positive and negative charges of the sample collected within the Faraday’s cup. The outer 
metal container acts as a shield and prevents the interference of the surrounding noise 
during charge measurement (Kelly and Spottiswood, 1989; Pu et al., 2008). 
Milling and co-milling of IB with a crystalline and amorphous excipient were carried 
out using a planetary ball mill, while physical blending was performed using turbula 
mixer. The co-milled and blended fractions were stored in a controlled environment 
under phosphorous pentoxide and further characterized for any changes in particle size by 
laser diffraction and specific electrostatic charge with the Faraday’s Cage and 
electrometer. 
5.2 Selection of Excipients for Co-milling  
5.2.1 Clarithromycin (CAM) 
 Its solubility has an impact on the ability of a substance to form a miscible single-
phase product (Yoo et al., 2009). A correlation between amorphous miscibility and 
solubility existed in a system containing functional additives and polymers. A difference 
of less than 7.0 MPa
1/2
 between materials is considered to be a miscible system (Choksi 
et al., 2005). This parameter has been used to select an appropriate polymer system in 
order to prepare a miscible system. In our study, it was used to select the excipients for 





(Yonemochi et al., 2009) which is equivalent to 20.82 MPa
1/2
 (Forster et al., 2001). Thus, 
polymers such as polymethacrylate polymer (Eudragit EPO) and co-povidone (Kollidon 
VA 64) with solubility of 18.9 and 22.7 Mpa
1/2
 (Zheng, et al., 2007) respectively with a 
difference of less than 4.0 MPa
1/2
 compared to that of CAM, were selected. Eudragit EPO 
is a powdered form of Eudragit E 100, a pH-dependent cationic polymer based on 
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dimethylaminoethyl methacrylate and other neutral methacrylic acid esters. It is normally 
used as a coating material for taste masking and moisture protection in solid dosage 
pharmaceutical forms. It is soluble in gastric fluid, swellable and permeable above pH 5 
(Quinteros et al., 2008). Eudragit E 100 and EPO have been incorporated in solid 
dispersions to improve the solubility and / or dissolution of low water soluble drugs such 
as sodium divalproex (Rao et al., 2003), piroxicam (Valizadeh et al., 2007) and 
nimodipine (Zheng et al., 2007). Co-povidone (Kollidon VA 64) is a water soluble 
vinylpyrrolidone-vinyl acetate copolymer. Co-povidone have been used as an additive of 
solid dispersions to improve the solubility of poorly water soluble pharmaceutical actives 
such as IB (Xu et al., 2007) and itraconazole (Chowdary and Rao, 2000).  
5.2.2 Ibuprofen (IB) 
The excipients selected for co-milling with IB were MgSt (crystalline) and colloidal 
SiO2 (amorphous). MgSt is a very fine, light white powder widely used as a lubricant in 
the manufacture of capsules and tablets while colloidal SiO2 is a light, loose, bluish-
white-colored amorphous powder commonly used to improve the flow properties of dry 
powders. The maximum allowable concentration of 5 wt% of the excipients was used for 
co-milling and blending (Kibbe et al., 2000a,b). 
5.3 Milling and Co-milling of CAM 
5.3.1 Effect of Milling and Co-milling on Solid-state and Physico-chemical    
        Properties 
5.3.1.1 X-ray Powder Diffraction (XRPD)  
  Fig 5.1 shows the XRPD diffractograms of samples ball-milled for different durations 
and a 45-min milled sample stored under accelerated stress conditions for 7 days. The 
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XRPD pattern of unmilled CAM in Fig. 5.1a showed characteristic crystalline peaks at 
8.60°, 9.56°, 10.92° and 11.56° 2θ (Salem, 1996) which were verified with the reference 
polymorphic Form II from the Cambridge Structural Database. At least four distinct 
polymorphic forms of CAM have been reported and Form II is the most stable and 
commercially available polymorph (Gómez-Burgaz et al., 2009). A significant decrease 
Figure 5.1 Effect of ball milling of CAM (a) 0 min, (b) 30 min, (c) 45 min, (d) 60 min, 
 (e) milled CAM stored at 40°C/75% RH for 7 days 
 
in peak counts was seen after ball milling for 30 min (Fig 5.1b). The pattern was similar 
to the XRPD pattern of CAM milled for 30 min in a vibrational mill (Yonemochi et al., 
1999). After further milling of 45 min (Fig 5.1c), no significant change in the peak counts 
was observed in the XRPD pattern. Interestingly, after 60 min, the residual crystalline 
peaks in XRPD pattern (Fig. 5.1d) showed an increase in peak counts, indicating a 
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reversal to a more crystalline state (Fig. 5.1e). The trend was similarly observed during 
co-milling of SS with ball-milled LAC (Fig. 3.9) and discussed in section 3.5. To achieve 
 
Figure 5.2 Effect of cryomilling of CAM (a) 0 min, (b) 10 min, (c) 20 min, (d) 30 min, 
(e) 45 min, (f) 60 min, (g) 75 min, (h) cryo-milled CAM stored at 40°C/75% RH for 7 
days 
 
a X-ray amorphous form, low temperature cryogenic ball milling of CAM was attempted. 
As shown in Fig. 5.2, a significant decrease in peak counts could be observed after 10-
min cryomilling. Thereafter, a gradual decrease in peak counts was noted with increasing 
milling time (Fig. 5.2 c-g). An X-ray amorphous halo pattern of the drug was evident 
after 75 min of cryomilling (Fig. 5.2g). A stability study of 45-min ball-milled and 75-
min cryo-milled samples was carried out by storing the samples under 40°C/75% RH for 
7 days. Re-emergence of characteristic crystalline peaks of the drug resembling Form II 
of CAM were observed in XRPD patterns of ball-milled (Fig. 5.1e) and cryo-milled 
samples (Fig. 5.2 h) indicating that ball milling or cryomilling was not sufficient to obtain 
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a stable amorphous form of CAM. These results agreed with the re-crystallization of 
milled and spray dried CAM subjected to 40°C/82% RH for 7 days as reported 
(Yonemochi et al., 1999). Therefore, in order to improve physical stability of milled 
amorphous CAM, co-milling with amorphous excipients were carried out at similar 
milling conditions. 
 
Figure 5.3 Powder X-ray diffractograms of (a) CAM, (b) ball-milled CAM, (c)  Kollidon 
VA 64, (d) co-milled mixture of CAM : Kollidon VA 64 1:1, (e) physical mixture of ball-
milled CAM : ball-milled Kollidon VA 64 1:1, (f) Eudragit EPO, (g) co-milled mixture 
of CAM : Eudragit EPO 1:1 
 
In Fig. 5.3, the XRPD of CAM co-milled with selected excipients (Kollidon VA 64 
and Eudragit EPO) for 45 min at ratio of 1:1 was compared with those of milled and 
crystalline CAM, and physical mixtures at similar ratio. The selected excipients were 
amorphous as evident from the amorphous halos observed in XRPD patterns (Fig 5.3c & 
f). Co-milling with both the excipients reduced the characteristic crystalline peaks of 
CAM (Fig. 5.3a) at 8.60°, 9.56°, 10.92° and 11.56° 2θ giving rise to a broad halo 
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confirming the X-ray amorphous state (Fig 5.3d & g). In comparison, residual crystalline 
peaks of CAM at 9.56°, 10.92° and 11.56° 2θ were still evident in all physical mixtures 
including ball-milled CAM : ball-milled Kollidon VA 64 1:1 (Fig. 5.3e).  
To evaluate whether co-milling could minimize reversion of the amorphous to 
crystalline surfaces of milled CAM, co-milled and physical mixtures of CAM and two 
polymers were stored for 90 days at 40°C and 75% RH. The samples were analyzed in 
terms of crystallinity prior to and after storage using XRPD and DSC. Fig. 5.4 
summarizes the XRPD patterns. XRPD analysis of 7-day stored samples of all co-milled 
and physical mixtures containing Kollidon VA 64 showed occurrence of re-
crystallization indicated by the presence of sharp crystalline peaks (Fig. 5.4a-d). On the 
other hand, no emergence of crystalline peaks was noted in 90-day stored samples of co-
milled mixtures containing ≥ 60 wt% Eudragit EPO (Fig 5.4f & g). The XRPD patterns 
of 7-day stored sample of physical mixtures containing more than 80 wt% Eudragit EPO 
(Fig. 5.4e) showed occurrence of re-crystallization of amorphous CAM as indicated by 
the emergence of crystalline peaks.  
As in section 3.5, milling time affected the amorphization behavior of drug in co-
milled mixtures. Hence, co-milled mixtures of CAM and Eudragit EPO at different ratios 
were prepared by reducing the milling time from 45 to 30 min. The freshly co-milled and 
stored samples were analyzed by XRPD and DSC. Fig. 5.5 summarizes the XRPD 
patterns of freshly co-milled and stability samples. However, a stable amorphous form of 
CAM could only be obtained in a 90-day stored sample of co-milled mixture containing  
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Figure 5.4 Powder X-ray diffraction patterns of stability samples (45 min) (a) physical 
mixture of ball-milled CAM : ball-milled Kollidon VA 64 1:1 (40°C/75%RH/7 days), (b) co-
milled mixture of CAM : Kollidon VA 64 1:1(40°C/75%RH/7 days), (c) co-milled mixture 
of CAM : Kollidon VA 64 1:4 (40°C/75%RH/7 days), (d) co-milled mixture of CAM : 
Kollidon VA 64 1:5 (40°C/75%RH/7 days), (e) physical mixture of ball-milled CAM : ball-
milled Eudragit EPO 1:5 (40°C/75%RH/7 days), (f) co-milled mixture of CAM : Eudragit 
EPO 2:3 (40°C/75%RH/90 days), (g) co-milled mixture of CAM : Eudragit EPO 1:2 
(40°C/75%RH/90 days)  
 
80 wt% Eudragit EPO (Fig. 5.5e) as emergence of small crystal peaks could be seen in 
XRPD patterns of 30-day (Fig. 5.5b) and 60-day stored samples of co-milled mixtures 
containing ≤ 75 wt% Eudragit EPO (Fig. 5.5c & d). Although CAM re-crystallized, the 
low intense peaks of CAM in co-milled mixtures containing less than 80 wt% Eudragit 
EPO content suggested the presence of drug polymer interactions. 
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Figure 5.5 Powder X-ray diffraction patterns of stability samples (30 min) (a) co-milled 
mixture of CAM : Eudragit EPO 1:1, (b) co-milled mixture of CAM : Eudragit EPO 
1:1(40°C/75%RH/30 days), (c) co-milled mixture of CAM : Eudragit EPO 1:2 
(40°C/75%RH/60 days), (d) co-milled mixture of CAM : Eudragit EPO 1:3 
(40°C/75%RH/60 days), (e) co-milled mixture of CAM : Eudragit EPO 1:4 
(40°C/75%RH/ 90 days) 
 
As in section 3.5, the effect of milling temperature on stabilizing amorphous milled 
form of CAM milling was studied by preparing cryo-milled mixtures of CAM with two 
polymers at 1:1 w/w ratio. The freshly cryo-milled and 7-day stored mixtures were 
evaluated using XRPD (Fig. 5.6). An X-ray amorphous form of CAM (Fig. 5.6a) could 
be obtained in cryo co-milled mixture containing 50 wt% Kollidon VA 64. However, the 
crystalline peaks were noted in XRPD pattern of the 7-day stored sample (Fig. 5.6b). 
Cryomilling of CAM containing 50 wt% Eudragit EPO was carried out for a period of 75 
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Figure 5.6 Powder X-ray diffraction patterns of cryo co-milled mixtures [(45 min)  
(a) cryo co-milled mixture of CAM : Kollidon VA 64 1:1, (b) cryo co-milled mixture of 
CAM : Kollidon VA 64 1:1 (40°C/75%RH/7 days), (c) cryo co-milled mixture of CAM : 
Eudragit EPO 1:1] [(75 min) (d) cryo co-milled mixture of CAM : Eudragit EPO 1:1, 
 (e) cryo co-milled mixture of CAM : Eudragit EPO 1:1 (40°C/75%RH/7 days)] 
 
min as 45-min cryomilling time (Fig. 5.6c) was found to be insufficient in obtaining an 
X-ray amorphous form of CAM. In Fig. 5.6d, an X-ray amorphous form of CAM was 
obtained in cryo co-milled mixture containing 50 wt% Eudragit EPO, however re-
crystallization of CAM was noted in XRPD pattern (Fig. 5.6e) of 7-day stored sample 
indicating that intermolecular interactions and milling temperature had an effect on 
stabilizing amorphous form of CAM.  
5.3.1.2 Infra-red Spectroscopy (FT-IR) 
The interactions of CAM-excipients, IR spectra of individual components, physical 
and co-milled mixtures were measured using FT-IR similar to section 4.1.3. The 
characteristic peaks of CAM, Kollidon VA 64, Eudragit EPO and changes on co-milling 
and physical blending have been summarized in Tables 5.2 – 5.3.  
   


















Figure 5.7 Molecular structure of CAM (reproduced from Liang and Yao, 2008) 
Upon ball milling for 45 min, the carbonyl peak at 1734 cm
-1
 was reduced to a broad 
single peak as compared to twin peaks noted in case of CAM (Fig. 5.8a-b(i)). This was in 
agreement with a previous report about FT-IR spectra of grounded CAM (Yonemochi et 
al., 1999). The characteristic carbonyl peaks in FT-IR spectrum of Kollidon VA 64 (Fig. 
5.8a-b(iii)) have been reported to act as potential
 
hydrogen bond acceptors (Table 5.2) 
(Patterson, 2008). Co-milled mixtures of drug with Kollidon VA 64 exhibited distinct 
changes in the IR spectra (Table 5.2). The broadening of peak at 1670 cm
-1 
was found to 
further increase in intensity at higher ratios of Kollidon VA 64 (Fig 5.8a(vi)). The 
broadening of the peak (1670 cm
-1
) in spectra of co-milled mixtures containing 50 wt% 
and 80 wt% Kollidon VA 64 ((Fig 5.8a(iv) & (vi)) could be due to the bond stretches as 
observed previously in case of PVP/piroxicam impregnated samples (Banchero et al., 
2009). These changes (Table 5.2) do indicate possible inter-molecular interactions 
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Table 5.2 – 5.3  Characteristic absorptions, functional groups of  CAM, excipients and changes in CAM : excipient mixtures
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involving C-H groups, ketone and lactone C=O groups in CAM as well as C=O groups in 
polymer. Although the exact nature of interactions could not be clearly understood, the 
amorphous nature of CAM on co-milling with Kollidon VA 64 could have been brought 
about by H-bond formation involving carbonyl groups of the polymer.  
Eudragit EPO is a basic butylated methacrylate copolymer of 2-dimethylaminoethyl 
methacrylate (DMAEMA), methyl methacrylate (MMA) and n-butyl methacrylate 
(BuMA) in ratio of 1:2:1. The FT-IR spectra of the Eudragit EPO, milled Eudragit EPO, 
co-milled and physical mixtures with CAM are presented in Fig. 5.9a-d and summarized 
in Table 5.3. The carbonyl and dimethylamino groups of Eudragit EPO are groups of 
interest (Fig. 5.9a-b(iii)) as they act as strong proton acceptors capable of forming strong 
hydrogen bonds with acid hydroxyls in polyacids (Menjoge and Kulkarni, 2007). Some 
of the changes in the spectra of the co-milled and physical mixtures of CAM with 












































Figure 5.8a-b FT-IR spectra of (i) CAM, (ii) ball-milled CAM, (iii) Kollidon VA 64, 
(iv) co-milled mixture of CAM : Kollidon VA 64 1:1, (v) physical mixture of ball-milled 
CAM : ball-milled Kollidon VA 64 1:1, (vi) co-milled mixture of CAM : Kollidon VA 64 
1:4  
 
absorption bands at 1541 cm
-1
, which may correspond to asymmetric stretching of 
carboxylate groups (Weuts et al., 2005) and 1558 cm
-1
 (Fig. 5.9c(vi-ix)) were noted in 
spectra of co-milled mixtures containing ≥ 60 wt% and physical mixture containing 80 
wt% Eudragit EPO reduced in intensity on milling of Eudragit EPO alone (Fig. 5.9c(iv)). 
These changes relate to a probability of a carboxylate salt formation involving carbonyl 
groups of the polymer. Additionally, the peak around 1560 cm
-1
 have been related to the 
formation of interpolymer complexes involving carboxylate groups of Eudragit L 100-55 
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and dimethylamino groups of Eudragit E (Moustafine et al., 2006). Menjoge and 












































Figure 5.9a-d FT-IR spectra of (i) CAM, (ii) ball-milled CAM, (iii) Eudragit EPO, 
(iv) ball-milled Eudragit EPO, (v) co-milled mixture of CAM : Eudragit EPO 1:1, (vi) co-
milled mixture of CAM : Eudragit EPO 2:3, (vii) co-milled mixture of CAM : Eudragit 
EPO 1:2, (viii) co-milled mixture of CAM : Eudragit EPO 1:4, (ix) physical mixture of 
ball-milled CAM : ball-milled Eudragit EPO 1:4 
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xylate salt as a result of proton transfer resulting in polyelectrolyte salt (IPEC) formation 
between Eudragit E and Eudragit L100 physical blends. Other changes include presence 





milled mixture CAM : Eudragit EPO (1:1) (Fig. 5.9b(v)). However, they are no longer 
visible in co-milled mixtures containing ≥ 60 wt% Eudragit EPO. In comparison, a broad 
band in region (2940-2980 cm
-1





were noted in the spectra of physical mixture containing 80 wt% of Eudragit 
EPO (Fig. 5.9b(ix)). The reduction in intensity of absorption bands at 2770 cm
-1
 and 2824 
cm
-1
 in the co-milled mixtures containing ≥ 60 wt% Eudragit EPO could have contributed 
to the formation of an ammonium salt involving dimethyl amino groups of Eudragit EPO. 
This agrees with earlier reports involving polyelectrolyte complexes formed between 
Eudragit EPO and carrageenan (Prado et al., 2008). Interestingly the intensity of 
absorption bands at 1148 cm
-1
 and 1240-1270 cm
-1
 were appreciably reduced in co-milled 
mixtures containing ≥ 60 wt% Eudragit EPO (Fig. 5.9d(vi-viii)). In comparison, these 
peaks were found to be sharper and more intense in physical mixture containing 80 wt% 
Eudragit EPO (Fig. 5.9d(ix)). These spectral changes suggest a definite inter-molecular 
interaction which could be ionic or a H-bond formation as reported for Eudragit EPO 
IPEC prepared with other Eudragit polymers (Moustafine et al., 2005 and 2006).  
H-bond formation mainly involves hydroxyl groups of the drug with carbonyl or 
dimethylamino groups of Eudragit EPO discussed earlier. Although, CAM contains 
hydroxyl groups, these are no longer evident on ball milling as indicated by an absence of 
O-H stretching band at 3470 cm
-1
 observed in spectra of ball-milled CAM (Fig. 5.8b(ii)). 
Hence, the H-bond formation between CAM and Eudragit EPO could not be confirmed. 
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With a probable proton transfer involving dimethyl amino groups or carbonyl groups 
leading to formation of either a carboxylate or ammonium salt or both, ionic bonding 
may be the primary inter-molecular interactions involving carbonyl and dimethylamino 
groups of Eudragit EPO. The FT-IR studies indicate that intermolecular interactions (H-
bond/ionic) could have facilitated the formation of X-ray amorphous CAM on co-milling 
with polymers. 
5.3.1.3 Differential Scanning Calorimetry (DSC) 
In order to ascertain that spectral changes noted in the FT-IR spectra of co-milled 
mixtures of CAM and excipients were not due to presence of microdomains of polymers 
(Moustafine et al., 2006) or due to polymer dilution effect as observed in case of SS-PVP 
interactions, thermal properties of CAM, ball-milled CAM, cryo-milled CAM, as well as 
physical and co-milled mixtures were evaluated by DSC. As shown in (Fig. 5.10a), CAM 
is characterized by presence of a sharp endothermic melting peak at 224°C which agrees 
with previous data from Yonemochi et al (1999). However, ∆Hfusion value of 69.48 J/g 
obtained in the present study was higher than that reported for CAM (∆Hfusion = 41.3 J/g) 
analyzed under similar conditions (5°C/min) (Salem, 1996). The DSC thermogram of 45-
min ball-milled CAM sample (Fig. 5.10b) shows a broad exothermic peak (∆Hcrystallization 
= 5.54 J/g) in the range of 110-120°C. On the other hand, DSC thermogram of 75-min 
cryo-milled sample (Fig. 5.10c) shows two broad exothermic peaks in the range of 80-
100°C (∆Hcrystallization = 23.61 J/g) and 110-120°C (∆Hcrystallization = 3.45 J/g) respectively.  
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Figure 5.10 DSC thermograms of (a) CAM, (b) ball-milled CAM (45 min), (c) cryo-
milled CAM (75 min), (d) melt-quenched CAM (reversing heat flow signal at 50°C/min) 
 
Similar observations have been earlier reported for ball-milled and spray dried 
amorphous forms of CAM (Yonemochi et al., 1999). The authors attributed these 
transitions to irreversible crystallization of amorphous forms on heating. They further 
noted that increasing the grinding time of CAM in a vibrational mill from 1 to 30 min led 
to an increase in ∆Hcrystallization values. However, the ∆Hcrystallization value (22.32 J/g) 
obtained for 30-min milling in a vibrational mill was 3-fold higher than that for 45-min 
ball-milled sample in our present study. These results suggest that presence of residual 
crystalline peaks in XRPD pattern of 45-min ball-milled sample (Fig 5.1c) could have 
affected ∆Hcrystallization values. This inference was supported by a ∆Hcrystallization value 
(23.61 J/g) for X-ray amorphous 75-min cryo-milled sample (Fig. 5.10c) which is closer 
to the reported ∆Hcrystallization values for milled (22.32 J/g) and spray dried (23.52 J/g) 
CAM samples (Yonemochi et al., 1999). Due to a loss of baseline values beyond 150°C, 
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melting or fusion peak of drug around 220°C could not be noted in DSC thermograms of 
45-min ball-milled CAM (Fig. 5.10b) or 75-min cryo-milled CAM samples (Fig. 5.10c). 
As a clear detection of Tg for 75-min X-ray amorphous cryo-milled CAM sample was not 
evident, melt quenching the drug in cell of DSC was carried out. CAM was subjected to 
heat/cool/heat cycle at ramp rate of 50°C/min. As shown in Fig. 5.10d, a Tg was evident 
in the temperature range of 100-110°C. 
 
Figure 5.11 DSC thermograms of (a) Kollidon VA 64, (b) physical mixture of ball-
milled CAM : ball-milled Kollidon VA 64 1:1, (c) co-milled mixture of CAM : Kollidon 
VA 64 1:1, (d) Eudragit EPO, (e) co-milled mixture of CAM : Eudragit EPO 1:1 
 
Fig. 5.11 shows the DSC thermograms of co-milled and physical mixtures of CAM 
with the two polymers. As CAM is a low molecular weight drug, mixing or milling with 
high molecular weight polymers such as Eudragit EPO (150000 g/mol) and Kollidon VA 
64 (45,000-70,000 g/mol) could result in lowering of Tg values as small drug molecules 
allowed more freedom for the polymer chain segments to move thus acting as a 
plasticizer. On the other hand, an increase in drug Tg
 
value indicates that the 
intermolecular interactions between drug and polymer decreased the free volume of the 
polymer thus acting as an antiplasticizer (Choksi et al., 2005). Kollidon VA 64 and 
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Eudragit EPO showed a Tg around 95°C (Fig. 5.11a), and 52°C (Fig. 5.11d) respectively. 
The Tg values obtained was found to be closer to the reported values of 106°C (Patterson, 
2008) and 45°C (Choksi et al., 2005) for Kollidon VA 64 and Eudragit EPO respectively. 
Interestingly, the presence of Tg was not evident in DSC thermogram of co-milled 
mixture containing 50 wt% Kollidon VA 64 (Fig. 5.11c) instead broad exothermic peak 
was detected in the temperature range of 90-100°C (∆Hcrystallization = 11.31 J/g). A Tg 
(closer to Tg of drug) with no exothermic peak was detected in DSC thermogram of 
physical mixture containing 50 wt% Kollidon VA 64 (Fig. 5.11b). Similar observations 
were noted in DSC thermograms of co-milled mixtures containing ≥ 50 wt% Kollidon 
VA 64. A shift in Tg to a higher temperature (62°C) was evident in the DSC thermogram 
of co-milled mixture containing 50 wt% Eudragit EPO (Fig. 5.11e) suggesting that CAM 
may have acted as plasticizer resulting in a shift of Tg to a value in between Tg values of 
the drug and the polymer. The presence of exothermic broad peak at temperature range of 
110-120°C (∆Hcrystallization = 11.73 J/g) was evident. Co-milling of CAM with both 
polymers led to a 2-fold increase in ∆Hcrystallization value in comparison to value obtained 
for ball-milled CAM (Fig. 5.10b). Although the presence of exothermic peak (resisting 
crystallization) (Yonemochi et al., 1999) was noted in DSC thermograms of co-milled 
mixtures with Kollidon VA 64 and Eudragit EPO, a shift in Tg indicates that the 
formation of an amorphous dispersion was probable in co-milled mixtures containing 50 
wt% Eudragit EPO. 
Fig. 5.12 shows the DSC thermograms of co-milled mixtures containing ≥ 50 wt% 
Eudragit EPO. A significant shift in Tg (68°C) with presence of a sharp exothermic peak 
(∆Hcrystallization = 13.42 J/g) in temperature range of 100-105°C was detected in DSC 
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thermogram of co-milled mixture containing 60 wt% Eudragit EPO (Fig. 5.12b). The 
appearance of a sharp endothermic peak (∆Hfusion = 0.45 J/g) at 139°C was also detected. 
A shift of Tg to a temperature range of 57-59°C along with presence of a broad exotherm 
(100-105°C) with a higher ∆Hcrystallization value of 8.33J/g was noted in DSC thermogram 
of co-milled mixture containing 66.6 wt% Eudragit EPO (Fig. 5.12c). The endothermic 
peak was detected at 110°C with a greater than 2-fold increase in ∆Hfusion value (1.02J/g) 
in comparison to the earlier observed value for co-milled mixture containing 60 wt% 
Eudragit EPO. No further shifts in Tg values were noted in DSC thermograms of co-
milled mixtures containing ≥ 75 wt% Eudragit EPO (Fig. 5.12 d, f & g). The exothermic 
peak at 100-105°C was less prominent (∆Hcrystallization = 7.51J/g) (Fig. 5.12d) in DSC 
thermogram of co-milled mixture containing 75 wt% Eudragit EPO and was no longer 
evident in the DSC thermograms of co-milled mixtures containing ≥ 80 % Eudragit EPO 
(Fig. 5.12f & g). On the other hand, a single endothermic peak at 78°C (∆Hfusion = 
0.23J/g), three endothermic peaks at 75°C (∆Hfusion = 0.45J/g), 109°C (∆Hfusion = 0.52J/g), 
115°C (∆Hfusion = 1.60J/g) and a single endothermic peak at 115°C (∆Hfusion = 0.69J/g) 
were detected in DSC thermograms of co-milled mixtures containing (75, 80 & 83.3 
wt%) Eudragit EPO respectively. In comparison, no shift in Tg (52°C) and no exotherm 
was detected in DSC thermogram of physical mixture containing 80 wt% Eudragit EPO 
(Fig. 5.12e). However a single endothermic peak (125°C) (∆Hfusion = 1.07J/g) was 
detected. The presence of exotherm and endothermic peaks on co-milling and physical 
mixing suggested that a partially melted amorphous form (resisting crystallization) of 
milled CAM could have formed in co-milled mixtures containing ≥ 60 wt% Eudragit 
EPO. 
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Fig. 5.12 DSC thermograms of (a) co-milled mixture of CAM : Eudragit EPO 1:1, (b) co-
milled mixture of CAM : Eudragit EPO 2:3, (c) co-milled mixture of CAM : Eudragit 
EPO 1:2, (d) co-milled mixture of CAM : Eudragit EPO 1:3, (e) physical mixture of ball-
milled CAM : ball-milled Eudragit EPO 1:4, (f) co-milled mixture of CAM : Eudragit 
EPO 1:4, (g) co-milled mixture of CAM : Eudragit EPO 1:5 
 
In order to ascertain whether CAM formed a miscible system on co-milling with Eudragit 
EPO, Tg of the co-milled mixtures with respect to Eudragit EPO concentration was 
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Figure 5.13 Gordon Taylor plot of CAM-Eudragit EPO mixtures 
As shown in Fig. 5.13, experimental Tg values deviated from the predicted values in 
co-milled mixtures containing ≤ 60 wt% Eudragit EPO. However, an ideal mixing 
behavior could be found in co-milled mixtures containing ≥ 66.6 wt% Eudragit EPO, 
where experimental and predicted Tg values agreed with each other. Eudragit EPO has 
been reported to be incompatible with anionic drug such as IB (Petereit and Weisbrod, 
1999), where loss of melting peak was noted in a mixture containing milled Eudragit E 
100 and crystalline IB. As mentioned previously, loss of baseline signal in DSC 
thermogram of ball-milled CAM > 150°C made it difficult to identify the melting peak of 
CAM in co-milled mixtures with Eudragit EPO. However, CAM content of 95 ± 4% (n = 
3) with absence of any additional peak in HPLC chromatogram of co-milled mixture 
containing 80 wt% Eudragit EPO suggest that co-milling with Eudragit EPO did not lead 
to degradation of the drug. These results supported the FT-IR (Fig. 5.9) and XRPD (Fig. 
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5.4) analysis, suggesting that strong inter-molecular interactions (ionic) between CAM 
and Eudragit EPO could have stabilized the milled amorphous form of CAM in co-milled 
mixtures containing more than 60 wt% Eudragit EPO. 
  
 
Figure 5.14 DSC thermograms of co-milled mixtures [(30 min) (a) co-milled mixture of 
CAM : Eudragit EPO 1:4, (b) co-milled mixture of CAM : Eudragit EPO 1:4 
(40°C/75%RH/90days)], [(45 min) (c) co-milled mixture of CAM : Eudragit EPO 1:4, (d) 
co-milled mixture of CAM : Eudragit EPO 1:4 (40°C/75%RH/90 days)] 
 
Ohta and Buckton (2004a) reported that Tg of Eudragit EPO in physical mixtures with 
cefditorin pivoxil was reduced on storage at 60°C for a period of 14 days. The 
incompatibility was attributed to acid-base interactions involving acidic surface (KD/KA= 
0.8) of cefditorin pivoxil and basic surface (KD/KA= 2.5) of Eudragit EPO. Incompatibility 
was not observed with Eudragit S100 (KD/KA= 0.4) and Eudragit L100 (KD/KA= 0.1) 
having acidic surfaces. To further confirm the stability of co-milled mixtures and also 
ascertain incompatibility between surfaces of CAM and Eudragit EPO, comparative DSC 
analyses of freshly co-milled and 90-day stored (40°C/75% RH) samples were carried out. 
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As shown in Fig. 5.14, a single Tg in the range of 57-59°C was detected in DSC 
thermograms of 30-min freshly co-milled (Fig. 5.14a) and stored (Fig. 5.14b) mixtures 
containing 80 wt% Eudragit EPO. A slight increase in Tg (62°C) was detected in DSC 
thermogram of stored 45-min co-milled sample (Fig. 5.14d) containing 80 wt% Eudragit 
EPO. Thus, the presence of Tg in the similar range further suggests an absence of 
incompatibility between CAM and Eudragit EPO surfaces in freshly co-milled and stored 
mixtures containing atleast 80 wt% Eudragit EPO.  
5.3.2 Effect of Milling and Co-milling on Triboelectrification  
 Table 5.4 summarizes the effect of milling and co-milling on electrostatic charges 
of CAM. CAM was found to charge negatively with stainless steel (Faraday’s metal cup). 
With reference to the triboelectric series described earlier (section 1.7), stainless steel is 
positioned at the electropositive end and has been reported to donate electrons to 
pharmaceutical excipients such as LAC (Bennett et al., 1999). Pharmaceutical materials 
such as SS and LAC exhibited similar negative charging in contact with stainless steel 
(Elajnaf et al., 2006). Interestingly, a decrease in magnitude of charge/mass ratio along 
with a reversal in polarity was measured with ball-milled and cryo-milled CAM 45-min 
samples. An increase in magnitude of charge/mass ratio was noted in 60-min and 75-min 
cryo-milled samples with no change in polarity of charge. Typically, as the charge is  
proportional to its surface area (approximately square of particle diameter), while the 
mass is proportional to the volume (approximately cube of particle diameter), a smaller 
particle size tends to acquire a higher magnitude of charge/mass ratio (Pu et al., 2008). 
The results do not reflect the influence of particle size as the BET surface area of cryo-
milled and 45-min ball-milled samples were several times greater than unprocessed CAM  
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Sample Specific Charge/mass 
(nC/g) 




+0.70 ± 0.27 
Ball-milled CAM 
(45-min) 
(40°C/75% RH/7 days) 
 
 


















+1.63 ± 0.14 
Co-milled mixture of CAM 
with 66.6 wt% Eudragit EPO 
 
+3.85 ± 0.72 
Physical mixture of CAM 
with 66.6 wt% Eudragit EPO 
 
+3.66 ±0.23 
Co-milled mixture of CAM 
with 80 wt% Eudragit EPO  
 
          +3.07 ± 0.49 
Physical mixture of CAM 
with 80 wt% Eudragit EPO 
 
+4.77 ± 1.63 
Eudragit EPO           +5.72  ± 1.07 
 
Table 5.4 Effect of milling and co-milling on triboelectrification of CAM 
 





Particle Size (d0.5) 
(µm) 
CAM 0.21 126 ± 0.01 
Ball-milled CAM (45-min)         1.87     55.70 ± 8.28 
Ball-milled CAM (45-min) 
(40°C/75% RH/7 days) 
         
        0.67 
 
    82.63 ± 9.71 
 
Cryo-milled CAM (45-min) 
        
       7.87 
 
    40.62 ± 5.30 
Cryo-milled CAM (45-min) 
(40°C/75%RH/7days) 
 
       3.10 
 
    39.91 ± 5.33 






    81.83 ± 8.28 
 
Table 5.5 Changes in particle size and surface area on milling of CAM 
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with a reduction of the particle sizes (Table 5.5).  
 



























Figure 5.15 SEM images of (a) CAM, (b) ball-milled CAM, (c) cryo-milled CAM, (d) 
ball-milled CAM (40°C/75% RH/7 days), (e) cryo-milled CAM (40°C/75% RH/7 days) 
 
SEM analyses were carried out to visualize changes in particle morphology on 
milling and upon storage. Figure 5.15a–e illustrates the SEM images of CAM, ball-milled 
CAM, cryo-milled CAM and stored samples. CAM crystals were largely individual 
crystals with well defined block-like morphology (Fig. 5.15a) (Bele et al., 2005; Zhang et 
al., 2007). On ball milling for 45 min, the crystals became agglomerated with a wider 
range of particle sizes (Fig. 5.15b). Cryo-milled sample particles were similarly 
agglomerated with finer primary particle size than the ball-milled sample (Fig. 5.15c). 
The SEM photomicrograph of ball-milled CAM and cryo-milled CAM stored under 
40°C/75% RH for 7 days (Fig. 5.15d & e) showed a distinct increase in size of particles 
which was likely due to agglomeration resulting from re-crystallization as shown in 
XRPD pattern. As milled CAM samples (Fig. 5.15b & c) were found to have an 
agglomerative appearance, particle-particle interactions may have affected measured net 
charge. The effect of adhering particle or particle-particle interactions was difficult to 
ascertain as the Faraday’s cage method has limitations for measuring the charge on 
individual particles and therefore only a net charge was reported (Pu et al., 2008). 
(e) 
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Additionally, determination of the effect of particle morphology in case of milled and 
agglomerated samples becomes difficult as the particles tend to have irregular 
morphology where regions of higher curvature may cause a re-distribution of charges 
across particle surfaces. Although CAM is not hygroscopic, effect of moisture content 
(Fig. 5.16) on ball milling and cryomilling was also studied. Higher moisture contents in 
cryo-milled (45-min) samples compared to 45-min ball-milled CAM and unprocessed 
CAM samples, could have reduced the magnitude of surface charge on CAM. A decrease 
in moisture contents of 60-min and 75-min cryo-milled samples showed a slight increase  
 
 
Figure 5.16 Effect of moisture content on triboelectrification of milled CAM 
 
in magnitude of electrostatic charge. Interestingly, the moisture content of stored (40°C/ 
75%RH/7 days) cryo-milled 45-min sample decreased, in contrast to an increase in 
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moisture noted for stored ball-milled 45-min sample (Fig. 5.16). Both the stored (40°C/ 
75%RH/7 days) 45-min ball-milled and cryo-milled samples showed an increase in 
magnitude of electrostatic charge with no change in polarity. The increase in magnitude 
of charge was at least 4-fold for the stored 45-min ball-milled sample. With reversion 
from amorphous to crystalline form from the XRPD pattern (Fig 5.1e), a decrease in BET 
surface areas of stored ball-milled and cryo-milled samples was observed. An increase in 
particle size of stored ball-milled sample only was seen (Table 5.5). The ambiguities in 
results indicate that the particle size, surface area and moisture content could not account 
for changes in electrostatic properties of milled and re-crystallized CAM samples. 
An increase in magnitude of charge/mass ratio along with a reversal in polarity (in 
comparison to unmilled CAM) was observed with samples of co-milled mixture 
containing more than 66.6 wt% Eudragit EPO (Table 5.4). As Eudragit EPO exhibited 
positive charging and greatest magnitude of charge among all samples, the presence of 
higher content of polymer (≥ 66.6 wt%) could have contributed to the increase in 
magnitude of charges of the co-milled mixtures. The measured charges for co-milled and 
physical mixtures containing 66.6 wt% Eudragit EPO were found to be similar in 
magnitude and polarity. However, the measured charges for co-milled mixture containing 
80 wt% Eudragit EPO were lower than charges of the physical mixture containing similar 
Eudragit EPO content and the stored (40°C/ 75%RH/7 days) 45-min ball-milled CAM 
sample. These results suggest that preparing stable amorphous mixtures on co-milling 
with an amorphous excipient was effective in reducing the triboelectrification of ball-
milled CAM.  
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5.3.3 Effect of Milling and Co-milling on Surface Energetics 
Elsdon and Mitchell (1976) investigated the effect of triboelectrification in 
pharmaceutical powders using different contact surfaces such as steel, brass and 
cellulose. The negative charging of LAC with both brass and steel was attributed to the 
location of the material with respect to the contact surfaces (steel, brass) in the 
triboelectric series. However, it charged positively with cellulose. The charging of LAC 
with cellulose was found to be complex involving contributions from chemical (ionic) 
groups on the surface. Elajnaf and co-workers proposed to use surface energetic electron 
donating and accepting properties for a triboelectric series as the surface groups could 
guide the ability of the powders to donate and accept electrons (Elajnaf et al., 2006). 
Ahfat and researchers (2000) examined the inter-relationship between surface electron 
donating and accepting tendencies with triboelectric charging data of different forms of 
LAC and other pharmaceutical materials. Although the data set was limited, authors 
concluded that charging of powders with stainless steel surface did correlate with the 
electron donating and accepting tendencies of the surface.  
5.3.3.1 Inverse Gas Chromatography (IGC) 
The electron donating and accepting tendencies were explored using IGC. IGC 
applies gas chromatographic principles to surface analysis of polymers and fibers 
(Buckton and Gill, 2007). The IGC instrumentation involves modification of the standard 
GC chromatography experiment, wherein the unknown is the column packed with 
powder, while the known is injected vapor/vapors (Buckton and Gill, 2007). IGC is 
different from the common surface energy measurements using contact angle technique. 
As for IGC, the vapor probe molecules at infinite dilution preferentially interact with the 
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most energetic dispersive sites on the powder surface. As these sites are not present 
uniformly throughout the surface, a small population of the surface is used. On the other 
hand, contact angle techniques include solid-liquid interactions over regions of the 
surface having different surface energies (Ahfat et al., 2000). Surface energy 
determinations on pharmaceutical materials, such as caffeine and theophylline, showed 
that IGC resulted in a higher or comparable value for dispersive energy (γs
d
) than the 
contact angle technique suggesting that it is a more sensitive technique for determination 
of surface energies on solid surfaces (Dove et al., 1996). IGC has also been employed to 
measure physical (dispersive) as well as chemical (polar, acid-base) interactions 
(Buckton and Gill, 2007). Other important pharmaceutical applications of IGC include 
assessing batch to batch variability of pharmaceutical actives such as SS (Ticehurst et al., 
1994), analyzing interaction of solid surface with absorbed water (Sunkersett et al., 2001) 
and studying amorphous surfaces in terms of surface energetics (Feeley et al., 1998).  
The dispersive component of surface free energy (γs
d
) was calculated using Eq. 5.1 
(Hasegawa et al., 2009). 








 + C´                                                              (5.1) 
 R = gas constant, T = temperature, Na = Avogadro’s number, A= surface area of 
adsorbed probe molecules, γs
d 
= dispersive component of solid surface energy, γs
l
 = 
surface tension of the adsorbate, the term ‘C´’ is a  constant which takes into account the 
weight, surface, area, and vapor pressure of probes in the gaseous phase and VN is the net 
retention volume . 
VN is obtained using the Eq. 5.2 
  VN= JF(tv-tm)                                                                                                      (5.2) 
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J = correction factor due to pressure differences, F = carrier flow rate, tv = retention time 
of the probe, tm = retention time of the reference methane probe.  




 yields a straight line (also referred to as 
alkane line) and γs
d




. The retention 
behaviour of the polar probes (ethanol, acetone, ethyl acetate, chloroform) is located 
above the alkane line. The vertical distance between data points of polar probes and 
alkane line gives specific energy of adsorption of a polar probe with solid material (-
ΔGAB). The values of -ΔGAB is subsequently related to the acidic or electron accepting 
parameter (KA) and basic or electron donating parameter (KD) as described in Eq. 5.3  
proposed by Gutmann (1978). 
   -ΔGAB= KADN + KDAN*                                                                    (5.3) 
DN = electron donor or base number, AN* = Corrected electron acceptor or acid number 
The values of DN and AN* are obtained from literature for presenting a linear plot of -
ΔGAB/ AN* versus DN/ AN*. KA and KD were determined from the gradient and 
intercept of the line. The values of KA and KD are independent of each other as well as of 
the solid. The ratio (KD/ KA) corresponds to the electron donating and electron accepting 
tendencies of the materials used. A value of KD/KA greater than 1 implies that surface in 
question is basic in nature, whereas lesser than 1 is acidic in nature (Ohta and Buckton, 
2004b) and was used to understand the polar nature of a surface (Ahfat et al., 2000). 
5.3.3.2 Changes in Surface Energy on Co-milling of CAM  
Table 5.6 summarizes the changes in the dispersive and polar components of the 
surface energy on cryomilling. CAM possesses a highly acidic surface based on the value  
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of 0.18 obtained for KD/KA.  This could be understood from a lower value of surface 
energy of adsorption (ΔGAB) for chloroform (acidic probe) compared to the basic probes 
(ethanol, ethyl acetate and acetone) (Fig. 5.17). Having an acidic surface meant that 
surface groups were more of electron acceptors as per Lewis acid-base concept 
(Gutmann, 1978). With reference to triboelectric series, electron accepting tendency 
meant that CAM could acquire a negative charge when in contact with stainless steel 
(higher positioned materials) which was measured experimentally (Table 5.4). An 
accurate estimation of surface energy and ΔGAB values of ball-milled (45-min) sample 
could not be obtained as the sample was found to show reversion from partially 
crystalline (Fig. 5.1c) to crystalline form during IGC analyses. On cryomilling for 45 
min, an overall increase in surface energetics in terms of dispersive surface energy and 
specific energy of absorption was observed. The significant increase in surface energy 
could be attributed to increase in higher energy sites (in amorphous milled samples) 





) KA KD KD/KA 




58.56 ± 1.13 
 
1.05 ± 0.05 
 





(40°C/75% RH/7 days) 
 
 
59.27 ± 3.43 
 
 
0.96 ± 0.02 
 
 







52.33 ± 0.84 
 
1.21 ± 0.01 
 






47.12 ± 2.82 
 
1.18 ± 0.03 
 




Table 5.6 Effect of cryomilling on surface energetics of CAM 
 
Interestingly, dispersive energy component of the surface energy was found to 
gradually decrease as cryomilling continued from 45 to 75 min. A decrease in dispersive 
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component of surface energy has been previously reported in milling studies with dl-
propranolol hydrochloride where the value of γs
d
 increases to a critical point as particle 
size reduces from 75 to 6 µm followed by a decrease in γs
d
 values in finest powders 
(York et al., 1998). The authors suggested that mechanism of size reduction was more of 
particle attrition beyond the critical point, which could have been due to ageing of a new 
milled surface or an attempt of the new surface to achieve minimum surface energy.     
 Cryomilling of CAM from 45 to 75 min led to an increase in average particle size 
(Table 5.5) suggesting that new surfaces created after cryomilling for more than 45 min 
caused particle attrition in spite of an amorphous XRPD pattern for 75-min cryo-milled 
sample (Fig. 5.2g). The value for γs
d
 of the stored (40°C/75% RH/7 days) 45-min cryo-
milled sample did not change, suggesting that surface properties of milled and re-
crystallized CAM could not be clearly explained using γs
d
. 
 A 10-fold increase in ΔGAB values for chloroform in comparison to a 2-fold increase 
in the values for the basic probes increased the KD/KA ratio to 0.89 indicating that surface 
on cryomilling appeared to be more basic (Fig. 5.17). Zaria and Etaiw (2007) reported 
that presence of oxygen, hydroxyl, methyl groups and one nitrogen atom on the surface 
of CAM could act as electron donors and play an important role in forming charge 
complexes with iodine, a strong electron acceptor. As the process of milling led to 
breakage in crystal surfaces having weakest attachment energy (Rasenack and Müller, 
2004), crystal faces with higher distribution of electron donating groups (Fig. 5.7) may 
have been preferentially exposed on cryomilling contributing to the increase in relative 
basicity. Similar changes in surface basicity/acidity (studied using IGC) due to 
preferential exposure of functional groups have previously been reported on milling of 
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pharmaceutical actives such as cefditoren pivoxil (Ohta and Buckton, 2004a) and dl-
propranolol hydrochloride (York et al., 1998). The increase in basicity may lead to 
surface of CAM acquiring a positive charge reversing the polarity of the charge as noted 
earlier in electrostatic measurements of ball-milled and cryo-milled 45-min CAM 
samples (Table 5.4). The KD/KA ratio increased to a value of greater than 1 as cryomilling 
increased from 45 to 60 min. At 75 min, the ratio was found to decrease slightly but still 
remained greater than 1. The 75-min cryo-milled CAM sample had an X-ray amorphous 
XRPD pattern (Fig 5.1g) which indicates that amorphous milled surface is more basic 
and polar in nature in contrast to the acidic surface of crystalline CAM. The increase in 
polarity on cryomilling agreed with an earlier report, where a 2-fold increase in surface  
 
Figure 5.17 Specific surface energies of adsorption of polar probes of cryo-milled and 
stored samples at 25°C (n = 3) 
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polarity (evaluated based on estimation of solubility parameters) of CAM was found on 
grinding for 30 min in a vibrational mill (Yonemochi et al., 1999). It was further noted 
that KD/KA ratio decreased from 0.89 for cryo-milled 45-min sample to 0.24 for stored 
(40°C/75%RH/7days) 45-min cryo-milled sample which is closer to value of 0.18 
obtained earlier for CAM (Table 5.6). Little change in γs
d
 was observed for the stored 45-
min cryo-milled sample (40°C/75%RH/7days). 
 To further understand whether co-milling with Eudragit EPO had an effect (as noted in 
case of electrostatic charge measurements) on the KD/KA ratio of CAM, IGC analyses of 
Eudragit EPO, co-milled and physical mixtures containing 66.6 wt% Eudragit EPO was 
carried out under conditions previously used. The ball-milled Eudragit EPO was found to 
have a KD/KA ratio of 2.6 which tallied with reported value of 2.5 (Ohta and Buckton, 
2004b). The higher KD/KA ratio was attributed to the presence of dimethylaminoehtyl 
groups in Eudragit EPO having a basic nature. A KD/KA of 1.78 was quantified for co-
milled mixture containing 66.6 wt% Eudragit EPO. This value lied in between KD/KA 
ratios of milled forms of CAM (0.18) and Eudragit EPO (2.6). A KD/KA ratio of 1.47 for 
physical mixture containing 66.6 wt% Eudragit EPO was closer to value obtained for cryo-
milled CAM (0.89). These changes indicated that groups on surfaces of CAM and Eudragit 
EPO interacted on co-milling and contributed to an increase in surface basicity of co-milled 
CAM, which could have contributed to the stabilization of milled amorphous form CAM as 
indicated in XRPD patterns of freshly co-milled (Fig. 5.3) and stored samples (Fig. 5.4).  
A correlation between electrostatic charges measured using stainless steel and KD/KA 
ratio obtained from IGC data of different materials has been reported (Ahfat et al., 2000). 
However, authors found it difficult to determine any correlation. To understand whether a 
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correlation (if any) exists between values of surface electrostatic charges and KD/KA 
ratios of milled and co-milled CAM samples, electrostatic charges of unmilled, milled 




Figure 5.18 The electron-donor to the electron-acceptor parameter ratios [KD/KA] of 
cryo-milled and co-milled samples, as a function of their electrostatic charges  
 
As shown in Fig. 5.18, a correlation (although not strong, R
2
 = 0.76) between values 
of electrostatic charges and KD/KA ratios did exist for all samples except for stored 45-
min cryo-milled sample (40°C/75%RH/7days) (Fig. 5.18). With reference to IGC data in 
Fig. 5.17, it should be recalled that amorphization on milling led to an increase in both 
surface acidity (2-fold) and basicity (10-fold). This meant that relatively more basic 
functional groups are exposed on the milled surface with a KD/KA ratio of 0.89 (Table 
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5.4). In case of re-crystallized sample (stored 45-min cryo-milled sample 
(40°C/75%RH/7days), a greater decrease in surface basicity (0.5 fold) compared to 
surface acidity (0.2 fold) with a KD/KA ratio of 0.24 was observed. Based on this ratio, 
the surface appears to become more acidic (electron accepting) but the charge polarity 
remains positive and at a higher magnitude. Mirza and co-workers (2008) in their study 
on use of excipients to modify morphology of erythromycin A dihydrate studied the 
surface chemistry of  erythromycin A dihydrate and found presence of electron donating 
(basic) groups such as hydroxyl, methyl, ethyl, N,N- dimethyl on dominant hkl (002a, 
002b) crystal faces. As the absolute configuration of asymmetric centres and crystal 
structure of CAM (6-O-methyl derivative) (Fig. 5.7) is same as that in erythromycin A 
(Iwasaki and Sugawara, 1993), these surface faces could have been exposed on milling of 
CAM. Additionally, from the IGC data, as the surface of re-crystallized sample actually 
possesses higher acidic and basic properties compared to unmilled state (KD/ KA = 0.18), 
it may be possible that the basic surface characteristic exposed on milling is more 
dominant and exerts overall positive polarity upon tribocharging, while the ordered 
molecular structure in the re-crystallized sample may have contributed to a higher 
propensity for electrostatic charging. A similar increase in mean (n = 10) specific 
electrostatic charge of stored spray dried (21°C/32% RH/180 days) lactose sample 
actuated from Taifun
TM
 DPI has been reported (Murtomaa et al., 2004). The authors 
attributed the change in specific charge to the presence of amorphicity as sample 
underwent gradual re-crystallization during storage. The slow re-crystallization was due 
to presence of dessicant in the DPI. Amorphous contents quantified for initial and 6-
month stored sample was 95% and 54% respectively. As infinite dilution method 
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employed during IGC analyses preferentially interact with the most energetic dispersive 
sites on the powder surface (Ahfat et al., 2000) the results could only be interpreted 
qualitatively. More work is currently undertaken to further understand the tribocharging 
mechanism and its correlation to surface acid-base properties of milled and co-milled 
APIs. 
5.4 Milling and Co-milling of IB 
5.4.1 Effect of Milling and Co-milling on Solid-state Properties 
In Fig. 5.19, the XRPD of IB co-milled with excipients (MgSt and colloidal SiO2) at 
ratio of 19:1 was compared with those of milled IB, and physical mixtures at similar 
ratio. The characteristic peaks (Oguchi et al., 2002) of IB at 6.0° and 16.5° 2θ were still 
evident in XRPD pattern of ball-milled IB (Fig. 5.19a). MgSt is crystalline and colloidal 
SiO2 is amorphous in nature as evident from the XRPD patterns (Fig 5.19b & c). Co-
milling or physical blending with either of excipients did not turn IB amorphous and 
characteristic crystalline peaks of IB were still evident in XRPD patterns (Fig 5.19d - g).  
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Figure 5.19 Powder X-ray diffractograms of (a) ball-milled IB, (b) MgSt, (c) colloidal 
SiO2, (d) ball-milled IB-MgSt physical mixture, (e) IB-MgSt co-milled mixture,  
(f) ball-milled IB-colloidal SiO2 physical mixture, (g) IB-colloidal SiO2 co-milled 
mixture 
 
5.4.2 Effect of Milling and Co-milling on Triboelectrification 
Fig. 5.20 shows the electrostatic charge measurements of ball-milled IB, IB-MgSt and 
IB-colloidal SiO2 physical and co-milled mixtures. Co-milling with MgSt led to a 
reduction in triboelectrification of 32% in comparison to electrostatic charges measured 
for ball-milled IB. However, physical blending of ball-milled IB with MgSt resulted in a 
greater reduction of 44% in triboelectrification. On the other hand, co-milled and 
physically blended IB-colloidal SiO2 mixtures showed an increase of more than 150% in 
triboelectrification in comparison to electrostatic charges measured for ball-milled IB.  
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Figure 5.20 Electrostatic charges of IB-MgSt and IB-colloidal SiO2 mixtures 
To further investigate the differences in triboelectrification of the two processes 
(physical blending and co-milling) and the effects of the two additives (MgSt or colloidal 
SiO2), particle size analysis of mixtures were carried out and results are shown in Fig. 
5.21. The ball-milled IB sample showed a bimodal particle size distribution with d0.5 
value of 19 µm and presence of fines (<1 µm). Unmilled MgSt and colloidal SiO2 showed 
unimodal particle size distributions with d0.5 of 10 and 40 µm respectively (Fig. 5.21 a & 
b). On co-milling, an increase in volume of fines was noted in both mixtures with MgSt 
and colloidal SiO2 accompanied by a decrease in d0.5 values to 16 and 10 µm respectively. 
In comparison, a unimodal particle size distribution along with the absence of fines (<1 
µm) was noted in the physical blended mixtures. The d0.5 values in physical mixtures was 
larger (31 µm with MgSt; 30 µm with colloidal SiO2) than those obtained from co-milled 
mixtures. The absence of fines suggested that fine excipients are well coated and  








Figure 5.21 Particle size distributions of a) IB-MgSt mixtures, b) IB-colloidal SiO2 
mixtures 
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agglomerated to IB surface in physical mixtures which could have reduced the surface 
areas of particles in contact with the wall of the Faraday’s cage and led to a reduction in 
tribocharging (Bailey, 1984). However, triboelectrification was found to decrease in case 
of IB-MgSt physical mixture only. In IB-MgSt co-milled mixture, the presence of 
particles with different size fractions could be a contributing factor in reducing the charge 
as charge separation (between fine and coarser particles) as well as charge transfer 
(between particles and contact surface) could occur simultaneously (Mehrani et al., 
2007). These phenomena however, make the process of charging difficult to understand. 
A major reason for reduction in triboelectrification with use of MgSt in comparison to 
colloidal SiO2 could be the tendency of MgSt to easily form agglomerates on mixing. 
This tendency is referred to as autoagglomeration (Lachiver et al., 2006). Formulations 
containing 1 wt% MgSt could coat a surface area per unit mass as high as 20%. The 
autoagglomeration behavior of MgSt could further lead to formation of larger 
agglomerates in contact with oppositely charged particles (Lachiver et al., 2006). As IB 
exhibits negative charging (in the present study) and MgSt is positively charged with 
most contact surfaces (Lachiver et al., 2006), the higher concentration of MgSt (5 wt%) 
could have contributed to the increase in particle size noted in IB-MgSt physical 
mixtures. Additionally, depending on the concentration and mixing time, MgSt could 
form hydrophobic films reducing its interactions with cohesive drugs such as SS (Tay et 
al., 2010). This film forming property of MgSt allows it to act as a lubricant in solid 
dosage formulations, whereby it coats particles of the blend and partially fills any 
cavities. This prevents charge acquisition due to less friction between particles resulting 
in improved powder flow (Lachiver et al., 2006). In addition, blending studies with 0.5 % 
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MgSt have been found to form a fine layer of powder on IB surface, reducing the inter-
particle friction of IB bulk powder resulting in further improvement in flowability of IB 
(Liu et al., 2008). On the other hand, colloidal SiO2, a commonly employed glidant in 
oral dose formulations (Pingali et al., 2009b) has a surface area of 200 m
2
/g (Ramirez-
Dorronsoro et al., 2006) which is approximately 20-fold greater than MgSt (8.2 m
2
/g). 
Hence it holds a higher charge (Ramirez-Dorronsoro et al., 2006) contributing to higher 
triboelectrification in IB-colloidal SiO2 physical and co-milled mixtures (Fig. 5.19). 
These results suggest that co-milling with crystalline or amorphous additives that do not 
form amorphous solid dispersions may contribute to a higher or similar surface 
electrostatic charge  than on physical blending. 
5.5 Summary  
 
This study evaluates the feasibility of using co-milling in preparing stable amorphous 
dispersions and influencing triboelectrification of model APIs, CAM and IB. An X-ray 
amorphous form of CAM could only be obtained on cryomilling for 75 min. An 
amorphous halo in XRPD patterns could be achieved on co-milling with Kollidon VA 64 
and Eudragit EPO under similar conditions. However, the XRPD patterns of 90-day 
stored co-milled samples indicated that only co-milled mixtures containing more than 60 
wt% EPO retained their X-ray amorphous characters while co-milled mixtures containing 
Kollidon VA 64 showing signs of re-crystallization upon storage for 30 days. However, 
the amorphous cryo co-milled CAM mixtures with Kollidon VA 64 and Eudragit EPO re-
crystallized on storage for 7 days indicating that the milling temperature was important 
for stability. FT-IR of co-milled mixtures containing ≥ 60 wt% indicate the formation of 
carboxylate and ammonium salts involving acidic and basic functional groups of the drug 
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and amino groups of the polymer. Although, inter-molecular interactions of H-bonding 
nature were noticeable in co-milled mixtures with Kollidon VA 64, they were not strong 
enough to stabilize the milled amorphous form of CAM. The DSC thermograms of co-
milled mixtures containing more than 50 wt% Eudragit EPO showed the presence of a 
single Tg between those of drug and polymer. A stable amorphous form of CAM could 
also be achieved in 30-min co-milled mixtures containing 80 wt% Eudragit EPO. 
Additionally, ideal mixing behavior (as per Gordon Taylor plot) in co-milled mixtures 
containing ≥ 60 wt% Eudragit EPO suggest that ionic interactions with Eudragit EPO 
(indicated by FT-IR studies) helped to form a stable amorphous miscible system of co-
milled CAM.  
Crystalline CAM charged negatively with the stainless steel of the vessel. A reversal 
in charge polarity and a change in magnitude of balance surface electrostatic charge were 
noted on ball milling and cryomilling of CAM. Changes in material properties such as 
particle size, surface area or moisture content did not explain the reversal in polarity or 
change in balance of surface electrostatic charge of milled CAM. However, the surface 
acid-base parameters determined by IGC indicate a change from acidic to basic surface 
on milling which could be correlated to reversal in polarity from negative to positive 
charging of milled CAM. Dispersive surface energy of milled CAM samples did not 
reflect changes in surface electrostatic charges. Amorphous milled CAM samples re-
crystallized on storage under accelerated storage conditions (40°C/75%RH) for 7 days. 
An increase in the magnitude of surface electrostatic charge along with a reversion from 
basic to acidic surface was noted on electrostatic charge measurements and IGC analysis 
of stored CAM samples. On the other hand, IGC analyses of stable amorphous co-milled 
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mixtures containing greater than 60 wt% Eudragit EPO indicated that co-milling was 
effective in increasing the basicity of CAM surface which aided in reducing the 
magnitude of surface electrostatic charge in comparison to physically blended and stored 
milled CAM samples. A correlation could be found between electrostatic charge and 
KD/KA ratios of milled and co-milled CAM except for re-crystallized CAM sample. The 
probable exposure of basic functional groups and KD/KA parameter ratio values (from 
IGC) could explain the positive charging and lack of reversal in polarity of re-crystallized 
CAM sample.   
Formation of crystalline co-milled mixtures of IB with MgSt did lower the 
triboelectrification of ball-milled IB. However, it was higher in comparison to physical 
mixture. Crystalline physical or co-milled IB-collodial SiO2 mixtures showed an increase 
in triboelectrification of IB.  
Thus, the findings of this study indicate that preparing stable amorphous mixtures or 
amorphous dispersions of milled and unstable charged APIs (using CAM and IB as 
model compounds) by co-milling with suitable additives could be more effective in 
minimizing the surface electrostatic charge than co-milling with additives which do not 
alter the crystalline surfaces. 
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CHAPTER 6 
CONCLUSIONS AND FUTURE WORK 
Milling is a commonly employed operation in the pharmaceutical and other related 
industries. However, the instability of the milled surfaces limits the application of this 
unit operation especially in size reduction of APIs, and subsequent formulation of a stable 
product with the desired in vivo bioavailability. Co-milling with suitable excipients has 
been carried out in mitigating or stabilizing amorphous forms as well as improving the 
processability of electrostatically charged APIs with the following results. 
6.1 Conclusions 
6.1.1 Co-milling with Crystalline Excipients Mitigated Amorphization of Milled API 
Our work demonstrated that crystalline excipients at certain drug-excipient ratios 
minimized amorphization of salbutamol sulphate (SS) below detectable limits on co-
milling. Factors such as milling time, temperature rise (>Tg) or crystal seeds of excipients 
were found to contribute to the minimization of amorphous form on co-milling.. The 
crystalline form of SS obtained on co-milling with lactose (LAC) or magnesium stearate 
(MgSt) remained stable and did not re-crystallize upon 7-day storage under elevated 
humidity conditions.  
6.1.2 Co-milling with Amorphous Excipient Stabilized Milling-induced 
Amorphization of API  
Our work demonstrated that milling-induced amorphization of SS could be stabilized 
by co-milling with an amorphous excipient, at least 80 wt% polyvinyl pyrrolidone (PVP), 
for a period of 7 days under elevated humidity conditions. Hydrogen bonding between 
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functional groups of SS and PVP contributed to the formation of stable and homogeneous 
amorphous dispersion as supported by RM analysis.  
6.1.3 Co-milling with Amorphous Ionic Polymer Produced Amorphous Dispersion 
of API  
Our work demonstrated that a stable amorphous dispersion of Clarithromycin (CAM) 
could be prepared on co-milling with atleast 60 wt% of an ionic polymer, Eudragit EPO... 
FT-IR analysis indicated that ionic interactions between CAM and Eudragit EPO 
contributed to the stability of the co-milled amorphous form of CAM. The stabilization of 
amorphous form in co-milled mixtures was further supported by no alteration in Tg of 
CAM in co-milled mixtures stored under accelerated conditions for 90 days.  
6.1.4 Co-milling Produced Physically Stable Amorphous Mixture with Reduced 
Triboelectrification of API 
Our work demonstrated that co-milling produced amorphous stable mixtures with 
reduced triboelectrification of a readily chargeable API, CAM, in comparison to the 
milled CAM. In addition, co-milling of crystalline mixtures reduced triboelectrification 
of readily chargeable API, Ibuprofen (IB) to a lesser extent than physical mixing. IGC 
studies of re-crystallized CAM surface indicated an increase in magnitude of electrostatic 
charge, a change in surface from base to acid, but with no reversal in surface polarity. On 
the other hand, stable co-milled mixture of CAM with Eudragit EPO increased the 
triboelectrification of CAM. However, the increase in triboelectrification was lesser than 
that of physical mixtures and re-crystallized ball-milled CAM sample. In addition, IGC 
analyses showed that an increase in surface basicity of co-milled CAM aided in reducing 
the surface electrostatic charge in comparison to re-crystallized CAM sample. Crystalline 
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co-milled mixtures of IB with MgSt did reduce triboelectrification of milled IB  and those 
with  colloidal SiO2 were higher charged than milled IB.  
6.2 Future Work  
6.2.1 Study the Change in Triboelectrification of Stable Amorphous Co-milled 
Mixtures of IB  
The influence of acid-base properties of the surface on the charging behavior of the 
milled pharmaceutical active, CAM was reported. Co-milling of IB with polymers or 
suitable additives will be attempted in order to prepare stable amorphous co-milled 
mixtures. In comparison, co-milling of CAM with MgSt or colloidal SiO2 will be carried 
out to prepare crystalline co-milled mixtures. The electrostatic charge measurements and 
estimation of dispersive or polar surface energies and acid-base parameters of co-milled 
mixtures will be carried out. The studies explore the feasibility of preparing amorphous 
co-milled mixtures over crystalline co-milled mixtures to reduce the triboelectrification 
of APIs. 
6.2.2 Study the Change in Triboelectrification of Wet Milling API with Polymers 
Coating, a common unit operation in the pharmaceutical industry, could create an 
interparticulate barrier in cohesive powders that reduces the electrostatic interactions 
while improving the flow and packing properties of powder. The particle thin-coating of 
IB have been attempted using an ultrasound assisted system with a HPMC polymer 
solution (Genina et al., 2010). A significant improvement in flow properties was 
observed in HPMC thin-coated IB powder. This was attributed to the change of the 
superficial structure of the untreated raw IB to a flat and smooth surface IB as elucidated 
by the ultrasound technique. In addition, the method was found to be insensitive to batch 
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size and environmental conditions. It is suitable for processes such as granulation of 
highly charged material. The use of HPMC solution of similar or lower concentration in a 
wet milling process to reduce triboelectrification of APIs, such as IB, could be explored. 
6.2.3 Dissolution Studies of Stable Amorphous Co-milled CAM-EPO Mixtures  
CAM has good oral bioavailability along with excellent tissue penetration allowing 
for once or twice daily dosing (McCarty, 2000). However, a drug with low water 
solubility in a very soluble and stable amorphous formulation could further reduce the 
oral dose of the drug (250 - 500 mg). CAM, marketed by Abbott Laboratories, has a 
dissolution limit of not less than 80 wt% of drug released with the standard dissolution 
assay. A comparison of generic with Abbott CAM products showed that drug dissolution 
as well as limits of impurities of generic products were less ideal (Nightingale, 2005). A 
dissolution study of prepared amorphous CAM-EPO mixtures and the impurity levels 
may result in an improved low-dose formulation containing a co-milled CAM-EPO 
mixture.  
6.2.4 Use of Other Ionic Polymers for Co-milling with APIs 
Acrylic polymers such as Eudragit RS100 and Eudragit RL 100 are acidic in nature and 
may interact with drugs containing carboxylic groups. The interactions are strong enough 
to alter the dissolution properties of the drug (Pignatello et al., 2002). Additionally, 
Eudragit L 100, an anionic polymer is capable of forming IPEC as Eudragit EPO 
(Moustafine et al., 2005). Co-milling of CAM with the aid of these polymers may 
identify ionic polymers which could form stable amorphous dispersions with CAM or 
drugs with similar characteristics.  
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6.3 Summary 
The findings of this thesis explored new applications of co-milling in formulating 
pharmaceutical products by:  
1) providing a new dimension to potential application of co-milling in handling the 
challenges of the unstable amorphous state of milled APIs and possibly other materials; 
2) demonstrating that a stable and homogenous amorphous dispersion of API can be 
obtained with the addition of sufficient amorphous excipient; 
3) indicating that drug-polymer ionic interactions can produce stable amorphous form of 
API on co-milling and for subsequent storage; 
4) demonstrating that stable amorphous co-milled mixtures with suitable additives were 
more effective in minimizing the surface electrostatic charge than co-milling with 
additives which do not alter the crystalline surfaces of charged APIs. 
These findings may contribute to the fields of formulation science and manufacturing 
of pharmaceutical, food, chemical and other products where size reduction of the 
ingredients and components is required.  
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